McGill University, Faculty of Medicine

Curriculum Vitae for Promotion and Tenure Consideration

Date of Last Revision: November 30, 2015

A. IDENTIFICATION Name: Brett D. Thombs, Ph.D. Address: Jewish General Hospital, 4333 Cote Ste. Catherine Road, Montreal, QC, H3T 1E4 Telephone: (514) 340-8222 ext. 5112 E-mail: [email protected]

B. EDUCATION Post-doctoral fellowship, Clinical Health Psychology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Supervisor: Dr. James A. Fauerbach. 2004-2005. MA, PhD, Clinical Psychology, Fordham University, Bronx, New York, USA. Doctoral Thesis: Measurement invariance of the Childhood Trauma Questionnaire across gender and race/ethnicity: applications of structural equation modeling and item response theory. Supervisors: Dr. Charles Lewis and Dr. David P. Bernstein. 1999-2004. MA, Special Education, University of Arizona, Tucson, Arizona, USA. Supervisor: Dr. Aldine Von Isser.1994-1995 BA, Economics and the Honors Program in Mathematical Methods in the Social Sciences, Northwestern University, Evanston, Illinois, USA. Supervisor: Dr. Michael F. Dacey. 1985-1989.

C. APPOINTMENTS University Professor with Tenure, Department of Psychiatry, McGill University, Montreal, Quebec, Canada. 2015- present. Associate Professor with Tenure (early), Department of Psychiatry, McGill University, Montreal, Quebec, Canada. 2011-2015. Assistant Professor, Department of Psychiatry, McGill University, Montreal, Quebec, Canada. 2006- 2011. Associate Member, Department of Psychology, McGill University, Montreal, Quebec, Canada. 2013- present. Associate Member, Department of Educational and Counselling Psychology, McGill University, Montreal, Quebec, Canada. 2011-present. Associate Member, School of Nursing, McGill University, Montreal, Quebec, Canada. 2011-present. Associate Member, Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada. 2009-present. Associate Member, Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada. 2008-present.

Brett D. Thombs, PhD: Curriculum Vitae 1 of 55 Instructor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 2005-2006. Hospital Senior Investigator, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada. 2011-present. Investigator, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada. 2006-2011.

D. SPECIAL HONORS, AWARDS, RECOGNITION - Principal’s Prize for Outstanding Emerging Researchers (Inaugural Recipient), McGill University. Awarded to a faculty member up to 10 years beyond highest degree distinguished for exceptional contributions to research. 2014. - Bill Silverman Prize, Cochrane Collaboration (for Roseman et al., BMJ 2012;345:e5155). Awarded to authors of a high-quality publication that constructively criticizes the work of Cochrane and will positively impact the scientific quality, relevance, and use of Cochrane Reviews. 2013. - Investigator Salary Award (2013 – 2017). The Arthritis Society. Recognizes an investigator up to 10 years into career with outstanding contributions and demonstrated leadership in arthritis research. 2013. - Research Award. Academy of Psychosomatic Medicine. Awarded to an investigator with record of exceptional clinical research on psychopathology in the medically ill. 2013. - Distinguished Scholar Award. Association of Rheumatology Health Professionals. Awarded to a scholar with exceptional achievements in activities pertinent to arthritis and the rheumatic diseases. 2013. - Research Scholar Award, Junior 2. Fonds de la Recherche en Santé Quebec (2013 – 2015; declined). For investigators with 4 to 7 years since first academic appointment. 2013. - Paper of the Month. Lady Davis Institute for Medical Research, Jewish General Hospital (for Roseman et al., BMJ 2012;345:e5155). 2012. - William Dawson Scholar Award. McGill University (2012 – 2017). For a scholar developing into an outstanding and original researcher of world-class caliber who is poised to become a leader in his or her field, Equivalent to Tier II Canada Research Chair. 2012. - Award for Excellence in Clinical Research. Jewish General Hospital. Presented to a researcher whose insights and initiatives have resulted in unique and significant contribution to patient treatment and care. 2010. - Early Career Award. Canadian Psychological Association, Health Psychology Section. Awarded to an individual within 10 years of doctoral degree who has made a significant contribution to the field of health psychology. 2010. - Partnership Award. Canadian Institutes of Health Research, to Canadian Scleroderma Research Group and Scleroderma Society of Canada ($25,000). To recognized a partnership that exemplifies excellence. 2009. - Finalist (top 8)– Research Paper of the Year. BMJ Group Awards (for Thombs et al., JAMA, 2008;300:2161-2171). Recognizes original research with the potential to contribute significantly to improving health and health care. 2009. - President’s New Researcher Award. Canadian Psychological Association. Recognizes the exceptional quality of the contribution of new researchers to psychological knowledge in Canada. 2009.

Brett D. Thombs, PhD: Curriculum Vitae 2 of 55 - Investigator Award. Rheumatology Research Foundation. To support exceptional early- to mid-career investigators. 2009. - Research Scholar Award Junior 1. Fonds de la Recherche en Santé Quebec, (2008 – 2012; declined). For investigators with 0 to 3 years since first academic appointment. 2008. - New Investigator Salary Award. Canadian Institutes of Health Research (2008 – 2013). For outstanding new investigators. 2008. - Carolyn Thomas Award. Arthritis Health Professionals Association. For Best Scientific Abstract, 2008 Canadian Rheumatology Association Annual Meeting. 2008. - Outstanding Dissertation Award. Fordham University, Department of Psychology. 2004. - Student Travel Award. American Psychological Association. 2001, 2002. - Bennett Prestigious Fellowship. Fordham University, Graduate School of Arts and Sciences. 1999- 2003. - Merit-Based Tuition Scholarship. University of Arizona, Department of Special Education. 1994-1995. - Graduated with “Highest Distinction,” Departmental Honours. Northwestern University. 1989. - President, Mortar Board Senior Honorary Society. Northwestern University. 1988-1989. - Phi Beta Kappa Honor Society. Northwestern University. 1988.

E. TEACHING E.1. McGill University Courses - Diploma Course in Psychiatry, lecture (Meta-analysis in psychiatry) 2.5 class hours, 2012-present. - NUR2-515 Applied Statistics for Nursing, Coordinator/Instructor, 39 class hours, 2008-present. - PSYT-713 Psychiatric Epidemiology, 2 lectures (Reliability, validity, and evaluation of diagnostic instruments; Systematic reviews and meta-analyses, 4 class hours, 2008-present. - EPIB-628 Measurement in Epidemiology, lecture (Measurement equivalence and differential item functioning in epidemiological research), 2 class hours, 2008 – present. - EPIB-619 Systematic Reviews and Meta-Analyses, lecture (Reporting of Conflicts of Interest in Meta- analyses of Trials of Pharmacological Treatments, 2011; Systematic Reviews of Observational Studies, 2012-present), 1.5 class hours, 2011 – present. - EPIB-677 Knowledge Synthesis, lecture (Systematic Reviews of Observational Studies), 1.5 class hours, 2013 – present. - EDPC-677 Internship Research Seminar: Quantitative Studies, lecture (Systematic reviews and meta- analyses), 2 class hours, 2013 – present. - EPIB-600 Clinical Epidemiology, lecture (Reporting of Conflicts of Interest in Meta-analyses and Systematic Reviews), 1.5 class hours, 2012. - PSYC-729 Theory of Assessment, lecture (Issues in testing individuals from diverse populations), 2 class hours, 2008 – 2010. - PSYC-305 Psychological Statistics, Course coordinator/Instructor, 39 class hours, 2008 – 2009. - Quantitative Methods for Cross-Cultural Research, Summer Program in Social and Cultural Psychiatry, Workshop Co-Coordinator/Instructor, 15 class hours, 2007 – 2009.

E.2. Other University Courses - PSMU-2030 Introduction to Research Methods and Statistics (Part II), Department of Psychology, Marymount College of Fordham University, Tarrytown, NY, USA, Coordinator/Instructor, 45 class hours, 2004.

Brett D. Thombs, PhD: Curriculum Vitae 3 of 55 - PSMU-2020 Introduction to Research Methods and Statistics (Part II), Department of Psychology, Marymount College of Fordham University, Tarrytown, NY, USA, Coordinator/Instructor, 45 class hours, 2003. - PSRU-2000 Statistics, Department of Psychology, Fordham University, New York, NY, USA, Coordinator/Instructor, 45 class hours, 2003. - PSRU-3600 Multicultural Issues, Department of Psychology, Fordham University, New York, NY, USA, Coordinator/Instructor, 45 class hours, 2003. - PSRU-3200 Psychological Testing, Department of Psychology, Fordham University, New York, NY, USA, Coordinator/Instructor, 45 class hours, 2002.

E.3. Clinical Instruction - Supervision in cognitive-behavioural therapy, PGY3 residents in psychiatry, Anxiety Disorders Clinic, Johns Hopkins Hospital (3-4 hours weekly), 2004-2006.

E.4. Supervision of McGill University Students (with Awards) E.4.1. Postdoctoral Fellows - Kwakkenbos, Linda. 2012-present. • CIHR Banting Postdoctoral Fellowship Award (2015-2017; $70,000 per year). • European League Against Rheumatism Abstract Award (2015; €1000). • CIHR Institute of Musculoskeletal Health and Arthritis Travel Award (2013; $1,000). • FRSQ Bourse de Formation Postdoctorale (2013-2015; $30,000 per year). • Nationale Vereniging voor Lupus, APS, Sclerodermie en MCTD (Dutch patient organization for systemic autoimmune diseases) Award for Young Investigators in Systemic Sclerosis (2013; €2500). - El-Baalbaki, Ghassan. 2009-2010. Currently, Assistant Professor, Department of Psychology, Université du Québec à Montréal. • CIHR Institute of Musculoskeletal Health and Arthritis Travel Award (2010; $1,000). - Ruiz Casares, Monica. 2007-2008. Co-supervisor with Dr. Cécile Rousseau. Currently Assistant Professor, Department of Psychiatry, McGill University. - Benoit, Maryse. 2007-2008. Co-supervisor with Dr. Cécile Rousseau. Currently Assistant Professor, Department of Psychology, Sherbrooke University.

E.4.2. Doctoral Students - Rice, Danielle. 2015-present. Department of Psychology (Clinical). • FRSQ Bourse de Formation – Formation de maîtrise (2015-2017; $15,000 per year). - Levis, Brooke. 2014-present. Department of Epidemiology, Biostatistics, and Occupational Health. • FRSQ Bourse de Formation – Formation de doctorat (2014-2017; $20,000 per year). • GREAT Travel Award, McGill University (2015; $975). • Best Oral Presentation - PhD Category. McGill Epidemiology, Biostatistics and Occupational Health 11th Annual Student Research Day (2015; $100). • Emerging Leaders in Assessment Award, American Psychological Association Divisions 5 (Quantitative and Qualitative Methods), 12 (Society for Clinical Psychology), and 40 (Society for Clinical Neuropsychology) and the Association of Test Publishers (2015; $250). • Student Travel Award, Lady Davis Institute for Medical Research, Jewish General Hospital (2015; $1,000). - Coroiu, Adina. 2013-present. Co-supervisor with Dr. Annett Koerner. Department of Educational and Counseling Psychology. • Graduate Excellence Fellowship, Faculty of Education, McGill University (2013; $7,500). • FRSQ Bourse de Formation – Formation de maîtrise (2012-2014; $15,000 per year).

Brett D. Thombs, PhD: Curriculum Vitae 4 of 55 • Psychosocial Oncology Research Training Doctoral Fellowship, CIHR (2013-2016; $6,000 per year). • FRSQ Bourse de Formation – Formation de doctorat (2014 – 2017; $20,000 per year). • GREAT Travel Award, McGill University (2014; $280). • Graduate Research Mobility Award, McGill University (2014; $1,900). • CIHR Doctoral Research Award (2015-2018; $30,000 per year + $5,000 per year research allowance). - Delisle, Vanessa. 2011-present. Department of Educational and Counseling Psychology. • Rare Disease Foundation. Microgrant Program. Illuminating the scleroderma support group experience through qualitative interviews (2015; $3,420). • FRSQ Bourse de Formation – Formation de maîtrise (2011-2013; $15,000 per year). • CIHR Doctoral Research Award (2013-2016; $30,000 per year + $5,000 per year research allowance). • FRSQ Bourse de Formation – Formation de doctorat (2013 – 2016; $20,000 per year; declined). • American College of Rheumatology Research and Education Foundation / Abbott Health Professional Graduate Student Preceptorship (2014, $3,500). - Milette, Katherine. 2012-present. Department of Educational and Counseling Psychology. • FRSQ Bourse de Formation – Formation de doctorat (2015-2018; $20,000 per year). • Association of Rheumatology Health Professionals Graduate Student Recognition Award (2013; $500). • Graduate Excellence Fellowship, Faculty of Education, McGill University (2012, $6,000). • CIHR Doctoral Research Award (2012-2015; $30,000 per year + $5,000 per year research allowance). • FRSQ Bourse de Formation – Formation de doctorat (2012-2015; $20,000 per year; declined). • American College of Rheumatology Research and Education Foundation / Abbott Health Professional Graduate Student Preceptorship (2012, $3,500). - Jewett, Lisa. 2012-present. Department of Educational and Counseling Psychology. • Rare Disease Foundation. Microgrant Program. Testing the Feasibility of the Changing Faces Practitioner Training Program for Scleroderma Patients (2014; $3,500). • FRSQ Bourse de Formation-Formation de doctorat (2012-2015; $20,000 per year; accepted 1 year). • The Arthritis Society/Canadian Arthritis Network Graduate PhD Student Award (2012-2015; $10,500 per year; declined). • CIHR Institute of Musculoskeletal Health and Arthritis Travel Award (2013; $1,000). • CIHR Doctoral Research Award (2013-2016; $30,000 per year + $5,000 per year research allowance). • CIHR Canada Graduate Scholarships – Michael Smith Foreign Study Supplement. 3-month research internship to study body image concerns at the University of the West of England, UK with Drs. Nichola Rumsey and Diana Harcourt (2014; $5,987). • American College of Rheumatology Research and Education Foundation / Abbott Health Professional Graduate Student Preceptorship (2014, $3,500). - Razykov, Ilya. 2013-2015. Department of Educational and Counseling Psychology. Withdrew due to medical illness. • Graduate Excellence Fellowship, Faculty of Education, McGill University (2013; $7,500). • CIHR Doctoral Research Award (2013-2016; $30,000 per year + $5,000 per year research allowance). • FRSQ Bourse de Formation – Formation de doctorat (2013-2016; $20,000 per year; declined). - Meijer, Anna. 2007-2012. Co-supervisor with Dr. Peter de Jonge. Interdisciplinary Center for Psychiatric Epidemiology, University Medical Center Groningen/University of Groningen, The Netherlands.

E.4.3. Master’s Students

Brett D. Thombs, PhD: Curriculum Vitae 5 of 55 - Azar, Marleine. 2015-present. Department of Epidemiology, Biostatistics, and Occupational Health. • CIHR. Frederick Banting and Charles Best Canadian Graduate Scholarships – Master’s Award (2015-2016; $17,500). - Gumuchian, Stephanie. 2015-present. Department of Psychiatry. • CIHR. Frederick Banting and Charles Best Canadian Graduate Scholarships – Master’s Award (2015-2016; $17,500). • FRSQ Bourse de Formation – Formation de maîtrise (2015-2017; $15,000 per year; accepted for 2016-2017). • GREAT Travel Award, McGill University (2014; $700). - Rice, Danielle. 2014-2015. Department of Psychiatry. • CIHR. Frederick Banting and Charles Best Canadian Graduate Scholarships – Master’s Award (2014-2015; $17,500). • FRSQ Bourse de Formation – Formation de maîtrise (2015-2017; $15,000 per year). - Coronado-Montoya, Stephanie. 2013-2015. Department of Psychiatry. • FRSQ Bourse de Formation – Formation de maîtrise (2014-2016; $15,000 per year). • CIHR Frederick Banting and Charles Best Canadian Graduate Scholarships – Master’s Award (2013-2014; $17,500). • Graduate Excellence Entry Award, Faculty of Medicine, McGill University (2013; $1,000). • 2014 Cochrane Canada Symposia Graduate Student Poster Award (1st prize). - Levis, Brooke. 2012-2014. Department of Epidemiology, Biostatistics, and Occupational Health. Currently, supervised PhD student. • CIHR Frederick Banting and Charles Best Canadian Graduate Scholarships – Master’s Award (2013-2014; $17,500). • FRSQ Bourse de Formation – Formation de maîtrise (2012 – 2014; $15,000 per year). • Association of Rheumatology Health Professionals Graduate Student Recognition Award (2012; $500). - Razykov, Ilya. 2011-2013. Department of Psychiatry. Currently, supervised PhD student. • Canadian Scleroderma Research Group Studentship (2011-2013; $17,500 per year, CIHR Strategic Training Initiative in Health Research grant, PI: M Baron). • Alexander McFee Fellowship, McGill University Faculty of Medicine (2011-2012, $10,000). • American College of Rheumatology Research and Education Foundation / Abbott Health Professional Graduate Student Preceptorship (2011, $3,500). - Delisle, Vanessa. 2010-2011. Department of Psychiatry. Currently, supervised PhD student. • CIHR Frederick Banting and Charles Best Canadian Graduate Scholarships – Master’s Award (2010-2011; $17,500). - Milette, Katherine. 2010-2012. Department of Educational and Counseling Psychology. Currently, supervised PhD student. • Maysie McSporran Graduate Studentship, Faculty of Medicine, McGill University (2011; $2,500) • CIBC Fellowship, Faculty of Education, McGill University (2011; $2,500). • Graduate Studies Fellowship, Faculty of Education, McGill University (2011; $5000) • CIHR Canada Graduate Scholarships – Michael Smith Foreign Study Supplement. 3-month research internship to study depression screening in cardiovascular care settings at the University of Groningen, the Netherlands with Dr. Peter de Jonge (2011; $6,000). • CIHR Institute of Musculoskeletal Health and Arthritis Travel Awards (2010, 2011; $1,000). • CIHR Frederick Banting and Charles Best Canadian Graduate Scholarships – Master’s Award (2010; $17,500). • Canadian Scleroderma Research Group Studentship (2010-2012; $8,925 per year, CIHR Strategic Training Initiative in Health Research grant, PI: M Baron).

Brett D. Thombs, PhD: Curriculum Vitae 6 of 55 • FRSQ Bourse de Formation – Formation de maîtrise (2010-2012; $15,000 per year, delayed 1st year). • McGill Provost’s Graduate Fellowship, Faculty of Education, McGill University (2010; $1,500). - Roseman, Michelle. 2010-2012. Department of Psychiatry, Currently, Doctor of Medicine and Master of Surgery program, McGill University. • CIHR Frederick Banting and Charles Best Canadian Graduate Scholarships – Master’s Award (2010-2011; $17,500). • FRSQ Bourse de Formation – Formation de maîtrise (2010-2012; $15,000 per year). • Birmingham – Dennis Award (2011; $1,000) – Top presentation at Student Research Day for a graduate student, Department of Psychiatry, McGill University. • CIHR Institute of Health Services and Research Policy Travel Award (2011; $1,500). • McGill MedStar Award for excellent research carried out in the McGill Faculty of Medicine (2012; $1,000). • FRQS, Étudiants-chercheurs étoiles du mois (March 2012; $1,000). - Ma, Denise. 2009-2011. Co-supervisor with Dr. David Dunkley. Department of Psychiatry. Currently, PhD program in clinical psychiatry, Concordia University. • SSHRC. Joseph-Armand Bombardier Canada Graduate Scholarships Program – Master’s Scholarship (2010-2011; $17,500). - Jewett, Lisa. 2009-2011. Department of Psychiatry. Currently, supervised PhD student. • CIHR Frederick Banting and Charles Best Canadian Graduate Scholarships – Master’s Award (2009-2010; $17,500). • FRSQ Bourse de Formation – Formation de maîtrise (2009 – 2011; $15,000). • Canadian Scleroderma Research Group Studentship (2009 – 2011; $8,925, CIHR Strategic Training Initiative in Health Research grant, PI: M Baron). • FRSQ Programme de Formation de maîtrise ou de doctorat – Stages internationaux. 3-month research internship to study and research couples relationships in chronic illness at the University of Groningen, the Netherlands with Dr. Mariet Hagedoorn (2009; $7,500). • Association of Rheumatology Health Professionals Graduate Student Recognition Award (2010; $500). • CIHR Institute of Musculoskeletal Health and Arthritis Travel Award (2011; $1,000). - Knafo, Ruby. 2009-2011. Department of Psychiatry. Currently, graduate program in occupational therapy, University of Toronto. • CIHR Frederick Banting and Charles Best Canadian Graduate Scholarships – Master’s Award (2009-2010; $17,500). • FRSQ Bourse de Formation – Formation de maîtrise (2009 – 2011; $15,000). • Canadian Scleroderma Research Group Studentship (2009 – 2011; $8,925, CIHR Strategic Training Initiative in Health Research grant, PI: M Baron). • FRSQ Programme de Formation de maîtrise ou de doctorat – Stages internationaux. 3-month research internship to study and research couples relationships in chronic illness at the University of Groningen, the Netherlands with Dr. Mariet Hagedoorn (2009; $7,500). • Association of Rheumatology Health Professionals Graduate Student Recognition Award (2009; $500). - Zhao, Yue. 2008-2010. Department of Psychiatry. Currently, PhD program in clinical psychology, Concordia University. • FRSC – Bourse de maîtrise en recherché (2009-2010; $15,000). • SSHRC. Joseph-Armand Bombardier Canada Graduate Scholarships Program – Master’s Scholarship (2008-2009; $17,500). • FRSQ – Programme de Formation de maîtrise ou de doctorat – Stages internationaux. 3-month research internship to study expression of psychological symptoms at Xiangya Hospital, an affiliated hospital of Central South University, Changsha, China with Dr. Zhu Xiongzhao (2010; $7,500).

Brett D. Thombs, PhD: Curriculum Vitae 7 of 55 - Newton, Evan. 2008-2010. Department of Psychiatry, 2008-2010. Currently, research coordinator. • Canadian Scleroderma Research Group Studentship (2008-2010; $8,925, CIHR Strategic Training Initiative in Health Research grant, PI: M Baron). - Adeponle, Ademola. 2007-2010. Co-supervisor with Dr. Laurence Kirmayer. Department of Psychiatry, Currently PhD student, Department of Psychiatry, McGill University. • Culture and Mental Health Services Studentship (2007-2010; $17,500, CIHR Strategic Training Initiative in Health Research grant, PI: L Kirmayer). - Nath, Yogini. 2007-2009. Co-supervisor with Dr. Laurence Kirmayer. Department of Psychiatry, Currently PhD student, Department of Educational and Counselling Psychology, McGill University. • Culture and Mental Health Services Studentship (2007-2009; $17,500, CIHR Strategic Training Initiative in Health Research grant, PI: L Kirmayer). - Schieir, Orit. 2007-2009. Department of Epidemiology, Biostatistics, and Occupational Health. Currently, PhD program, epidemiology, University of Toronto. • FRSQ Bourse de Formation – Formation de maîtrise (2008 -2009; $15,000). • CIHR Frederick Banting and Charles Best Canadian Graduate Scholarships – Master’s Award (2007-2008; $17,500). • Canadian Scleroderma Research Group Studentship (2007-2009; $8,925, CIHR Strategic Training Initiative in Health Research grant, PI: M Baron). • Association of Rheumatology Health Professionals Graduate Student Recognition Award (2008; $500).

E.4.4. McGill University Medical Student Research - Roseman, Michelle. 2013-present. • Mach-Gaensslen Foundation of Canada Student Grant, Summer 2013, ($3,125). • Murray R. Stalker Primary Care Research Bursary, Fall 2013 ($2,000).

E.4.5. Undergraduate Thesis and Summer Students - Azar, Marleine. 2015. Department of Psychology (thesis, summer student). • McGill University Faculty of Science Undergraduate Research Award, 2015 ($5,600). - Riehm, Kira. 2014, 2015. Department of Psychology (thesis, summer student). • CIHR Institute of Musculoskeletal Health and Arthritis, Studentship in Mobility, Musculoskeletal, Health and Arthritis, 2015 ($5,000). - Levis, Alexander. 2013-2015. Department of Pharmacology (summer student). • CIHR Institute of Musculoskeletal Health and Arthritis, Studentship in Mobility, Musculoskeletal, Health and Arthritis, 2014, 2015 ($5,000 per year). - Lallitto, Bianca. 2013-2014. Department of Psychology (thesis). - Syamchandra, Achyuth. 2012. Department of Psychology (summer student). • Canadian Scleroderma Research Group Summer Studentship, 2012 ($3,950; CIHR Strategic Training Initiative in Health Research grant, PI: M Baron). - Lober, Janie. 2009-2010. Department of Psychology (thesis). - Levis, Brooke. 2010-2011. Department of Psychology (thesis). • CIHR Institute of Musculoskeletal Health and Arthritis, Studentship in Mobility, Musculoskeletal, Oral, and Skin Health and Arthritis Across the Lifespan, 2010, 2011 ($4,950 per year). • Canadian Scleroderma Research Group Summer Studentship, 2010, 2011 (declined; CIHR Strategic Training Initiative in Health Research grant, PI: M Baron). • CIHR Institute of Musculoskeletal Health and Arthritis Travel Award (2011; $1,000). - Razykov, Ilya. 2008-2011. Department of Psychology (thesis x 2).

Brett D. Thombs, PhD: Curriculum Vitae 8 of 55 • CIHR Institute of Musculoskeletal Health and Arthritis Travel Award (2010; $1,000). • CIHR Institute of Musculoskeletal Health and Arthritis, Studentship in Mobility, Musculoskeletal, Oral, and Skin Health and Arthritis Across the Lifespan, 2009, 2010 ($4,950 per year). • Canadian Scleroderma Research Group Summer Studentship, 2009, 2010 (declined; CIHR Strategic Training Initiative in Health Research grant, PI: M Baron). - Bassel, Marielle. 2007. Department of Psychology (summer student). • Canadian Scleroderma Research Group Summer Studentship, 2007. (CIHR Strategic Training Initiative in Health Research grant, PI: M Baron). - Fuss, Samantha. 2006-2008. Department of Psychology (thesis x 2).

E.4.6. Doctoral and Master’s Dissertation Committees - Federico, Carole. 2015-present. PhD candidate. Department of Experimental Medicine, McGill University (committee member; supervisor, Dr. Jonathan Kimmelman). - Schartzman, Deborah. 2013-present. PhD candidate. Department of Educational and Counseling Psychology, McGill University (committee member; supervisor, Dr. Martin Drapeau). - Brosseau, Danielle. 2010-present. PhD candidate. Department of Educational and Counseling Psychology, McGill University (committee member; supervisor, Dr. Annett Koerner). - Nath, Yogini. 2010-present. PhD candidate. Department of Educational and Counseling Psychology, McGill University (committee member; supervisors, Drs. Nancy Heath and Laurence Kirmayer). - Gariepy, Genevieve. 2010-present. PhD candidate, Department of Epidemiology, Biostatistics, and Occupational Health, McGill University (committee member; supervisor, Dr. Norbert Schmitz). - Simoneau, Gabrielle. 2014-2015. MSc candidate, Department of Epidemiology, Biostatistics, and Occupational Health, McGill University (committee member; supervisor, Dr. Andrea Benedetti). - Graham, Eva. 2013-present. MSc candidate, Department of Epidemiology, Biostatistics, and Occupational Health, McGill University (committee member; supervisor, Dr. Norbert Schmitz). - Au, Bonnie. 2013-2014. MSc candidate, Department of Epidemiology, Biostatistics, and Occupational Health, McGill University (committee member; supervisor, Dr. Norbert Schmitz). - Farthing, Dasa. 2009-2011. MSc candidate, Department of Psychiatry, McGill University (committee member; supervisor, Dr. Anne Crocker). - Persson, Tonje. 2008-2010. MSc candidate, Department of Psychiatry, McGill University (committee member; supervisor, Dr. Cécile Rousseau). - Pierre, Andrena. 2006-2008. MSc candidate, Department of Psychiatry, McGill University (committee member; supervisor, Dr. Karl Looper).

E.4.7. External Examiner - Doctoral Dissertations and Master’s Theses - Powell, Guido. 2015. Masters Thesis – External Examiner. Department of Epidemiology, Biostatistics, and Occupational Health, McGill University (supervisors, Drs. Eric Latimer and Nancy Mayo). - Lipscombe, Carla. 2015. Masters Thesis – External Examiner. Department of Epidemiology, Biostatistics, and Occupational Health, McGill University (supervisor, Dr. Norbert Schmitz). - Singla, Daisy. 2015. Doctoral Dissertation Committee – External Examiner. Department of Psychology, McGill University (supervisor, Dr. Frances Aboud). - Clyde, Matthew. 2013. Masters Thesis – External Examiner. Department of Psychiatry, McGill University (supervisor, Dr. Norbert Schmitz).

Brett D. Thombs, PhD: Curriculum Vitae 9 of 55 - Kwakkenbos, Linda. 2012. Doctoral Examination Board. Radboud University Nijmegen, Nijmegen, The Netherlands (supervisors Drs. Eni S. Becker, Cornelia H.M. van den Ende, and Frank van den Hoogen).

E.5. Invited Talks E.5.1. International Scientific Community 1. Challenges in rare disease research. iSPIN: Combining Forces. Vrije Universiteit, Amsterdam, the Netherlands, October 2, 2015. 2. Improving behavioral science research through identifying and reducing the impact of reporting biases. Radboud University, Behavioral Science Institute, Nijmegen, the Netherlands, June 15, 2015. 3. Empirically supported therapies: Time for a 20-year tune-up. Association of Psychological Science 2015 Annual Convention, New York, New York, May 21-25, 2015. 4. The cmRCT design in a rare disease context: The Scleroderma Patient-centered Intervention Network. Trials within Cohorts Symposium, London School of Hygiene & Tropical Medicine, November 10-11, 2014. 5. A hydrid cohort-trial design for internet-based outcome data collection: The Scleroderma Patient- centered Intervention Network. Lupus 2014, Quebec City, Quebec, Canada, September 2014. 6. Leveraging an innovative trial design for a rare disease context: The cohort multiple RCT (cmRCT) design. In symposium (Geenen R and Redmond A, Chairs). The Scleroderma Patient-centered Intervention Network (SPIN): Meeting the challenges of research into a rare disease. European League Against Rheumatism Congress 2014, Paris, France, June 14, 2014. 7. Coping with the emotional aspects of living with scleroderma. 3rd Systemic Sclerosis World Congress, Patient Congress. Rome, Italy. February 8, 2014. 8. The Scleroderma Patient-centered Intervention Network (SPIN). Spanish Society for Rheumatology, Madrid, Spain. November 21, 2013. 9. The Scleroderma Patient-centered Intervention Network (SPIN): an international partnership to develop, test, and deliver psychosocial, educational, and rehabilitation interventions. Annual Meeting of the Groupe Francophone de Recherche sur la Sclérodermie, Paris, France. November 20, 2013. 10. Improving depression care in medical settings: is screening the answer? Research Award Plenary Lecture, Academy of Psychosomatic Medicine, 60th Annual Meeting. Tucson, Arizona, USA. November 14, 2013. 11. The Scleroderma Patient-centered Intervention Network (SPIN): An international patient-researcher partnership. 2013 National Patient Education Conference, Scleroderma Foundation, Atlanta, Georgia, USA. July 27, 2013. 12. The Scleroderma Patient-centered Intervention Network (SPIN): an international partnership to develop, test, and deliver psychosocial and rehabilitation services. Mexican College of Rheumatology, National Institute of Medical Sciences and Nutrition, Mexico City, Mexico. July 3, 2013. 13. Improving depression care in medical settings: is screening the answer? Oregon Health & Science University, Department of Medicine Grand Rounds, Portland, Oregon, USA. April 30, 2013. 14. Systematic reviews and meta-analyses: a user’s guide. Oregon Health & Science University, Department of Psychiatry, Evidence-based psychiatry course, Portland, Oregon, USA. April 30, 2013. 15. Improving depression care in medical settings: is screening the answer? San Diego State University / University of California San Diego Joint Doctoral Program in Clinical Psychology, Department of Psychology, San Diego State University and Department of Psychiatry, University of California San Diego. San Diego, California, USA. April 29, 2013. 16. The Scleroderma Patient-centered Intervention Network (SPIN): an international partnership to develop, test, and deliver psychosocial and rehabilitation services in a rare disease context. Institut Cochin, Institute de Recherche biomédicale, Paris, France. January 18, 2013. 17. Rethinking depression screening: is there evidence to support current recommendations? VU University, Faculty of Psychology and Education, Amsterdam, The Netherlands. January 17, 2013. 18. The Scleroderma Patient-centered Intervention Network (SPIN): an international partnership to develop, test, and deliver psychosocial and rehabilitation services in a rare disease context. Radboud University Nijmegen, Institute of Behavioral Sciences, Nijmegen, The Netherlands. January 16, 2013.

Brett D. Thombs, PhD: Curriculum Vitae 10 of 55 19. Using mental health outcome measures in research and practice: considerations for individual- and population-level applications. Sint Maartenskliniek, Department of Rheumatology, Nijmegen, The Netherlands. January 15, 2013. 20. Using the cmRCT model in a rare disease context: the Scleroderma Patient-centered Intervention Network. Cohort Multiple Randomised Controlled Trial (cmRCT) Design Workshop. The University of Sheffield, School of Health and Related Research, Public Health Section, Sheffield, United Kingdom. July 6, 2012. 21. Rethinking depression screening: a look at the evidence. The University of York, Department of Health Sciences, York, United Kingdom. July 5, 2012. 22. Should physicians screen for depression? a look at the evidence. Department of Psychological Medicine, Peninsula College of Medicine and Dentistry, Universities of Exeter and Plymouth, Exeter, United Kingdom, July 2, 2012. 23. An overview of assessment research in the Canadian Scleroderma Research Group. In symposium (BD Thombs, Chair), Measure by measure: assessing psychological health and well-being in scleroderma. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting. Atlanta, Georgia, USA. November 2010. 24. Screening for depression in cardiac patients. In symposium (P de Jonge, Chair), Should we apply routine screening for depression? evidence against screening in several populations, XIII Annual Scientific Meeting, European Association for Consultation-Liaison Psychiatry and Psychosomatics/XXVIII European Conference on Psychosomatic Research. Innsbruck, Austria. July 2010. 25. Does depression screening benefit patients? should we expect benefits in the absence of evidence? Plenary Session, XIII Annual Scientific Meeting, European Association for Consultation-Liaison Psychiatry and Psychosomatics/XXVIII European Conference on Psychosomatic Research. Innsbruck, Austria. July 2010. 26. To screen or not to screen: depression screening in cardiovascular disease. American Psychosomatic Society, Psychosomatic Interest Groups 2010 Online Interactive Seminars. March 2010. 27. Improving health-related quality of life of patients with scleroderma. Scleroderma World Congress. Florence, Italy. February 2010. 28. Health and well-being in scleroderma: a behavioral health research and practice agenda. In symposium (BD Thombs, Chair), The psychology of improving health and well-being in scleroderma: Assessment and intervention approaches. American College of Rheumatology / Association for Rheumatology Health Professionals Annual Scientific Meeting. Philadelphia, Pennsylvania, USA. October 2009. 29. Will recommendations for depression screening benefit patients with cardiovascular disease? In invited session, Whooley MA (Chair), The pros and cons of depression screening in patients with coronary heart disease. American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference 2009. Washington, DC, USA. April 2009. 30. Depression screening and patient outcomes in cardiovascular care: a systematic review. Author in the RoomTM teleconference. JAMA and the Institute for Healthcare Improvement. December 2008. 31. Why cardiologists don’t care about depression: should they? University Medical Center Groningen, Department of Psychiatry, Interdisciplinary Center for Psychiatric Epidemiology, Groningen, Netherlands. September 2008.

E.5.2. National Scientific Community 1. When less may be more: Why depression screening may not be as good as advertised. The Hospital for Sick Children, Mental Health Grand Rounds. Toronto, Ontario, Canada. November 26, 2015. 2. Research 101. Scleroderma Society of Canada, 16th Annual National Scleroderma Conference. Hamilton, Ontario, Canada. September 19, 2015. 3. When less may be more: Why health screening isn’t always a good idea. McGill University Cutting Edge Lecture Series. Montreal, Quebec, Canada. March 12, 2015. 4. The Scleroderma Patient-centered Intervention Network. Scleroderma Society of Canada, 14th Annual Conference. Hamilton, Ontario, Canada. September 28, 2013.

Brett D. Thombs, PhD: Curriculum Vitae 11 of 55 5. How can direct patient collaboration increase relevance and value of research projects: the Scleroderma Patient-Centered Intervention Network. Canadian Organization for Rare Disorders 5th Rare Disease Day Conference. Toronto, Ontario, Canada. February 28, 2013. 6. Scleroderma Patient-centered Intervention Network (SPIN). Scleroderma Society of Canada, 13th Annual Conference. Vancouver, British Columbia, Canada. September 28, 2012. 7. “SPIN” – Managing depression and body image. Scleroderma Society of Canada, 13th Annual Conference. Vancouver, British Columbia, Canada. September 29, 2012. 8. Challenges in evaluating evidence on depression screening: the DEPRESSD Registry. Mental Health Commission of Canada, Systems Performance Initiative Project Team Meeting. Montreal, Quebec, Canada. September 26, 2012. 9. The Scleroderma Patient-centered Intervention Network. 43rd Laurentian Conference of Rheumatology. Mt. Tremblant, Quebec, Canada. May 11, 2012. 10. The Scleroderma Patient-centered Intervention Network. 2012 Rare Disease Day Conference: Innovations in Research, Therapies and Policy for Rare Disorders. Canadian Organization for Rare Disorders. Ottawa, Ontario, Canada. March 1, 2012. 11. The Scleroderma Patient-centered Intervention Network. 5th Annual Scientific Meeting of the Canadian Scleroderma Research Group. Quebec City, Quebec, Canada. October 2011. 12. New directions for patient-centered care in scleroderma: the Scleroderma Patient-centered Intervention Network. Tipping Point for Rare Disorders in Canada. Canadian Organization for Rare Disorders. Toronto, Ontario, Canada. September 2011. 13. Living well with scleroderma: a patient’s toolbox – self-management. Scleroderma Society of Canada Annual General Meeting. Halifax, Nova Scotia, Canada. November 2010. 14. Behavioral health in systemic sclerosis: a(nother) progress report. 3rd Annual Scientific Meeting of the Canadian Scleroderma Research Group. Winnipeg, Manitoba, Canada. October 2009. 15. Smoke screens: do recommendations for depression screening in cardiovascular care benefit patients? In Lee CM (Chair), Canadian Psychological Association President’s New Investigator Award Symposium. 2009 Canadian Psychological Association Convention, Montreal, Quebec, Canada. June 2009. 16. Psychological well-being in scleroderma: should rheumatologists care? Canadian Scleroderma Research Group Annual Clinical Researcher’s Meeting. Web conference. April 2009. 17. Detection, assessment, and treatment of mental health issues in the general healthcare setting. University of New Brunswick, Department of Psychology. Fredericton, New Brunswick, Canada. October 2008. 18. The Canadian Scleroderma Research Group – Scleroderma Society of Canada National Survey. Scleroderma Society of Canada Annual General Meeting. Ottawa, Ontario, Canada. September 2008 19. Behavioral health in systemic sclerosis: a progress report. 2nd Annual Scientific Meeting of the Canadian Scleroderma Research Group. Ottawa, Ontario, Canada. September 2008. 20. Patient reported outcome assessment in scleroderma: quality of life, depression, fatigue, pain, body image distress. Canadian Scleroderma Research Group Annual Clinical Researcher’s Meeting. Web conference. April 2008. 21. Things we know and things we need to know about living with scleroderma: developing collaborative approaches to improving quality of life. 1st Annual Scientific Meeting of the Canadian Scleroderma Research Group. Calgary, Alberta, Canada. September 2007. 22. Cultural sensitivity in screening for history of childhood abuse among adults. Western Washington University, Department of Psychology, Bellingham, Washington, USA. January 2006.

E.5.3. Local Scientific Community 1. A method for identifying journal-generated self-citation: Application to general medicine and psychiatry journals. McGill University, Faculty of Medicine, Department of Epidemiology, Biostatistics, and Occupational Health, 2015-2016 Seminar Series. Montreal, Quebec, Canada. November 2, 2015. 2. Identifying excessive rates of journal-generated self-citation: Application to general medicine, cardiology, and psychiatry journals. McGill University, Faculty of Medicine, Studies of Translation, Ethics, and Medicine (STREAM) Group, Montreal, Quebec, Canada. October 30, 2015.

Brett D. Thombs, PhD: Curriculum Vitae 12 of 55 3. Individual patient data meta-analyses to address reporting biases in studies of the diagnostic accuracy of depression screening tools. Jewish General Hospital, Lady Davis Institute for Medical Research, Centre for Clinical Epidemiology and Community Studies. Montreal, Quebec, Canada, January 20, 2015. 4. Individual patient data meta-analyses: The diagnostic accuracy of depression screening tools. McGill University Biostatistics Reading Group, Montreal, Quebec, Canada. November 26, 2014. 5. Using the cohort multiple randomized controlled trial (cmRCT) design for pragmatic intervention trials in a rare disease context: The Scleroderma Patient-centered Intervention Network. Royal Victoria Hospital, Division of Clinical Epidemiology, Montreal, Quebec, Canada. September 18, 2014. 6. Should physicians screen for depression in medical settings? Evidence on depression screening and its components. McGill University, Faculty of Medicine, Department of Epidemiology, Biostatistics, and Occupational Health, 2013-2014 Seminar Series. Montreal, Quebec, Canada. January 20, 2014. 7. Using the cohort multiple randomized controlled trial (cmRCT) design for pragmatic intervention trials: An example from a rare disease context. Réseau de recherche en interventions en sciences infirmières du Québec, Montreal, Quebec, Canada. January 15, 2014. 8. Meta(analyze) this: a user’s guide to identifying credible evidence syntheses. Jewish General Hospital, Combined Rounds, Departments of Obstetrics and Gynecology and Surgery, Montreal, Quebec, Canada. May 23, 2013. 9. Delivering patient-centered care in a rare disease context: the Scleroderma Patient-centered Intervention Network. Jewish General Hospital, Department of Psychiatry Research Day, Montreal, Quebec, Canada. April 26, 2013. 10. The Scleroderma Patient-centered Intervention Network (SPIN): an international partnership to develop, test, and deliver psychosocial and rehabilitation services in a rare disease context. Lady Davis Institute for Medical Research, Principal Investigator Talk Series, Montreal, Quebec. April 10, 2013. 11. Using the cohort multiple randomized controlled trial (cmRCT) design in a rare disease context: the Scleroderma Patient-centered Intervention Network. Jewish General Hospital, Lady Davis Institute for Medical Research, Centre for Clinical Epidemiology and Community Studies. Montreal, Quebec, Canada. April 9, 2013. 12. Myths and measures: the ins and outs of depression and its measurement. McGill Doctoral Nursing Colloquium, McGill University, Montreal, Quebec, Canada. March 20, 2013. 13. A user’s guide to systematic reviews and meta-analyses. Hôpital du Sacré-Coeur de Montréal, Department of Psychiatry, Montreal, Quebec, Canada. February 14, 2013. 14. An introduction to systematic reviews and meta-analyses. Academic Grand Rounds, Department of Psychiatry, Jewish General Hospital, Montreal, Quebec, Canada. February 7, 2013. 15. Using a cohort trial design in a rare disease context: the Scleroderma Patient-centered Intervention Network. Montreal Chest Institute. Respiratory Epidemiology and Clinical Research Unit. Montreal, Quebec, Canada. February 1, 2013. 16. Systematic reviews and meta-analyses: a “user’s guide.” Jewish General Hospital, Lady Davis Institute for Medical Research, Psychosocial Axis Seminar Series, Montreal, Quebec, Canada. January 9, 2013. 17. Rethinking recommendations for depression screening: a look at the evidence. Department of Psychology, McGill University, Montreal, Quebec, Canada. November 7, 2012. 18. The reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. Royal Victoria Hospital, Division of Clinical Epidemiology, Montreal, Quebec, Canada. May 24, 2012. 19. Systematic reviews and meta-analyses: a user’s guide. Department of Educational and Counselling Psychology, McGill University, Montreal, Quebec, Canada. May 1, 2012. 20. Rethinking recommendations for depression screening. Montreal Chest Institute. Respiratory Epidemiology and Clinical Research Unit. Montreal, Quebec, Canada. February 2012. 21. Propaganda-based medicine: the case of depression screening. Lady Davis Institute, Jewish General Hospital, Second Annual Scientific Retreat, Montreal, Quebec, Canada. May 2011. 22. Screening for depression in medical settings: a series of studies. Lady Davis Institute, Jewish General Hospital, Principal Investigator Meetings, Montreal, Quebec, Canada. May 2011.

Brett D. Thombs, PhD: Curriculum Vitae 13 of 55 23. The reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. Jewish General Hospital, Lady Davis Institute for Medical Research, Centre for Clinical Epidemiology and Community Studies, Montreal, Quebec, Canada. February 2011. 24. Does depression screening benefit patients? should we expect benefits in the absence of evidence? Jewish General Hospital, Medical Grand Rounds. Montreal, Quebec, Canada. February 2010. 25. Smoke screens: will recommendations for depression screening benefit patients in medical care? McGill University, Faculty of Medicine, Department of Epidemiology, Biostatistics, and Occupational Health, 2009-2010 Seminar Series. Montreal, Quebec, Canada. January 2010. 26. Does depression screening benefit patients? should we expect benefits in the absence of evidence? Douglas Hospital Research Centre, Clinical Research Division, Montreal, Quebec, Canada. December 2009. 27. Does screening for depression help patients? Can it harm them? Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. March 2009. 28. Does screening for depression improve outcomes for patients in cardiovascular care? A systematic review of the evidence. Jewish General Hospital, Lady Davis Institute for Medical Research, Psychosocial Axis Seminar Series, Montreal, Quebec, Canada. December 2008. 29. Should we screen for depression in specialty medicine? A systematic review of the evidence from cardiovascular care. Concordia University, Department of Psychology, Clinical Health Science Research Group, Montreal, Quebec, Canada. December 2008. 30. Smoke screens: do recommendations for depression screening really benefit patients? Jewish General Hospital, Lady Davis Institute, Centre for Clinical Epidemiology and Community Studies, Montreal, Quebec, Canada. November 2008. 31. Behavioral health research in the Canadian Scleroderma Research Group. Improving Health and Well- Being in Scleroderma: Establishing a Collaborative Behavioural Health Research Agenda. Hosted conference. Montreal, Quebec, Canada. November 2008. 32. Depression in scleroderma. Improving Health and Well-Being in Scleroderma: Establishing a Collaborative Behavioural Health Research Agenda. Hosted conference. Montreal, Quebec, Canada. November 2008. 33. Fatigue in scleroderma. Improving Health and Well-Being in Scleroderma: Establishing a Collaborative Behavioural Health Research Agenda. Hosted conference. Montreal, Quebec, Canada. November 2008. 34. “I think my patients are depressed – should I ask them? Screening for depression in specialty medicine. Jewish General Hospital, Department of Psychiatry Research Day, Montreal, Quebec, Canada. April 2008. 35. Depression in cardiovascular disease: should cardiologists care? Jewish General Hospital, Division of Cardiology, Montreal, Quebec, Canada. April 2008. 36. Assessing and controlling for somatic symptom bias in measurement of depressive symptoms among patients with medical illness. Concordia University, Department of Psychology, Clinical Health Science Research Group, Montreal, Quebec, Canada. February 2008. 37. Is depression an independent predictor of post-acute myocardial infarction outcomes? A structural equation modeling approach. McGill University, Faculty of Medicine, Department of Epidemiology, Biostatistics, and Occupational Health, 2007-2008 Seminar Series. Montreal, Quebec, Canada. January 2008. 38. Do patient responses to research questionnaires mean what we think they do? The mysterious case of post-myocardial infarction depression and the missing somatic symptoms. Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. January 2008. 39. Does overreporting of somatic symptoms account for high rates of depressive symptoms among hospitalized post-acute myocardial infarction patients? Detecting differential item functioning using MIMIC modeling. Jewish General Hospital, Lady Davis Institute for Medical Research, Centre for Clinical Epidemiology and Community Studies, Montreal, Quebec, Canada. December 2008. 40. Can we measure symptoms of depression in patients with post-acute myocardial infarction well enough to talk about an independent risk factor? A structural equation modeling approach to controlling for somatic symptom overlap. McGill University, Faculty of Medicine, Department of Psychiatry Research Day, Montreal, Quebec, Canada. October 2007.

Brett D. Thombs, PhD: Curriculum Vitae 14 of 55 41. Culture and confounding: what does multiple regression really tell us? Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. July 2007. 42. Cross-cultural considerations in clinical assessment: screening for history of childhood maltreatment. Jewish General Hospital, Department of Psychiatry, Research Section, Montreal, Quebec, Canada. March 2007. 43. Getting to the heart of measurement in transcultural psychiatry. Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. February 2007. 44. Screening for depression among patients with acute myocardial infarction: disentangling the heart from mind-body depression. Jewish General Hospital, Department of Psychiatry, Montreal, Quebec, Canada. January 2006. 45. Assessing depression in patients with acute myocardial infarction: disentangling the heart from mind- body depression. Center for Mind-Body Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. November 2005. 46. What do culturally sensitive mental health services mean? Fifteen years later. The 8th Student Alliance for Multicultural and Mental Health Issues Conference, Bronx, New York, USA. April 2003.

E.5.4. Supervised Invited Talks by Trainees – International and National 1. Delisle VC, Gumuchian ST. The Scleroderma Support Group Survey: Understanding people’s experiences with scleroderma. 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 19, 2015. 2. Gholizadeh S, Jewett LR. Body image distress in scleroderma. 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 19, 2015. 3. Linda Kwakkenbos. Overcoming barriers to evaluating psychological interventions: the cohort multiple randomized controlled trial (cmRCT) design. Appearance Matters: An International Conference about the Impact of Appearance in our Society, Kristianstad, Sweden, December 10, 2014. 4. Linda Kwakkenbos. Ethical considerations in pre-consent randomization models. Trials within Cohorts Symposium, London School of Hygiene & Tropical Medicine, November 10-11, 2014. 5. Lisa Jewett. Visible differences from medical illness: Body image concerns in scleroderma. Changing Faces, London, England, August 12, 2014. 6. Linda Kwakkenbos. The Scleroderma Patient-centered Intervention Network (SPIN). Scleroderma Society UK Annual General Meeting, London, United Kingdom, June 29, 2013. 7. Linda Kwakkenbos. A Novel Approach for Pragmatic Evaluations of Psychological Interventions: the Cohort Multiple Randomized Controlled Trial (cmRCT) Design. Center for Appearance Research, University of the West of England, Bristol, United Kingdom, June 28, 2013. 8. Lisa Jewett. Let’s talk about scleroderma and sexuality: keeping ourselves and relationships healthy. Scleroderma Society of Ontario, Mississagua, Ontario, Canada. April 20, 2013. 9. Lisa Jewett. The Scleroderma Patient-centered Intervention Network: internet-based management of body image distress. Scleroderma Educational Forum. Scleroderma Society of Ontario / Scleroderma Foundation. Niagara Falls, New York, USA. October 20, 2012. 10. Lisa Jewett. “SPIN” – Managing depression and body image. Scleroderma Society of Canada, 13th Annual Conference. Vancouver, British Columbia, Canada. September 29, 2012. 11. Marielle Bassel. Psychological health and well-being in scleroderma. Scleroderma Patient Education Bilingual Conference. Scleroderma Society of Canada. Quebec City, Quebec, Canada. October 2011. 12. Katherine Milette. Measuring depression in systemic sclerosis. In symposium (BD Thombs, Chair), Measure by measure: Assessing psychological health and well-being in scleroderma. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting. Atlanta, Georgia, USA. November 2010. 13. Ghassan El-Baalbaki. Measuring pain in systemic sclerosis: the Short-Form McGill Pain Questionnaire or a single-item measure of pain? In symposium (BD Thombs, Chair), Measure by measure: Assessing psychological health and well-being in scleroderma. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting. Atlanta, Georgia, USA. November 2010.

Brett D. Thombs, PhD: Curriculum Vitae 15 of 55 14. Katherine Milette. Clinical Correlates of Sleep Problems in Systemic Sclerosis: the Prominent Role of Pain. 3rd Annual Scientific Meeting of the Canadian Scleroderma Research Group. Halifax, New Brunswick, Canada. November 2010.

E.5.5. Supervised Invited Talks by Trainees – Local 1. Brooke Levis. Selective cutoff reporting in studies of diagnostic accuracy of depression screening tools: Comparing traditional meta-analysis to individual patient data meta analysis. McGill Epidemiology, Biostatistics and Occupational Health 50th Anniversary Conference and Alumni Reunion, Montreal, Quebec, Canada. April 30, 2015. 2. Brooke Levis. Using individual patient data meta-analysis to address reporting biases in studies of the diagnostic accuracy of depression screening tools. Montreal Chest Institute. Respiratory Epidemiology and Clinical Research Unit. Montreal, Quebec, Canada. February 12, 2015. 3. Ilya Razykov. The utility of the Patient Health Questionnaire - 9 to assess suicide risk in medical patients. Jewish General Hospital, Department of Psychiatry Student Research Day, Montreal, Quebec, Canada. June 12, 2013. 4. Michelle Roseman. Reporting of conflicts of interest from drug trials in systematic reviews and meta- anaalyses. Jewish General Hospital, Department of Psychiatry Student Research Day, Montreal, Quebec, Canada. June 13, 2012. 5. Michelle Roseman. Reporting of conflicts of interest in Cochrane reviews of trials of pharmacological treatments. Montreal Chest Institute. Respiratory Epidemiology and Clinical Research Unit. Montreal, Quebec, Canada. April 2012. 6. Vanessa Delisle. Revisiting the role of somatic symptoms among depressed men and women: much ado about nothing? Jewish General Hospital, Department of Psychiatry Student Research Day, Montreal, Quebec, Canada. June 2011. 7. Michelle Roseman. Unreported conflicts of interest when pharmacological treatment trials are synethesized in meta-analyses. Jewish General Hospital, Lady Davis Institute for Medical Research, Psychosocial Axis Seminar Series, Montreal, Quebec, Canada. January 2011. 8. Katherine Milette. Outcome reporting and trial registration standards: a neglected necessity for quality research. McGill University, Department of Educational and Counselling Psychology, Montreal, Quebec, Canada. October 2010. 9. Michelle Roseman. Hidden conflicts of interest in meta-analyses of pharmacological treatments. Montreal Chest Institute. Respiratory Epidemiology and Clinical Research Unit. Montreal, Quebec, Canada. October 2010. 10. Ademola Adeponle. Use of cultural consultation to resolve uncertainty of psychosis diagnosis. Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. June 2010. 11. Evan Newton. The experience of women living with scleroderma; a qualitative approach. 2nd Jewish General Hospital Department of Psychiatry Student Research Day, Montreal, Quebec, Canada. June 2010. 12. Katherine Milette. Transparency of outcome reporting in behavioral health research: a systematic review. Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. June 2010. 13. Michelle Roseman. Hidden conflicts of interest in meta-analyses of pharmacological treatments. Lady Davis Institute, Jewish General Hospital, First Annual Scientific Retreat, Montreal, Quebec, Canada. May 2010. 14. Michelle Roseman. Hidden conflicts of interest in meta-analyses of pharmacological treatments. McGill University, Faculty of Medicine, Department of Epidemiology, Biostatistics, and Occupational Health, 2009-2010 Seminar Series. Montreal, Quebec, Canada. May 2010. 15. Michelle Roseman. How transparent is evidence reporting in meta-analyses? An assessment of hidden conflicts of interests in meta-analyses of pharmacological treatments. Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. April 2010. 16. Evan Newton. The experience of women living with scleroderma: a qualitative approach. Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. March 2010.

Brett D. Thombs, PhD: Curriculum Vitae 16 of 55 17. Yue Zhao. Risk for suicide ideation and attempt among adolescents reporting “unsure” sexual identity or heterosexual identity plus same-sex attraction or behavior: forgotten groups? Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. January 2010. 18. Yue Zhao. Risk of mental health problems among non-heterosexual identified adolescents: what about adolescents who are unsure of their sexual identity? Jewish General Hospital, Department of Psychiatry, Student Research Day, Montreal, Quebec, Canada. June 2009. 19. Orit Schieir. Clinical signs and symptoms associated with pain in patients with systemic sclerosis. Jewish General Hospital, Lady Davis Institute, Centre for Clinical Epidemiology and Community Studies, Montreal, Quebec, Canada. April 2009. 20. Orit Schieir. Where does it hurt? An examination of clinical signs and symptoms associated with pain in patients with systemic sclerosis. McGill University Hospital Center, Division of Clinical Epidemiology, Montreal, Quebec, Canada. January 2009. 21. Ademola Adeponle. Family participation in treatment and post-discharge appointment and medication adherence at a Nigerian psychiatric hospital. Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. August 2008. 22. Monica Ruiz Casares. Promoting child and adolescent mental health in the context of HIV/AIDS: measuring Depression in Namibia. Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. April 2008. 23. Orit Schieir. Baseline depression predicts depression and pain at 6-month follow-up when controlling for objective disease severity. Jewish General Hospital, Lady Davis Institute, Centre for Clinical Epidemiology and Community Studies, Montreal, Quebec, Canada. January 2008.

F. OTHER CONTRIBUTIONS F.1. Academic Journals and Scientific Meetings F.1.1. Editorial Appointments - Research Synthesis Methods, Editorial Board. 2015-present. - Cochrane Collaboration: Depression, Anxiety and Neurosis Group, Methods Editor. 2013-present. - Cochrane Collaboration: Diagnostic Test Accuracy Working Group, Contact Editor. 2014-present. - PLOS ONE, Academic Editor. 2013-2015. Section Editor 2015-present. - Journal of Psychosomatic Research, Editorial Board. 2009-2010. Associate Editor. 2010-present. - Canadian Journal of Psychiatry, Editorial Board. 2008-present. - Arthritis Care & Research, Editorial Board. 2010-2016. - Transcultural Psychiatry, Statistical Editor. 2006-2013. - Burns, Editorial Board. 2006-2010. - Journal of Burns and Wounds, Editorial Board. 2005-2007.

F.1.2. Journal Peer Review Activities Since 2006 (398 Total Reviews) 2015 – 2016 (11 Total Reviews): Arthritis & Rheumatism (1); Canadian Journal of Psychiatry (2); Cochrane Reviews (1); Journal of Consulting and Clinical Psychology (1); Journal of Clinical Rheumatology (1); Journal of Psychosomatic Research (4); Systematic Reviews (1). 2014 – 2015 (42 Total Reviews): Arthritis Care & Research (2); BMJ (1); Canadian Journal of Psychiatry (1); Cochrane Reviews (3); JAMA (7); Journal of Consulting and Clinical Psychology (1); Journal of Psychosomatic Research (21); Journal of Rheumatology (2); Nature Reviews: Disease Primers (1); PLOS Medicine (1); Psychotherapy and Psychosomatics (1); Trials (1). 2013 – 2014 (37 Total Reviews): Arthritis Care & Research (4); BMC Public Health (1); BMJ (2); Canadian Journal of Community Mental Health (1); Canadian Journal of Psychiatry (3); Cochrane Reviews (2); Depression and Anxiety (1); Health and Quality of Life Outcomes (1); JAMA (2); Journal of Psychiatric Research (1); Journal of Psychosomatic Research (16); PLOS ONE (2); Psychotherapy and Psychosomatics (1).

Brett D. Thombs, PhD: Curriculum Vitae 17 of 55 2006 – 2013 (308 Total Reviews): Acta Psychiatrica Scandinavica (2); Addiction (1); American Journal of Cardiology (1); American Journal of Managed Care (1); American Journal of Psychiatry (1); Annals of Behavioral Medicine (2); Annals of Internal Medicine (2); Annals of Oncology (1); Annals of the Rheumatic Diseases (2); Archives of General Psychiatry (6); Arthritis Care & Research (16); Arthritis & Rheumatism (1); Biological Psychiatry (1); BMC Health Services Research (1); BMJ (4); Brain Research Bulletin (1); British Journal of Psychiatry (1); Burns (24); Canadian Journal of Psychiatry (26); Circulation (2); CMAJ (1); Contemporary Clinical Trials (2); Critical Care Medicine (1); Diabetes Care (3); European Journal of Cardiovascular Prevention and Rehabilitation (1); European Journal of Heart Failure (1); European Journal of Psychiatry (1); General Hospital Psychiatry (2); Harvard Review of Psychiatry (1); Health Psychology (2); Health and Quality of Life Outcomes (2); Heart (2); JAMA (3); Journal of Affective Disorders (1); Journal of the American College of Cardiology (13); Journal of Burn Care & Research (2); Journal of Burns and Wounds (3); Journal of Consulting and Clinical Psychology (1); Journal of General Internal Medicine (3); Journal of Health Psychology (1); Journal of Psychosomatic Research (77); Journal of Rheumatology (2); Medicine (1); PLOS ONE (7); Psychiatry Research (2); Psychological Bulletin (1); Psychological Medicine (1); Psychology, Health, & Medicine (1); Psychosomatic Medicine (6); Rheumatology (3); Scandinavian Journal of Rheumatology (2); Transcultural Psychiatry (64).

F.1.3. Supervised Journal Peer Review Activities by Trainees (61 Total Reviews) 2015-2016 (8 Total Reviews): Marleine Azar: Journal of Consulting and Clinical Psychology (1); Vanessa Delisle: Stigma and Health (2); Stephanie Gumuchian: Journal of Clinical Rheumatology (1); Brooke Levis: International Journal of Geriatric Psychiatry (1); Kira Riehm: Journal of Consulting and Clinical Psychology (1); PLOS ONE (1); Danielle Rice: Journal of Affective Disorders (1). 2014-2015 (14 Total Reviews): Adina Coroiu: PLOS ONE (2); Vanessa Delisle: Stigma and Health (1). Linda Kwakkenbos: Journal of Psychosomatic Research (2); PLOS ONE (1). Alex Levis: Journal of Psychosomatic Research (1). Brooke Levis: Journal of Psychosomatic Research (2). Kira Riehm: PLOS ONE (1); Michelle Roseman: American Journal of Preventive Medicine (1); Danielle Rice: Circulation: Heart Failure (1); Journal of Psychosomatic Research (1); PLOS ONE (1). 2013 – 2014 (18 Total Reviews): Vanessa Delisle: Journal of Psychosomatic Research (1); Linda Kwakkenbos: Arthritis Care & Research (2); Health and Quality of Life Outcomes (1); Journal of Depression and Anxiety (1); Journal of Psychosomatic Research (1); PLOS ONE (5); Rheumatology International: Clinical and Experimental Investigations (2); Lisa Jewett: Journal of Burn Care & Research (1); Brooke Levis: American Journal of Managed Care (2); Michelle Roseman: JAMA (1); Journal of Psychosomatic Research (1). 2006- June 2013 (21 Total Reviews) Vanessa Delisle: Journal of Psychosomatic Research (2); PLOS ONE (1); Ghassan El-Baalbaki: Journal of Psychosomatic Research (1); Transcultural Psychiatry (1); Lisa Jewett: Arthritis Care & Research (1); Burns (2); Journal of Psychosomatic Research (1); Linda Kwakkenbos: Journal of Psychosomatic Research (2); Journal of Rheumatology (1); PLOS ONE (1); Brooke Levis: Clinical Rheumatology (1); PLOS ONE (1); Katherine Milette: Arthritis Care & Research (2); Journal of Psychosomatic Research (1); Michelle Roseman: BMJ (1); Journal of Clinical Epidemiology (1); Psycho-oncology (1).

F.1.4. Peer-Review for Scientific Meetings - Society for Behavioral Medicine, Annual Meeting and Scientific Sessions. 2009-2011. - Canadian Psychological Association. Annual Convention. 2011-2013.

F.1.5. Conferences/Meetings Organized/Hosted - Scleroderma Patient-centered Intervention Network (SPIN) Project Teams Meeting. Anaheim, California, USA September 27-28, 2013, 40 attendees. CIHR-funded (PI Thombs). - Scleroderma Patient-centered Intervention Network (SPIN) Project Development Meeting. Hamilton, Ontario, Canada, September 27-28, 2013, 45 attendees. CIHR-funded (PI Thombs).

Brett D. Thombs, PhD: Curriculum Vitae 18 of 55 - Scleroderma Patient-centered Intervention Network (SPIN) Planning Meeting. Montreal, Quebec, Canada, July 14-15, 2011, 40 attendees. CIHR-funded (PI Thombs). - Initial Organizational Meeting of the International Consortium for Behavioral, Educational, and Psychological Trials to Improve Health in Scleroderma. Montreal, Quebec, Canada, October 14-15, 2010, 35 attendees. CIHR-funded (PI Thombs). - Evidence-based Perspectives on Detection and Clinical Care for Depression in Medical Settings. Montreal, Quebec, Canada, October 22-23, 2009, 15 attendees. CIHR-funded (PI Thombs). - Joint Patient – Researcher Meeting to Interpret and Plan for Dissemination of Patient Survey Results. Montreal, Quebec, Canada, September 17-18, 2009, 18 attendees. CIHR-funded (PI Thombs). - Improving Health and Well-Being in Scleroderma: establishing a Collaborative Behavioural Health Research Agenda. Montreal, Quebec, Canada, November 13-14, 2008, 15 attendees. CIHR-funded (PI Thombs).

F.1.6. Session Organizer/Chair/Moderator 1. Small Group Session Co-Chair, Access to healthcare and support services. Canadian Organization for Rare Disorders 2013 Fall Conference, Ottawa, Ontario, Canada. September 30, 2013. 2. Symposium Organizer/Chair, Psychological measurement in hospital and health centers. 2013 Canadian Psychological Association Convention, Quebec City, Quebec, Canada. June 2013. 3. Symposium Organizer/Chair, Myths and measures: mental health assessment in medical settings. 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada. June 2011. 4. Session Chair, What a pain rheumatic disease can be! American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting. Atlanta, Georgia, USA. November 2010. 5. Symposium Organizer/Chair, Measure by measure: assessing psychological health and well-being in scleroderma. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting. Atlanta, Georgia, USA. November 2010. 6. Symposium Organizer/Chair, Current controversies in the definition, identification, and care of depression. Canadian Psychiatric Association Annual Conference, Toronto, Ontario, Canada. September 2010. 7. Symposium Chair, Cognitive and somatic depression in cardiac patients, XIII Annual Scientific Meeting, European Association for Consultation-Liaison Psychiatry and Psychosomatics/XXVIII European Conference on Psychosomatic Research. Innsbruck, Austria. July 2010. 8. Session Chair, 1st Annual Lady Davis Institute for Medical Research Scientific Retreat. Montreal, Quebec, Canada. June 2010. 9. Symposium Organizer/Chair, The psychology of improving health and well-being in scleroderma: assessment and intervention approaches. American College of Rheumatology / Association for Rheumatology Health Professionals Annual Scientific Meeting. Philadelphia, Pennsylvania, USA. October 2009. 10. Symposium Organizer/Chair, Clinical psychology in medical settings: does one size fit all? 2009 Canadian Psychological Association Convention, Montreal, Quebec, Canada. June 2009.

F.2. Grant and Guideline Reviews F.2.1. Grant Review Committee Member - European Commission Horizon 2020, Personalizing Health and Care. 1 committee. 2014. - CIHR, Knowledge Synthesis Grant Program. 4 committees, 2012-2014. - CIHR, Pfizer Operating Grant in Disease Prevention and Management. 3 committees, 2010-2012. - CIHR, Team Grant: Chronic Disease Risk and Intervention Strategies. 2 committees, 2011. - CIHR, Meetings, Planning, and Dissemination Grants. 3 committees, 2010-2011. - The Arthritis Society / Canadian Arthritis Network Training Competition. 1 committee, 2012. - Heart and Stroke Foundation of Canada – Grants-in-Aid. 2 committees, 2010-2011.

F.2.2. External Grant Reviewer

Brett D. Thombs, PhD: Curriculum Vitae 19 of 55 - Manitoba Medical Service Foundation, 2015. - Dutch Cancer Society, 2013. - Fondation des pompiers du Québec pour les grands brûlés, 2013. - Preventing Violence Across the Lifespan Research Network - CIHR Centre, 2013. - Rheumafonds – Dutch Arthritis Association, 2012. - European League Against Rheumatism (EULAR), 2011. - Ireland Health Research Board – Health Research Awards, 2010, 2013. - The Netherlands Organisation for Health Research and Development, 2010. - Douglas Mental Health University Research Center – Bombardier Fellowship, 2010. - Yale University School of Medicine – Donaghue Women’s Health Investigator Program, 2009. - Dutch Burns Foundation, 2009.

F.2.3. External Reviewer for Tenure/Promotion - 2 reviews, 2012, 2013 (both USA).

F.2.4. Guideline Reviewer - Canadian Task Force on Preventive Health Care, Screening for Depression in Adults, 2012.

F.3. Administrative Responsibilities F.3.1. Institutional Administrative Appointments and Responsibilities McGill University - Search Committee, Quantitative Psychology Faculty Hire, Department of Psychology, 2015 - Preliminary Selection Committee, Nominees for CIHR Banting Postdoctoral Fellows, 2015-present. - Selection Committee, Principal’s Prize for Outstanding Emerging Researchers, 2015-present. - Task Force, Institute of Public and Population Health, Faculty of Medicine, 2014-present. - University Tenure Committee, Faculty of Medicine, 2014-present. - Evaluator, Undergraduate Theses, Department of Psychology (3 theses), 2014-present. - Internal Pre-Submission Grant Peer-Reviewer (2 proposals), 2010-present. - MSc in Epidemiology Admissions Committee, 2010-present. Lady Davis Institute for Medical Research, Jewish General Hospital - 6-year Reappointment Review Committee, 2013-present. - Annual Scientific Retreat Organizing Committee, 2012-present. - Clinical Research Pilot Project Funding Initiative Review Committee, 2012-present. - Internal Studentship Review Committee, 2011-present. - Internal Pre-Submission Grant Peer-Reviewer (31 proposals), 2010-present. - Chair, Seminar Series, Psychosocial Axis, 2010-2014. - Research Ethics Committee/Science Review Committee, 2007-present. - Research Day Program Committee, Department of Psychiatry, 2007.

F.3.2. Policy and Advisory Committees - Canadian Task Force on Preventive Health Care, 2013-present (Chair - Child and Adolescent Smoking Prevention and Cessation Guideline Working Group; Member – Hepatitis C Screening Guideline Working Group, Developmental Delay Screening Guideline Working Group; Periodic Health Exam Working Group; Screening for Cognitive Impairment Working Group; Methods Working Group). - Steering Committee, National Plan for Rare Disorders, Canadian Organization for Rare Disorders, 2013- present. - Expert Work Group on Depression Monitoring Tools, National Committee for Quality Assurance (United States), 2015 - Nominating Committee for Editor-in-Chief, Canadian Journal of Psychiatry, 2012. - Member, Research Committee, Association of Rheumatology Health Professionals, 2009-2011.

Brett D. Thombs, PhD: Curriculum Vitae 20 of 55 - Clinical Research Committee, Canadian Scleroderma Research Group, 2007-present. - Knowledge Transfer Committee, Canadian Scleroderma Research Group, 2007-present. - Chair, Joint National Patient Survey Committee, Canadian Scleroderma Society and Canadian Scleroderma Research Group, 2007-2009 - Research Committee, American Burn Association, 2005-2008.

G. RESEARCH G.1. Personal Support Awards - Arthritis Society Investigator Salary Award ($350,000, 2013-2017). - FRSQ Chercheur-Boursier, Junior 2 ($133,783; declined, 2013-2015). - McGill University William Dawson Scholar Award ($125,000, 2012-2017). - CIHR New Investigator Award ($300,000, 2008-2013). - FRSQ Chercheur-Boursier, Junior 1 ($225,075; declined, 2008-2012).

G.2. Research Grants G.2.1. Current Grants as the Principal Investigator - CIHR. Knowledge Synthesis and Exchange Grant. Improving Depression Screening by Reducing Bias in Accuracy Estimates: An Independent Patient Data Meta-Analysis of the Edinburgh Postnatal Depression Scale (EPDS) ($100,000, 2015-2016). - Scleroderma Society of Ontario. Scleroderma Support Group Leader Training Program ($30,000, 2014- 2015). - CIHR. Knowledge Synthesis and Exchange Grant. Improving Depression Screening by Reducing Bias in Accuracy Estimates: An Independent Patient Data Meta-Analysis of the PHQ-9 ($100,000, 2014-2015). - SSHRC. Insight Development Grant. Searching for identity in the dark: The experiences of women living with a rare disease ($74,888, 2012-2014). - CIHR. Emerging Team Grant: Rare Diseases. Emerging team: The Scleroderma Patient-centered Intervention Network ($1,499,765 + $205,000 partner funding, 2012-2017).

G.2.2. Current Operating Grants as Co-investigator - Rare Disease Foundation. Microgrant Program. Illuminating the scleroderma support group experience through qualitative interviews (PI Delisle VC; $3,420, 2015). - CIHR. Operating Grant. Secondary prevention of melanoma through early detection via skin self- examination: A mixed-methods study of psychosocial barriers and facilitators of long-term adherence to medical advice (PI Körner A; $92,478, 2014-2016). - CIHR. Knowledge Synthesis and Exchange Grant. The Clinical, Regulatory, and Ethical Implications of Electronic Cigarettes: A Knowledge Synthesis Grant (PI Eisenberg M; $100,000, 2014-2015). - Rare Disease Foundation. Microgrant Program. Testing the Feasibility of the Changing Faces Practitioner Training Program for Scleroderma Patients (PI Jewett LR; $3,500, 2014). - Children & Violence Evaluation Challenge Fund. Families First Home Visiting Program (PI Ruiz-Casares M; €309,055, 2013-2015). - FRSQ. Operating Grant. Réduction de la mortalité liée auz melanomes chez les patients à risque: les facteurs facilitant et réduisant l’adhérence à un protocole d’auto-examen de la peau (PI Koerner A; $172,547, 2011-2014). - CIHR. Operating Grant. Assessment of a Drama Workshop Program for Immigrant and Refugee Adolescents (PI Rousseau C; $389,781, 2011-2014). - US NIH. Research Project Grant Program (R01). Mechanisms of Platelet Activation in Depression and Acute Coronary Syndromes (PI Williams M; US$2,050,000, 2010-2015).

G.2.3. Current Team, Centre, and Training Grants as Co-investigator

Brett D. Thombs, PhD: Curriculum Vitae 21 of 55 - CIHR. Centre for Research Development Grant. Centre for research development in gender, mental health and violence across the lifespan (PIs MacMillan HL, Stewart D, Wathen CN, Coben J, Herrman H; $2,000,000, 2009-2014).

G.2.4. Past Grants as Principal Investigator - CIHR. Knowledge Synthesis and Exchange Grant. Depression screening and mental health outcomes in children and adolescents: A systematic review ($99,977, 2012-2013). - Scleroderma Society of Ontario. Coordinator for the Scleroderma Patient-centered Intervention Network ($25,000, 2011-2012). - Scleroderma Society of Canada. Coordinator for the Scleroderma Patient-centered Intervention Network ($12,500, 2011-2012). - CIHR. Knowledge Synthesis and Exchange Grant. Will routine depression screening benefit patients in cardiovascular care settings? An updated systematic review ($92,989, 2011-2012). - CIHR. Knowledge Synthesis and Exchange Grant. Will screening for distress improve patient well-being in cancer? A systematic review ($88,489, 2010-2011). - CIHR. Knowledge Synthesis and Exchange Grant. Depression screening and patient outcomes in pregnancy and postpartum: A systematic review ($97,766* – funding for full project to complement bridge funding – accepted non-overlapping funds of $91,588, 2010-2011). - CIHR. Operating Grant – Priority Announcement Knowledge Translation. Depression screening and patient outcomes in pregnancy and postpartum: A systematic review ($60,000*, 2010-2011). - American College of Rheumatology Research and Education Foundation. Health Professional Investigator Award. Improving depression screening in rheumatology clinics: Detection of persistent versus acute depression in systemic sclerosis (US$100,000, 2009-2010). - FRSQ. Operating Grant. Development and validation of an integrated system to evaluate fatigue in systemic sclerosis ($217,160, 2008-2011). - FRSQ. Startup Funding. Patient-reported outcomes in scleroderma ($45,000, 2008-2011). - Canadian Breast Cancer Research Alliance. Developmental and Exploratory Grant. Depression screening in cancer: systematic review and recommendations for research and practice ($50,000, 2009- 2010). - CIHR. Operating Grant. Evaluation of a self-management program for scleroderma: Predictors of participation, attrition and beneficial health outcomes ($78,317, 2008-2009).

G.2.5. Past Grants as Co-Investigator - CIHR. Emerging Team Grant. CIHR team in perinatal mental health (PIs Gold IJ, Groleau D, Zelkowitz P; $947,600, 2009-2013). - CIHR. Strategic Training in Health Research Initiative. Strategic training initiative: The Canadian Scleroderma Research Group (PIs Baron M, Leask AC, Mort JS, Philip A, Pope JE; $1,800,000, 2007- 2013). - CIHR. Emerging Team Grant. New and emerging team: The Canadian Scleroderma Research Group (PIs Baron M, Philip A, Pope JE; $895,865, 2007-2012). - FRSQ. Team Grant. Écoles, culture et santé mentale: une articulation à repenser dans une société en transformation (PI Rousseau C; $405,000, 2009-2012). - Ride to Conquer Cancer Research Fund, Jewish General Hospital Foundation. Understanding psychological core issues and coping patterns in reaction to melanoma and skin self-examination: a mixed-methods approach (PI Koerner, A; $22,324, 2011-2012). - CIHR. Operating Grant. Parents, daughters, and the HPV vaccine: Factors affecting parental decision- making in a universal immunization program (PI Rosberger Z; $100,000, 2009-2010). - Max Bell Foundation. Creativity and prevention of mental health problems in multiethnic schools (PI Rousseau, C; $100,000, 2007-2009).

G.2.6. Meetings and Travel Grants as Principal Investigator

Brett D. Thombs, PhD: Curriculum Vitae 22 of 55 - CIHR. Planning Grant. Supporting Peer Supporters: Planning the Development and Testing of a Training Program for Peer Facilitators of Scleroderma Support Groups (2015, $10,000). - CIHR. Planning Grant. The Scleroderma Patient-centered Intervention Network (SPIN) Feasibility Trial Planning Meeting (2013, $25,000). - CIHR. Planning Grant. Scleroderma Patient-centered Intervention Network (SPIN) Planning Meeting - II (2013, $25,000). - CIHR. Meetings, Planning, and Dissemination Grant. Scleroderma Patient-centered Intervention Network (SPIN) Planning Meeting (2011, $24,994). - CIHR. Meetings, Planning, and Dissemination Grant. Consortium for clinical trials of behavioral, psychological, and educational interventions in scleroderma; Initial planning meeting (2010, $18,880). - Sclérodermie Québec. Research Support Program. Consortium for clinical trials of behavioral, psychological, and educational interventions in scleroderma; Initial planning meeting (2010, $8,000). - CIHR. Meetings, Planning, and Dissemination Grant. Joint Patient – Researcher Meeting to Interpret and Plan for Dissemination of Patient Survey Results (2009, $11,240). - CIHR. Meetings, Planning, and Dissemination Grant. Evaluating evidence for detection and treatment of mental health problems in medical settings: Developing a “user’s guide” for behavioral health professionals and a collaborative behavioral health research agenda (2009, $14,497). - CIHR. Institute of Health Services and Policy Research, Institute Community Support Program, New Investigator Travel Award. Symposium on screening for major depressive disorder in cardiovascular care (2009, $2,150). - CIHR. Meetings, Planning, and Dissemination Grant. Improving health and well-being in scleroderma: Developing a collaborative behavioural health research agenda (2008, $18,454).

G.3. Publications1 G.3.1. Articles in Peer-Reviewed Journals: Submitted or in Revision 1. Lewin G, Morissette K, Dickinson J, Bell N, Bacchus M, Singh H, Tonelli M, Jaramillo Garcia A, Canadian Task Force on Preventive Health Care. Recommendations on screening for lung cancer. CMAJ. 2. Manea L, Hewitt C, North A, Plummer F, Richardson R, Thombs BD, Williams B, Gilbody S, McMillan D. Identifying depression with the PHQ-2: A diagnostic meta-analysis. PLOS ONE. 3. Connor Gorber S, Moore A, Thombs BD, Tonelli M, Canadian Task Force on Preventive Health Care. Canadian Task Force on Preventive Health Care adoption of American College of Physicians guideline on routine screening for pelvic examination. CMAJ. 4. Tonelli M, Parkin P, Leduc D, Brauer P, Pottie K, Dunfield L, Jaramillo A, Martin W, Connor-Gorber S, Ugnat A-M, Thombs BD, Canadian Task Force on Preventive Health Care. Recommendations on screening for developmental delay. CMAJ. 5. Rice DB, Thombs BD*. Inclusion of Currently Diagnosed or Treated Patients in Studies of Depression Screening Tool Accuracy: A Cross-sectional Analysis of Recently Published Primary Studies and Meta-Analyses. PLOS ONE. 6. Delisle VC, Gumuchian ST, Peláez S, Malcarne VL, El-Baalbaki G, Körner A, Hudson M, Baron M, Thombs BD*. Reasons for non-participation in scleroderma support groups. Clin Exp Rheumatol. 7. Rice DB, Shrier I, Kloda LA, Benedetti A, Thombs BD*. Methodological quality of meta-analyses of the diagnostic accuracy of depression screening tools was suboptimal based on AMSTAR. J Clin Epidemiol. 8. Rice DB, Kloda LA, Shrier I, Thombs BD*. Reporting quality in abstracts of meta-analyses of depression screening tool accuracy was deficient based on PRISMA for Abstracts J Clin Epidemiol. 9. Harel D, Steele R, Thombs BD, Hudson M, Baron M, Canadian Scleroderma Research Group. A weighted summed score for the Center for Epidemiologic Studies – Depression Scale for systemic sclerosis. Multivar Beh Res.

1 Names of supervised trainees are underlined and in bold in this and subsequent sections. My publications as corresponding/senior author are indicated by *.

Brett D. Thombs, PhD: Curriculum Vitae 23 of 55 10. Lallitto B, Coronado-Montoya S, Kwakkenbos L, Levis AW, Thombs BD. An assessment of possible excess significance bias in randomized controlled trials of acceptance and commitment therapy. PLOS ONE (revision requested). 11. Coronado-Montoya S, Levis AW, Kwakkenbos L, Steele R, Turner EH, Thombs BD*. Excess significance bias in randomized controlled trials of mindfulness-based mental health interventions: A cross-sectional study. PLOS ONE (revision requested). 12. Levis AW, Kelley GA, Thombs BD*. Assessing reporting bias in trials of exercise interventions for pain management in rheumatic diseases: An application of the test for excess significance. PLOS ONE (revision requested). 13. Jewett LR, Malcarne VL, Körner A, Kwakkenbos L, Hudson M, Baron M, Haythornthwaite JA, Heinberg L, Wigley F, Thombs BD*, Canadian Scleroderma Research Group. Development and validation of the Body Concealment Scale for Scleroderma (BCSS). Arthritis Care Res (revision submitted). 14. Thombs BD*, Ells C, Black L. Should results from patient-reported outcome measures be returned to research participants? IRB (revision requested)

G.3.2. Articles in Peer-Reviewed Journals: Published or Accepted for Publication2 In press 1. Riehm KE, Kwakkenbos L, Carrier M-E, Bartlett SJ, Malcarne VL, Mouthon L, Nielson WR, Poiraudea S, Nielsen K, Baron M, Frech T, Hudson M, Pope J, Sauve M, Suarez-Almazor ME, Wigley FM, Thombs BD*, SPIN Investigators. Validity of the Self-Efficacy for Managing Chronic Disease (SEMCD) Scale in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. Arthritis Care Res. [IF=4.7]. 2. Pottie K, Rahal R, Birtwhistle R, Thombs BD, Singh H, Connor Gorber S, Dunfield L, Jaramillo A, Shane A, Bacchus M, Bell N, Tonelli M, Canadian Task Force on Preventive Health Care. Recommendations on screening for cognitive impairment in older adults. CMAJ. [IF=6.0]. 3. Levis B, Rice DB, Kwakkenbos L, Steele R, Hagedoorn M, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Using marital status and continuous marital satisfaction ratings to predict depressive symptoms in married and unmarried women with systemic sclerosis: A Canadian Scleroderma Research Group study. Arthritis Care & Res. [IF=4.7]. 4. Levis AW, Leentjens A, Levenson J, Lumley M, Thombs BD*. Comparison of self-citation by peer reviewers in a journal with single-blind peer review versus a journal with open peer review. J Psychosom Res. [IF=2.7]. 5. Tolin DF, McKay D, Forman EM, Klonsky ED, Thombs BD, Empirically supported treatment: Recommendations for new models. Clin Psychol Sci Pract. [IF=3.2]. 2015-2016 6. Azar M, Riehm KE, McKay D, Thombs BD*. Transparency of outcome reporting and trial registration of randomized controlled trials published in the Journal of Consulting and Clinical Psychology. PLOS ONE. 2015;10(11):e0142894. [IF=3.2]. 7. Montoro R, Thombs BD, Igartua K. The association of bullying with suicide ideation, plan, and attempt among adolescents with GLB or unsure sexual identity, heterosexual identity with same-sex attraction or behavior, or heterosexual identity without same-sex attraction or behaviour. Sante Ment Que. 2015;40(3):55-76. [IF=N/A] 8. Thombs BD*, Benedetti A, Kloda LA, Levis B, Riehm KE, Azar M, Cuijpers P, Gilbody S, Ioannidis JPA, McMillan D, Patten SB, Shrier I, Steele RJ, Ziegelstein RC, Tonelli M, Mitchell N, Comeau L, Schinazi J, Vigod S. The Diagnostic Accuracy of the Edinburgh Postnatal Depression Scale (EPDS) for Detecting Major Depression in Pregnant and Postnatal Women: Protocol for a Systematic Review and Individual Patient Data Meta-analyses. BMJ Open. 2015;5:e009742. [IF=2.1].

2 Impact factors are the most recent published impact factor prior to the year of publication in this and subsequent sections (e.g., 2008 impact factor for articles published in 2008-2009).

Brett D. Thombs, PhD: Curriculum Vitae 24 of 55 9. Kwakkenbos L, Delisle VC, Fox RS, Gholizadeh S, Jewett LR, Levis B, Milette K, Mills SD, Malcarne VL, Thombs BD*. Psychosocial aspects of scleroderma. Rheum Dis Clin N Am. 2015;41(3):519-528. [IF=1.7]. 10. Gariepy G, Thombs BD, Kestens Y, Kaufman JS, Blair A, Schmitz N. The neighborhood build environment and trajectories of major depression symptoms in adults: a latent class growth analysis. PLOS ONE. 2015;10(7):e0133603. [Impact Factor = 3.5]. 11. Paris J, Bhat V, Thombs BD. Is adult ADHD being overdiagnosed? Can J Psychiatry. 2015;60(7):324-328. [IF=2.6]. 12. Kwakkenbos L, Minton O, Stone PC, Alexander S, Baron M, Hudson M, Thombs BD*, Canadian Scleroderma Research Group. Can the cancer-related fatigue case-definition criteria be applied to chronic medical illness? A comparison between women with breast cancer and systemic sclerosis. J Rheum. 2015;42(7):1156-1162. [IF=3.2]. 2014-2015 13. Riehm KE, Azar M, Thombs BD*. Transparency of outcome reporting and trial registration of randomized controlled trials in top psychosomatic and behavioral health journals: A five-year follow- up. J Psychosom Res. 2015;75(1)1-12. [IF=2.7]. 14. Thombs BD*, Jewett LR, Kwakkenbos L, Hudson M, Baron M, Canadian Scleroderma Research Group. Major depression diagnoses among patients with systemic sclerosis: Baseline and one- month follow-up. Arthritis Care Res. 2015;67(3):411-416. [IF=4.7]. 15. Thombs BD*, Levis AW, Razykov I, Syamchandra A, Leentjens A, Levenson J, Lumley M. Potentially coercive self-citation via peer review: A cross sectional study. J Psychosom Res. 2015;78(1):7-11. [IF=2.7]. 16. Brauer P, Connor Gorber S, Shaw E, Singh H, Bell N, Shane AR, Jaramillo A, Tonelli M, Canadian Task Force on Preventive Health Care. Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obestity in adults in primary care. CMAJ. 2015;187(3):184-195. [IF=6.0]. 17. Delisle VC, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Sex and time to diagnosis of systemic sclerosis: An updated analysis of 1,129 patients from the Canadian Scleroderma Research Group Registry. Clin Exp Rheumatol. 2014;32(6 Suppl 86):S1-S14. [IF=3.0]. 18. Bell N, Connor Gorber S, Shane A, Joffres M, Harminder S, Dickinson J, Shaw E, Tonelli M, Canadian Task Force on Preventive Health Care. Recommendations on screening for prostate cancer with the prostate specific antigen (PSA) test. CMAJ. 2014;186(16):1225-1234. [IF=6.0]. 19. Willems LM, Kwakkenbos L, Leite C, Thombs BD, van den Hoogen FHJ, Maia A, Vliet Vlieland TPM, van den Ende CHM. Frequency and impact of disease symptoms experienced by patients with systemic sclerosis: a comparison across five European countries. Clinical and Experimental Rheumatology. 2014;32(Suppl 86):88-93. [IF=2.7]. 20. Thombs BD*, Benedetti A, Kloda LA, Levis B, Nicolau I, Cuijpers P, Gilbody S, Ioannidis JPA, McMillan D, Patten SB, Shrier I, Steele RJ, Ziegelstein RC. The diagnostic accuracy of the Patient Health Questionnaire-2 (PHQ-2), Patient Health Questionnaire-8 (PHQ-8), and Patient Health Questionnaire-9 (PHQ-9) for detecting major depression: Protocol for a systematic review and individual patient data meta-analyses. Systematic Reviews. 2014;3:124. [IF=N/A]. 21. Thombs BD*, Kwakkenbos L, Coronado-Montoya S. Trial registration in rheumatology: The next step. Arthritis Care Res. 2014;66(10):1435-1437. [IF=4.7]. 22. Rousseau C, Beauregard C, Daignault K, Petrakos H, Thombs BD, Steele R, Vasiliadis H-M, Hechtman L. A randomized-controlled trial of a classroom-based drama workshop program to improve mental health outcomes among immigrant and refugee youth in special classes. PLOS ONE. 2014;9:e104704. [IF=3.2]. 23. Delisle VC, Kwakkenbos L, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. A comparison of the measurement equivalence of English and French versions of the Center for Epidemiologic Studies Depression (CES-D) Scale in systemic sclerosis. PLOS ONE. 2014;9:e102897. [IF=3.2]. 2013-2014

Brett D. Thombs, PhD: Curriculum Vitae 25 of 55 24. Wang J, Thombs BD, Schmid MR. The Swiss Health Literacy Survey: development and psychometric properties of a multi-dimensional instrument to assess competencies for health. Health Expect. 2014;17(3):396-417. [IF=2.9]. 25. Kwakkenbos L, Coyne JC, Thombs BD*. Prevalence of posttraumatic stress disorder (PTSD) in women with breast cancer. J Psychosom Res. 2014;76(6):485-486. [IF=2.8]. 26. Thombs BD*, Arthurs E, Coronado-Montoya S, Rosemn M, Delisle VC, Leavens A, Levis B, Azoulay L, Smith C, Ciofani L, Coyne JC, Feeley N, Gilbody S, Schinazi J, Stewart DE, Zelkowitz P. Depression screening and patient outcomes in pregnancy or postpartum: a systematic review. J Psychosom Res. 2014;76(6):443-446. [IF=2.8]. 27. Kwakkenbos L, Willems LM, Baron M, Hudson M, Cella D, van den Ende CHM, Thombs BD*, Canadian Scleroderma Research Group. The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): An assessment of differential item functioning in patients with systemic sclerosis. PLOS ONE. 2014;9(3):e91979. [IF=3.5]. 28. Thombs BD*, Ziegelstein RC, Roseman M, Kloda LA, Ioannidis JPA. There are no randomized controlled trials that support the United States Preventive Services Task Force guideline on screening for depression in primary care: A systematic review. BMC Med. 2014;12(1):13. [IF=7.3]. 29. Thombs BD*, Ziegelstein RC. Does depression screening improve depression outcomes in primary care settings? BMJ. 2014;348:g1253. [IF=16.4]. 30. Razykov I, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis: An updated analysis of 959 patients. Rheumatology. 2013;52(11):2056-2061. [IF=4.4]. 31. Thombs BD*, Ziegelstein RC. Depression screening in patients with coronary heart disease: Does the evidence matter? J Psychosom Res. 2013;75(6):497-499. [IF=2.8]. 32. Milette K Hudson M, Körner A, Baron M, Thombs BD*. Sleep disturbances in systemic sclerosis: Evidence for the role of pain, pruritus, and gastrointestinal symptoms. Rheumatology. 2013;52(9):1715-1720. [IF=4.4]. 33. Kwakkenbos L, Jewett LR, Baron M, Bartlett SJ, Furst D, Gottesman K, Khanna D, Malcarne VL, Mayes MD, Mouthon L, Poiraudeau S, Sauve M, Nielson WR, Poole JL, Assassi S, Boutron I, Ells C, van den Ende CHM, Hudson M, Impens A, Körner A, Leite C, Costa Maia A, Mendelson C, Pope J, Steele RJ, Suarez-Almazor ME, Ahmed S, Coronado-Montoya S, Delisle VC, Gholizadeh S, Jang Y, Levis B, Milette K, Mills SD, Razykov I, Sobel RM, Thombs BD*. The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomized controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation intervention trials in a rare disease context. BMJ Open. 2013;3:e003563. [IF=2.1]. 34. Meijer A, Roseman M, Delisle VC, Milette K, Levis B, Syamchandra A, Stefanek ME, Ziegelstein RC, Stewart DE, de Jonge P, Coyne JC, Thombs BD*. Effects of screening for psychological distress on patient outcomes in cancer? A systematic review. J Psychosom Res. 2013;75(1):1-17. [IF=2.8]. 2012-2013 35. Razykov I, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. The utility of the PHQ-9 to assess suicide risk in patients with systemic sclerosis. Arthritis Care Res. 2013;65(5):753-758. [IF=3.7]. 36. Jewett LR, Razykov I, Hudson M, Baron M, Thombs BD*. Lifetime, 12-month, and 30-day prevalence of major depressive disorder among patients with systemic sclerosis. Rheumatology. 2013;52(4):669-675. [IF=4.2]. 37. Körner A, Drapeau M, Thombs BD, Rosberger Z, Wang B, Khanna M, Spatz A, Coroiu A, Garland R, Batist G. Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care. BMC Dermatology. 2013;3. [IF=N/A]. 38. Kwakkenbos L, Arthurs E, van den Hoogen FHJ, Hudson M, van Lankveld WGJM, Baron M, van den Ende CHM, Thombs BD*, Canadian Scleroderma Research Group. Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) Scale in

Brett D. Thombs, PhD: Curriculum Vitae 26 of 55 systemic sclerosis: A comparison of Canadian and Dutch patients. PLOS ONE. 2013;8(1):e53923. [IF=3.7]. 39. Thombs BD*, Roseman M, Coyne JC, de Jonge P, Delisle VC, Arthurs E, Levis B, Ziegelstein R. Does Evidence Support the American Heart Association's Recommendation to Screen Patients for Depression in Cardiovascular Care? An Updated Systematic Review. PLOS ONE. 2013;8(1):e52654. [IF=3.7]. 40. Levis B, Burri A, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Comparison of rates of sexual activity and dysfunction between women with systemic sclerosis and women from a population sample. PLOS ONE. 2012;7(12):e52129. [IF=3.7]. 41. Arthurs E, Steele R, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Are scores on the English and French versions of the PHQ-9 comparable? An assessment of differential item functioning. PLOS ONE. 2012;7(12):e52028. [IF=3.7]. 42. Delisle V, Abbey SE, Beck AT, Dobson KS, Dozois DJA, Grace SL, Stewart DE, Ziegelstein RC, Thombs BD*. The influence of somatic symptoms on Beck Depression Inventory scores in hospitalized post-myocardial infarction patients. Can J Psychiatry. 2012;57(12):752-758. [IF=2.5]. 43. Harel D, Thombs BD*, Hudson M, Baron M. Steele R, Canadian Scleroderma Research Group. Measuring fatigue in systemic sclerosis: A comparison of the SF-36 Vitality subscale and FACIT fatigue scale. Rheumatology. 2012;51(12):2177-2185. [IF=4.2]. 44. Thombs BD*, Roseman M, Kloda LA. Depression screening and mental health outcomes in children and adolescents: A systematic review protocol. Systematic Reviews. 2012:1:58. [IF=N/A]. 45. Thombs BD*, Razykov I. Inappropriate self-citation via peer review: A simple solution. CMAJ. 2012;184(16):1864. [IF=6.5]. 46. Sjonnesen K, Berzins S, Fiest K, Bulloch AGM, Metz LM, Thombs BD, Patten SB. Evaluation of the PHQ-9 as an assessment instrument for symptoms of depression in multiple sclerosis patients. Postgrad Med. 2012;124(5):69-77. [IF=2.0]. 47. Delisle VC, Arthurs E, Abbey SE, Grace SL, Stewart DE, Steele R, Ziegelstein R, Thombs BD*. Somatic Symptom Reporting on the Beck Depression Inventory Among Post-Myocardial Infarction Patients: In-hospital Versus Follow-up Assessments. J Psychosom Res. 2012;73(5):356-361. [IF=3.3]. 48. Wathen CN, MacGregor JCD, Hammerton J, Coben JH, Herrman H, Stewart DE, MacMilllan HL, PreVAiL Research Network. Priorities for research in child maltreatment, intimate partner violence and resilience to violence exposures: results of an international Delphi consensus development process. BMC Public Health. 2012;12:684. [IF=2.1]. 49. Roseman M, Turner EH, Lexchin J, Coyne JC, Bero LA, Thombs BD*. Reporting of conflict of interest from drug trials in Cochrane reviews: A cross-sectional study. BMJ. 2012;345:e5155. [IF=17.2]. 50. Leavens A, Patten S, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Influence of somatic symptoms on PHQ-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample. Arthritis Care Res. 2012;64(8):1195-1201. [IF=3.7]. 51. Delisle VC, Beck AT, Ziegelstein RC, Thombs BD*. Symptoms of heart disease or its treatment may increase Beck Depression Inventory scores in hospitalized post-myocardial infarction patients. J Psychosom Res. 2012;73(3):157-162. [IF=3.3]. 52. Razykov I, Ziegelstein RC, Whooley MA, Thombs BD*. The PHQ-9 versus the PHQ-8 – Is Item 9 useful for assessing suicide risk in coronary artery disease patients? Data from the Heart and Soul Study. J Psychosom Res. 2012;73(3):163-168. [IF=3.3]. 53. Bassel M, Hudson M, Baron M, Taillefer SS, Mouthon L, Poiraudeau S, Poole JL, Thombs BD*. Physical and occupational therapy referral and use among systemic sclerosis patients with impaired hand function: Results from a Canadian national survey. Clin Exp Rheumatol. 2012;30(4):574-577. [IF=2.7]. 54. Nath Y, Paris J, Thombs BD, Kirmayer LJ. Prevalence and social determinants of suicidal behaviours among college youth in India. Int J Soc Psychiatry. 2012;58(4):393-399. [IF=1.5]. 55. Newton E, Thombs BD*, Groleau D. The experience of emotional distress among women with scleroderma. Qual Health Res. 2012;22(9):1195-1206 [IF=2.2].

Brett D. Thombs, PhD: Curriculum Vitae 27 of 55 2011-2012 56. Thombs BD*, Jewett LR, Assassi S, Baron M, Bartlett S, Costa Maia A, El-Baalbaki G, Furst D, Gottesman K, Haythornthwaite JA, Hudson M, Impens A, Korner A, Leite C, Mayes MD, Malcarne VL, Motivala SJ, Mouthon L, Nielson WR, Plante D, Poiraudeau S, Poole JL, Pope J, Sauve M, Steele RJ, Suarez-Almazor ME, Taillefer S, van den Ende C, Arthurs E, Bassel M, Delisle V, Milette K, Leavens A, Razykov I, Khanna D. New directions for patient-centered care in scleroderma: The Scleroderma Patient-centered Intervention Network (SPIN). Clin Exp Rheumatol. 2012;30(Suppl. 71):S23-S29. [IF=2.1]. 57. Thombs BD*, Ziegelstein RC. When prevention is a bad idea: Problems with the DECARD trial and the premise behind it. J Psychosom Res. 2012;72(5):333-335. [IF=3.3]. 58. Jewett LR, Hudson M, Baron M, Malcarne V, Thombs BD*, Canadian Scleroderma Research Group. Sociodemographic and disease correlates of body image distress among patients with systemic sclerosis. PLOS ONE. 2012;7(3):e33281. [IF=4.1]. 59. Thombs BD*, Coyne JC, Cuijpers P, de Jonge P, Gilbody S, Ioannidis JPA, Johnson BT, Patten SB, Turner EH, Ziegelstein RC. Rethinking recommendations for depression screening in primary care. CMAJ. 2012;184(4):413-418. [IF=8.2]. 60. Levis B, Hudson M, Knafo R, Baron M, Nielson WR, Hill M, Thombs BD*, Canadian Scleroderma Research Group. Sexual activity and impairment among women with systemic sclerosis. Arthritis Care Res. 2012;64(3):340-350. [IF=4.9]. 61. Delisle V, Beck AT, Dobson KS, Dozois DJA, Thombs BD*. Revisiting gender differences in somatic symptoms of depression: Much ado about nothing? PLOS ONE. 2012;7(2):d32490. [IF=4.1]. 62. Adeponle A, Thombs BD, Groleau D, Jarvis EG, Kirmayer LJ. Use of the cultural formulation to resolve uncertainty in the diagnosis of psychosis among ethnocultural minority and immigrant patients. Psychiatr Serv. 2012;63(2):147-153. [IF=2.4]. 63. El-Baalbaki G, Lober J, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. A comparison of the McGill Pain Questionnaire and single-item pain measures in systemic sclerosis. J Rheumatol. 2011;38(2):2581-2587. [IF=3.7]. 64. Meijer A, Roseman M, Milette K, Coyne JC, Stefanek M, Ziegelstein RC, Arthurs E, Leavens A, Palmer SC, Stewart DE, De Jonge P, Thombs BD*. Depression screening and patient outcomes in cancer: A systematic review. PLOS ONE. 2011; 6(11): e27181. [IF=4.1]. 65. Czarny MJ, Arthurs E, Coffee D-F, Smith C, Ziegelstein RC, Thombs BD*. The prevalence of antidepressant prescription or use in patients with acute coronary syndrome: A systematic review. PLOS ONE 2011;6(11): e27671. [IF=4.1]. 66. Thombs BD*, Körner A. Is there evidence that depression screening benefits patients with chronic medical illness? Should physicians routinely screen for depression in the absence of evidence? Der Nervenarzt. 2011;82(11):1469-1475. [IF=0.7]. 67. Magyar-Russell G, Thombs BD, Cai JX, Baveja T, Kuhl E, Singh PP, Barroso MMB, Arthurs E, Roseman M, Amin N, Marine J, Ziegelstein RC. Prevalence of anxiety and depression in patients with implantable cardioverter defibrillators: A systematic review of the literature. J Psychosom Res. 2011;71(4):223-231. [IF=3.3]. 68. Pottie K, Greenaway C, Feightner J, Welch V, Greenaway C, Swinkels H, Rashid M, Narasiah L, Kirmayer L, Ueffing E, MacDonald N, Hassan G, McNally C, Kahn K, Burhmann R, Dunn S, Dominic A, McCarthy AE, Gagnon A, Rousseau C, Tugwell P and the Canadian Collaboration for Immigrant and Refugee Health (listed author). Review: Evidence-based clinical guidelines for immigrants and refugees. CMAJ. 2011;183:E824-E925. [IF=8.2]. 69. Hassan G, Thombs BD, Rousseau C, Kirmayer LJ, Feightner J, Ueffing E, Pottie K. Child Maltreatment: Evidence-based clinical guidelines for immigrants and refugees. CMAJ. 2011;183:E824-E925, Appendix 12. [IF=8.2]. 70. Hassan G, Thombs BD, Rousseau C, Kirmayer LJ, Feightner J, Ueffing E, Pottie K. Intimate Partner Violence: Evidence-based clinical guidelines for immigrants and refugees. CMAJ. 183:E824- E925, Appendix 13. [IF=8.2].

Brett D. Thombs, PhD: Curriculum Vitae 28 of 55 71. Rousseau C, Pottie K, Thombs BD, Munoz M, Jurcik T. Post Traumatic Stress Disorder: Evidence- based clinical guidelines for immigrants and refugees. CMAJ. 2011;183:E824-E925, Appendix 11. [IF=8.2]. 72. Thombs BD*, Arthurs E, El-Baalbaki G, Meijer A, Ziegelstein RC, Steele RJ. Risk of bias from inclusion of patients who already have diagnosis of or are undergoing treatment for depression in diagnostic accuracy studies of screening tools for depression: systematic review. BMJ. 2011;343:d4825. [IF=14.1]. 2010-2011 73. Roest A, Thombs BD, Grace SL, Stewart DE, Abbey SE, de Jonge P. Somatic/affective, but not cognitive/affective symptoms, of depression after acute coronary syndrome are associated with 12- month all-cause mortality. J Affect Disord. 2011;131(1-3):158-163. [IF=3.7]. 74. Knafo R, Haythorthwaite JA, Heinberg L, Wigley F, Thombs BD*. The association of body image distress and pain with sexual impairment in women with systemic sclerosis. Rheumatol. 2011;50(6):1125-1130. [IF=4.2]. 75. Meijer A, Conradi HJ, Bos E, Thombs BD, van Melle J, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry. 2011;33(3):203-216. [IF=2.8]. 76. Rousseau C, Hassan G, Moreau N, Thombs BD. The perception of discrimination and its association with mental health in newly arrived immigrants before and after 9/11. Am J of Public Health. 2011;101(5):909-915. [IF=3.9]. 77. Milette K, Razykov I, Pope J, Hudson M, Baron M, Thombs BD*. Clinical correlates of sleep problems in systemic sclerosis. Rheumatol. 2011;50(5):921-925. [IF=4.2] 78. Bassel M, Hudson M, Taillefer S, Schieir O, Baron M, Thombs BD*. Frequency and impact of symptoms experienced by patients with systemic sclerosis: Results from a Canadian national survey. Rheumatol. 2011;50(4):762-767. [IF=4.2]. 79. Zuidersma M, Thombs BD, de Jonge P. Onset and recurrence of depression as a predictor for worsened cardiovascular prognosis in depressed ACS patients: a systematic review. Psychother Psychosom. 2011;80(4):227-237. [IF=6.0]. 80. Roseman M, Milette K, Bero LA, Lexchin J, Turner E, Coyne JC, Thombs BD*. Reporting of conflicts of interest in meta-analyses of pharmacological treatments. JAMA. 2011;305(10):1008- 1017. [IF=30.0]. 81. Milette K, Roseman M, Thombs BD*. Transparency of outcome reporting and trial registration of randomized controlled trials in psychosomatic and behavioural health research: A systematic review. J Psychosom Res. 2011;70(3):205-217. [IF=2.8]. 82. De Jonge P, Conradi HJ, Thombs BD, Rosmalen JGM, Burger H, Ormel J. Prevention of false positive findings in observational studies: Registration will not work But replication might. J Epidemiol Community Health. 2011;65(2):95-96. [IF=3.0]. 83. Lawrence JW, Rosenberg L, Rimmer RB, Thombs BD, Fauerbach JA. Measuring perceived stigmatization and social comfort among pediatric burn survivors. Rehabil Psychol. 2010;55(4):360- 371. [IF=1.7]. 84. Jewett LR, Hudson M, Haythornthwaite JA, Heinberg L, Wigley F, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Development and validation of the Brief-Satisfaction with Appearance Scale (Brief-SWAP) for systemic sclerosis. Arthritis Care Res. 2010;62(12):1779-1786. [IF=4.7]. 85. Hudson M, Impens A, Baron M, Thombs BD, Walker JG, Steele R, Canadian Scleroderma Research Group. Discordance between patient and physician assessments of disease severity in systemic sclerosis. J Rheumatol. 2010;37(11):2307-2312. [IF=3.6]. 86. El-Baalbaki G, Razykov I, Hudson M, Bassel M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. The association of pruritus with quality of life and disability in systemic sclerosis. Arthritis Care Res. 2010;62(10):1489-1495. [IF=4.7]. 87. Eze-Nliam CM, Thombs BD, Lima BB, Smith CG, Ziegelstein RC. The association of depression with adherence to antihypertensive medications: A systematic review. J Hypertens. 2010;28(9):1785-1795. [IF=4.0].

Brett D. Thombs, PhD: Curriculum Vitae 29 of 55 88. Thombs BD*, van Lankveld W, Bassel M, Baron M, Buzza R, Haslam S, Haythornthwaite JA, Hudson M, Jewett LR, Knafo R, Kwakkenbos L, Malcarne V, Milette K, Motivala S, Newton EG, Nielson W, Pacy M, Razykov I, Schieir O, Worron-Sauve M, Taillefer S. Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda. Arthritis Care Res. 2010;62(8):1181-1189. [IF=4.7]. 89. Thombs BD*, Ziegelstein RC, de Jonge P, Grace SL, Pilote L, Dozois DJA, Beck AT, Fuss S, Stewart DE, Ormel J, Dobson KS, Abbey SE. Somatic symptom overlap in Beck Depression Inventory-II Scores following myocardial infarction. Br J Psychiatry. 2010;197(1):61-66. [IF=5.9]. 2009-2010 90. Bhar SS, Thombs BD, Pignotti M, Bassel M, Jewett LR, Coyne JC, Beck AT. Is long term psychdynamic psychotherapy more efficacious than shorter term therapies? Review of the evidence. Psychother Psychosom. 2010;79(4):208-216. [IF=5.4]. 91. Thombs BD*, Adeponle AB, Kirmayer LJ, Morgan JF. A Brief Scale for Assessing Hospital Doctors’ Attitudes Toward Collaborative Care for Mental Health (DACC-MH). Can J Psychiatry. 2010;55(4):264-267. [IF=2.2]. 92. Milette K, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: Internal consistency reliability, convergent validity, and clinical correlates. Rheumatology. 2010;49(4):789-796. [IF=4.2]. 93. Coyne JC, Thombs BD, Hagedoorn M. Ain’t necessarily so: Review and critique of recent meta- analyses of behavioral medicine interventions in Health Psychology. Health Psychol. 2010;29(2):107-116. [IF=3.5]. 94. Schieir O, Thombs BD*, Hudson M, Boivin JF, Steele R, Bernatsky S, Hanley J, Baron M, Canadian Scleroderma Research Group. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res. 2010;62(3):409-417. [IF=4.2]. 95. Zhao Y, Montoro R, Igartua K, Thombs BD*. Risk for suicide ideation and attempt among adolescents reporting “unsure” sexual identity or heterosexual identity plus same-sex attraction or behavior: Forgotten groups? J Am Acad Child Adolesc Psychiatry. 2010;49(2):104-113. [IF=5.0]. 96. Parakh K, Bhat U, Thombs BD, Fauerbach JA, Bush DE, Ziegelstein RC. Self-Assessed Physical Health Predicts Ten-Year Mortality after Myocardial Infarction. J Cardiopulm Rehabil Prev. 2010;30(1):35-39. [IF=1.6]. 97. Stefanek M, Palmer SC, Thombs BD, Coyne JC. Finding what is not there: Unwarranted claims of an effect of psychosocial intervention on recurrence and survival. Cancer. 2009;115(24):5612-5616. [IF=5.4]. 98. Razykov I, Thombs BD*, Hudson M, Bassel M, Baron M, Canadian Scleroderma Research Group. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthritis Care Res. 2009;61(12):1765-1770. [IF=4.2]. 99. Igartua K, Thombs BD, Burgos G, Montoro R. Concordance and discrepancy in sexual identity, attraction, and behaviour among adolescents. J Adolesc Health. 2009;45(6):602-608. [IF=3.3]. 100. Hudson M, Steele R, Lu Y, Thombs BD, Schieir O, Baron M, Canadian Scleroderma Research Group. Work disability in systemic sclerosis. J Rheumatol. 2009;36(11):2481-2486. [IF=3.9]. 101. Thombs BD*, Bernstein DP, Lobbestael J, Arntz A. A validation study of the Dutch Childhood Trauma Questionnaire – Short Form: Factor structure, reliability, and known-groups validity. Child Abuse Negl. 2009;33(8):518-523. [IF=2.3]. 102. Thombs BD*, Jewett LR, Knafo R, Coyne JC, Ziegelstein RC. Learning from history: A commentary on the AHA Scientific Advisory on depression screening. Am Heart J. 2009;158(4):503- 505. [IF=4.4]. 103. Knafo R, Thombs BD*, Jewett LR, Hudson M, Wigley F, Haythornthwaite JA. (Not) talking about sex. A systematic comparison of sexual impairment in women with systematic sclerosis and other chronic disease samples. Rheumatology. 2009;48(10):1300-1303. [IF=4.2]. 104. Ziegelstein RC, Thombs BD, Coyne JC, de Jonge P. Routine screening for depression in patients with coronary heart disease: Never mind. J Am Coll Cardiol. 2009;54(10):886-890. [IF=12.5].

Brett D. Thombs, PhD: Curriculum Vitae 30 of 55 105. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Canadian Scleroderma Research Group. Health-related quality of life in systemic sclerosis: A systematic review. Arthritis Care Res. 2009;61(8):1112-1120. [IF=4.2]. 106. Thombs BD*, Hudson M, Bassel M, Taillefer SS, Baron M, Canadian Scleroderma Research Group. Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis. Arthritis Care Res. 2009;61(7):966-973. [IF=4.2]. 2008-2009 107. Hudson M, Steele R, Lu Y, Thombs BD, Panopalis P, Baron M, Canadian Scleroderma Research Group. Clinical correlates of self-reported physical health status in systemic sclerosis. J Rheumatol. 2009;36(6):1226-1229. [IF=3.3]. 108. Ruiz-Casares M, Thombs BD*, Rousseau C. The association of single and double orphanhood with symptoms of depression among children and adolescents in Namibia. Eur Child Adolesc Psychiatry. 2009;18(6):369-376. [IF=1.8]. 109. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Canadian Scleroderma Research Group. Quality of life in systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol. 2009;36(4):768-772. [IF=3.3]. 110. Coyne JC, Thombs BD, Stefanek M, Palmer SC. Time to let go of the illusion that psychotherapy extends the survival of cancer patients: A reply to Kraemer and colleagues. Psychol Bull. 2009;135(2):179-182. [IF=12.6]. 111. Schieir O, Thombs BD*, Berkson L, Couture F, Fitzcharles MA, Gagné M, Garfield B, Gutkowski A, Hudson M, Kang H, Kapusta M, Ligier S, Mathieu J-P, Ménard H, Starr M, Stein M, Zummer M, Baron M. Symptoms of depression predict trajectory of pain among patients with early inflammatory arthritis: A path analysis approach to assessing pain. J Rheumatol. 2009;36(2):231-239. [IF=3.3]. 112. Hudson M, Thombs BD, Baron M, Canadian Scleroderma Research Group. Time to diagnosis in systemic sclerosis: Is gender a factor? Arthritis Care Res. 2009;61(2):274-278. [IF=6.8]. 113. Adeponle AB, Thombs BD*, Adelekan ML, Kirmayer LJ. Family participation in treatment and post- discharge appointment and medication adherence at a Nigerian psychiatric hospital. Br J Psychiatry. 2009;194(1):86-87. [IF=5.1]. 114. Thombs BD*, Ziegelstein RC, Whooley MA. Optimizing detection of major depression among patients with coronary artery disease using the Patient Health Questionnaire: Data from the Heart and Soul Study. J Gen Intern Med. 2008;23(12):2014-2017. [IF=2.7]. 115. Thombs BD*, Ziegelstein RC, Stewart DE, Abbey SE, Parakh K, Grace SL. Physical Health Status Assessed During Hospitalization for Acute Coronary Syndrome Predicts Mortality 12 Months Later. J Psychosom Res. 2008;65(6):587-593. [IF=2.5]. 116. Thombs BD*, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, Mitchell AJ, Zuidersma M, Eze-Nliam C, Bezerra B, Smith CG, Soderlund K, Ziegelstein RC. Depression screening and patient outcomes in cardiovascular care: A systematic review. JAMA. 2008;300(18):2161-2171. [IF=31.7]. 117. Parakh K, Thombs BD, Bhat U, Fauerbach JA, Bush DE, Ziegelstein RC. Long-term significance of Killip class and left ventricular systolic dysfunction. Am J Med. 2008;121(11):1015-1018. [IF=5.1]. 118. Thombs BD*, Bassel M, McGuire L, Smith MT, Hudson M, Haythornthwaite JA. Fatigue in systemic sclerosis: A systematic comparison with other chronic illnesses. Rheumatology. 2008;47(10):1559- 1563. [IF=4.1]. 119. Thombs BD*, Ziegelstein RC, Stewart DE, Abbey SE, Parakh K, Grace SL. Usefulness of a single- item general self-rated health question to predict mortality 12 months after an acute coronary syndrome. Eur J Cardiovasc Prev Rehabil. 2008;15(4):479-481. [IF=2.4]. 120. Thombs BD*, Ziegelstein RC, Beck CA, Pilote L. A general factor model for the Beck Depression Inventory – II: Validation in a sample of patients hospitalized with acute myocardial infarction. J Psychosom Res. 2008;65(2):115-121. [IF=2.5]. 121. Thombs BD*, Ziegelstein RC, Parakh K, Stewart DE, Abbey SE, Grace SL. Probit structural equation regression model: General depressive symptoms predicted post-myocardial infarction mortality after controlling for somatic symptoms of depression. J Clin Epidemiol. 2008;61(8):832- 839. [IF=2.9].

Brett D. Thombs, PhD: Curriculum Vitae 31 of 55 2007-2008 122. Kirmayer LJ, Thombs BD, Jurcik T, Jarvis GE, Guzder J. Use of the DSM-IV cultural formulation on a cultural consultation service. Psychiatr Serv. 2008;59(6):683-686. [IF=2.1]. 123. Baron M, Sutton E, Hudson M, Thombs BD, Markland J, Pope J, Robinson D, Jones N, Docherty P, Abu-Hakima M, LeClercq S, Smith D, Mathieu J-P. The relationship of dyspnea to function and quality of life in systemic sclerosis. Ann Rheum Dis. 2008;67(5):644-650. [IF=6.4]. 124. Thombs BD*, Hudson M, Taillefer SS, Baron M, Canadian Scleroderma Research Group. Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Care Res. 2008;59(4):504-509. [IF=7.7]. 125. Parakh K, Thombs BD, Fauerbach JA, Bush DE, Ziegelstein RC. Effect of depression on late (8 years) mortality after myocardial infarction. Am J Cardiol. 2008;101(5):602-606. [IF=3.6]. 126. Thombs BD*, Hudson M, Schieir O, Taillefer SS, Baron M, Canadian Scleroderma Research Group. Reliability and validity of the Center for Epidemiological Studies Depression Scale in patients with systemic sclerosis. Arthritis Care Res. 2008;59(3):438-443. [IF=7.7]. 127. Thombs BD*, Fuss S, Hudson M, Schieir O, Taillefer SS, Fogel J, Ford DE, Baron M, Canadian Scleroderma Research Group. High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis Care Res. 2008;59(3):431-437. [IF=7.7]. 128. Thombs BD*. Patient and injury characteristics, mortality risk, and length of stay related to child abuse by burning: Evidence from a national sample of 15,802 pediatric admissions. Ann Surg. 2008;247(3):519-523. [IF=7.4]. 129. Hudson M, Thombs BD, Steele R, Watte R, Taillefer S, Baron M, Canadian Scleroderma Research Group. Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disease Assessment Schedule II. Arthritis Care Res. 2008;59(2):279-284. [IF=7.7]. 130. Thombs BD*, Notes LD, Magyar-Russell G, Lawrence JW, Bresnick MG, Fauerbach JA. Body image satisfaction in burn survivors: From survival to socialization. J Psychosom Res. 2008;64(2):205-212. [IF=1.9]. 131. Thombs BD*, Bresnick MG. Mortality risk and length of stay associated with self-inflicted burn injury: Evidence from a national sample of 30,382 adult patients. Crit Care Med. 2008;36(1):118- 125. [IF=6.3]. 132. Thombs BD*, Ziegelstein RC, Stewart DE, Abbey SE, Parakh K, Grace SL. Usefulness of persistent symptoms of depression to predict physical health status 12 months after an acute coronary syndrome. Am J Cardiol. 2008;101(1):15-19. [IF=3.6]. 133. Edwards RR, Magyar-Russell G, Thombs B, Smith MT, Holavanahalli R, Patterson DR, Blakeney P, Lezotte D, Haythornthwaite JA, Fauerbach JA. Acute pain at discharge from hospitalization is a prospective predictor of long-term suicidal ideation after burn injury. Arch Phys Med Rehabil. 2007;88(12 Supplement 2):S36-42. [IF=1.8]. 134. Thombs BD*, Miller SD, Ziegelstein RC. On pot, potomania, and (couch) potatoes: The link between habits and mood. J Psychosom Res. 2007;63(5):459-462. [IF=1.9]. 135. Thombs BD*, Lewis C, Bernstein DP, Medrano MA, Hatch JP. An evaluation of the measurement invariance of the Childhood Trauma Questionnaire – Short Form across gender and race in a sample of drug abusing adults. J Psychosom Res. 2007;63(4):391-398. [IF=1.9]. 2006-2007 136. Thombs BD*, Taillefer SS, Hudson M, Baron M. Depression in patients with scleroderma. A systematic review of the evidence. Arthritis Care Res. 2007;57(6):1089-1097. [IF=7.8]. 137. Price LA, Thombs BD, Chen CL, Milner SM. Liver disease in burn injury: Evidence from a national sample of 31,338 adult patients. J Burns Wounds. 2007;7(June 12):e1. [IF=N/A]. 138. Thombs BD*. Use of the Beck Depression Inventory for assessing depression in patients hospitalized with burn injuries: Disentangling symptoms of depressed mood from injury and treatment factors. Burns. 2007;33(5):547-553. [IF=1.1].

Brett D. Thombs, PhD: Curriculum Vitae 32 of 55 139. Ziegelstein RC, Meuchel J, Kim TJ, Latif M, Alvarez W, Dasgupta N, Thombs BD. Selective serotonin reuptake inhibitors in hospitalized acute coronary syndrome patients. Am J Med. 2007;120(6):525-530. [IF=4.5]. 140. Thombs BD*, Bresnick MG, Magyar-Russell G. Who attempts suicide by burning? An analysis of age patterns of mortality by self-inflicted burning in the United States. Gen Hosp Psychiatry. 2007;29(3):244-250. [IF=2.5]. 141. Thombs BD*, Magyar-Russell G, Bass EB, Stewart KJ, Tsilidis KK, Bush DE, Fauerbach JA, McCann UD, Ziegelstein RC. Performance characteristics of depression screening instruments in survivors of acute myocardial infarction: A review of the evidence. Psychosomatics. 2007;48(3):185- 194. [IF=2.0]. 142. Thombs BD*, Singh VA, Milner SM. The effect of pre-existing medical comorbidities on mortality and length of hospital stay in acute burn injury: Evidence from a national sample of 31,338 adult patients. Ann Surg. 2007;245(4):629-634. [IF=7.7]. 143. Thombs BD*, Bennett W, Ziegelstein RC, Bernstein DP, Scher CD, Forde DR. Cultural sensitivity in screening adults for a history of childhood abuse: Evidence from a community sample. J Gen Intern Med. 2007;22(3):368-373. [IF=3.0]. 144. Thombs BD*, Bresnick MG, Magyar-Russell G, Lawrence JW, McCann UD, Fauerbach JA. Symptoms of depression predict change in physical health after burn injury. Burns. 2007;33(3):292- 298. [IF=1.1]. 145. Thombs BD*, Bernstein DP, Ziegelstein RC, Bennett W, Walker EA. A brief 2-item screener for detecting a history of physical or sexual abuse in childhood. Gen Hosp Psychiatry. 2007;29(1):8-13. [IF=2.5]. 146. Thombs BD*, Haines J, Bresnick MG, Magyar-Russell G, Fauerbach JA, Spence RJ. Depression in burn reconstruction patients: Symptom prevalence and association with body image dissatisfaction and physical function. Gen Hosp Psychiatry. 2007;29(1):14-20. [IF=2.5]. 147. Brummett BR, Wade JC, Ponterotto JG, Thombs BD, Lewis C. Psychological well-being and a multicultural personality disposition. J Couns Dev. 2007;85(1):73-81. [IF=0.6]. 148. Thombs BD*, Bernstein DP, Ziegelstein RC, Scher CD, Forde DR, Walker EA, Stein MB. An evaluation of screening questions for childhood abuse in two community samples: Implications for clinical practice. Arch Intern Med. 2006;166(18):2020-2026. [IF=7.9]. 149. Thombs BD*, Bresnick MG, Magyar-Russell. Depression in survivors of burn injury: A systematic review. Gen Hosp Psychiatry. 2006;28(6):494-502. [IF=2.5]. 150. Lawrence JW, Fauerbach JA, Thombs BD. Frequency and correlates of depression symptoms among long-term adult burn survivors. Rehabil Psychology. 2006;51(4):306-313. [IF=0.9]. 2005-2006 151. Thombs BD*, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, Fauerbach JA, Bush DE, Ziegelstein RC. Prevalence of depression in survivors of acute myocardial infarction: A review of the evidence. J Gen Intern Med. 2006;21(1):30-38. [IF=3.0]. 152. Thombs BD*, Singh VA, Milner SM. Children under 4 years are at greater risk of mortality following acute burn injury: Evidence from a national sample of 12,902 pediatric admissions. Shock. 2006;26(4):348-352. [IF=3.1]. 153. Esselman PC, Thombs BD, Fauerbach JA, Magyar-Russell G. Burn rehabilitation: State of the science. Am J Phys Med Rehabil. 2006;85(4):383-413. [IF=1.1]. 154. Lawrence JW, Fauerbach JA, Heinberg LJ, Doctor M, Thombs BD. The reliability and validity of the Perceived Stigmatization Questionnaire (PSQ) and the Social Comfort Questionnaire (SCQ) among an adult burn survivor sample. Psychol Assess. 2006;18(1):106-11. [IF=2.6]. 155. Lawrence JW, Fauerbach JA, Thombs BD. A test of the moderating role of importance of appearance in relation between perceived scar severity and body-esteem among adult burn survivors. Body Image. 2006;3(2):101-111. [IF = N/A]. 156. Fauerbach JA, Bush DE, Thombs BD, McCann UD, Fogel J, Ziegelstein RC. Depression following acute myocardial infarction: a prospective relationship with ongoing health and function. Psychosomatics. 2005; 46(4):355-361. [IF=2.3].

Brett D. Thombs, PhD: Curriculum Vitae 33 of 55 2004-2005 157. McCann UD, Fauerbach JA, Thombs BD. Anxiety and cardiac disease. Prim Psychiatry. 2005;12(5):47-50. [IF=N/A]. 158. Thombs BD*, Fauerbach JA, McCann UD. Posttraumatic stress disorders following injury: Assessment and treatment. Prim Psychiatry. 2005;12(5):51-55. [IF=N/A]. 159. Ziegelstein RC, Kim SY, Kao D, Fauerbach JA, Thombs BD, McCann U, et al. Can doctors and nurses recognize depression in patients hospitalized with an acute myocardial infarction in the absence of formal screening? Psychosom Med. 2005;67(3):393-7. [IF=3.4].

G.3.3. Peer-Reviewed Technical Reports Produced for Government Agencies 1. Bush DE, Ziegelstein RC, Patel UV, Thombs BD, Ford DE, Fauerbach JA, et al. Evidence report on post-myocardial infarction depression. Agency for Healthcare Research and Quality Evidence Report/Technology Assessment. (Prepared by the Johns Hopkins Evidence-based Practice Center, Baltimore, MD). 2005. 2. Esselman PC, Thombs BD, Fauerbach JA, Magyar-Russell, G, Price MC. State of the science in rehabilitation from burn injury. National Institute on Disability and Rehabilitation Research White Paper. 2005.

G.3.4. Other Reports 1. Taillefer SS, Bernstein J, Schieir O, Buzza R, Hudson M, Baron M, Thombs BD, Scleroderma Society of Canada, Canadian Scleroderma Research Group. Canadian scleroderma patient survey of health concerns and research priorities: An initiative of the Scleroderma Society of Canada and the Canadian Scleroderma Research Group. 2010.

G.3.5. Invited Editorials, Commentaries 1. Ells C, Thombs BD. Ethically managing incidental findings. CMAJ. 2014;186(9):655-656. [IF=6.5]. 2. Thombs BD*, Stewart DE. Depression screening in pregnancy and postpartum: Who needs evidence? J Psychosom Res. 2014;76(6):492-493. [IF=3.3]. 3. Thombs BD*, Ziegelstein RC. Depression screening in primary care: Why the Canadian Task Force on Preventive Health Care did the right thing. Can J Psychiatry. 2013;58(12):692-696. [IF=2.5]. 4. Thombs BD*, Coyne JC. Moving forward by moving back: Re-assessing guidelines for cancer distress screening. J Psychosom Res. 2013;75(1):20-22. [IF=3.3]. 5. Thombs BD*. Quantitative – other: A depression screening tool finds that 54% of acute cardiac patients are at risk of depression: use of the tool improves documentation and referral. Evid Based Nurs 2013;16(2):47-48. [IF=N/A]. 6. Ziegelstein RC, Thombs BD. Coping with Rising Health Care Costs. Arch Intern Med. 2012;172(21):1684-1685. [IF=11.5]. 7. Ziegelstein RC, Thombs BD. Is routine screening a parachute for heart disease patients with depression? J Psychosom Res. 2011;71(1):3-5. [IF=2.8]. 8. Thombs BD*, Ziegelstein RC. Back to the future in style: Psychosomatic research in cardiovascular disease. J Psychosom Res. 2009;67(1):1-3. [IF=2.5]. 9. Ziegelstein RC, Thombs BD. The brain and the heart: The twain meet. Eur Heart J. 2005;26(24):2607-8. [IF=7.3]. 10. Thombs BD*, Fauerbach JA. A cross-cultural study of perceived stress among parents of children with large burn injuries: a comment on Rose et al. J Burn Care Rehabil. 2005;26(5):444-445. [IF=1.1].

G.3.6. Letters to the Editor and Replies 1. Thombs BD*. Routine depression screening for patients with diabetes. JAMA. 2014;312(22):2411. [IF=35.3]. 2. Thombs BD*, Stewart DE. Depression screening in pregnancy and postpartum: How close are we? J Psychosom Res. 2014;77(3):244-245. [IF=2.7].

Brett D. Thombs, PhD: Curriculum Vitae 34 of 55 3. Thombs BD*, Ziegelstein RC. Patient engagement programs and treatment of depression. JAMA. 2014;311(11):1158-1159. [IF=30.0]. 4. Thombs BD*, Razykov I, Hudson M, Baron M. The utility of the PHQ-9 to assess suicide risk in patients with systemic sclerosis - Reply. Arthritis Care Res. 2014;66(3):497-498. [IF=3.7]. 5. Thombs BD*, Ells C, Black L. Patient Reported Outcome Alert Monitoring. JAMA. 2014;311(4):420. 6. Thombs BD*, Ziegelstein RC. Evidence Does Matter - and Evidence Does Not Support the National Heart Foundation of Australia's Consensus Statement on Depression Screening. J Psychosom Res. 2014;76(2):173-174. [IF=3.3]. 7. Coronado-Montoya S, Kwakkenbos L, Levis B, Thombs BD*. Reassessing the clinical utility of the Patient Health Questionnaire (PHQ-9) for depression screening in prenatal women: A commentary on Sidebottom et al. Arch Womens Ment Health. 2013;16(3):253-254. [IF=2.0]. 8. Thombs BD*. Clarification of the REMIT trial protocol. Am Heart J. 2012;164(5):e15. [IF=4.5]. 9. Thombs BD*. No Evidence for Depression Screening in Cardiovascular Care Settings: A Comment on CANMAT Task Force Recommendations. Ann Clin Psychiatry. 2012;24(4):319-322. [IF=1.5]. 10. Hudson M, Thombs BD, Steele R, Baron M. Patient-reported outcome measures in systemic sclerosis: Comment on the article by Hinchcliff et al. Arthritis Care Res. 2012;64(6):942-943. [IF=4.7]. 11. Razykov I, Levis B, Thombs BD*. Screening for depression and risk of suicide in patients with arthritis: Comment on the article by Tektonidou et al. Arthritis Care Res. 2012;64(4):623. [IF=4.7]. 12. Thombs BD*. Postpartum depression screening: a comment on Leung et al. J Public Health. 2012;34(1):162-163. [IF=1.9]. 13. Thombs BD*, Coyne JC, Cuijpers P, de Jonge P, Gilbody S, Ioannidis JPA, Johnson BT, Patten SB, Turner EH, Ziegelstein RC. Rethinking the article by Thombs and colleagues – the authors respond. CMAJ. 2012;184(4):438-439. [IF=9.0]. 14. Delisle VC, Arthurs E, Ziegelstein RC, Thombs BD*. A Meta-Analysis of Selective Serotonin Reuptake Inhibitors in Acute Coronary Syndrome: Cause for Concern. J Psychopharmacol. 2011;25(12):1730-1731. [IF=3.6]. 15. Arthurs E, Leavens A, Levis B, Thombs BD*. Are couple-oriented interventions effective across chronic illnesses? A commentary on Martire et al. Ann Behav Med. 2011;42(1):134-135. [IF=3.2]. 16. Leavens A, Arthurs E, Thombs BD*. Should postpartum depression screening policies be re- evaluated? A commentary on Kozhimannil et al. Health Aff. 2011;30(6):1216. [IF=3.8]. 17. Thombs BD*, Jewett LR, Bassel M. Is there room for criticism of studies of psychodynamic psychotherapy? Am Psychol. 2011;66(2):148-149. [IF=6.0]. 18. Coyne JC, Hagedoorn M, Thombs BD. Most Published and Unpublished Dissertations Should Be Excluded from Meta-Analyses: Comment on Moyer et al. Psychooncology. 2011;20(2):224-225. [IF=2.9]. 19. Zhao Y, Montoro R, Igartua K, Thombs BD*. Sexual orientation and suicide: A comment on Renaud et al. Can J Psychiatry. 2010;55(11):746-747. [IF=2.5]. 20. Palmer SC, Stefanek ME, Thombs BD, Coyne JC. Psychological intervention and survival: Wishing does not make it so. Clin Cancer Res. 2010;16(21):5364-5365. [IF=7.3]. 21. Milette K, El-Baalbaki G, Thombs BD*. Letter to the Editor: Intimacy and psychological distress among couples coping with head and neck or lung cancer. Psychooncology. 2010;19(11):1235-1236. [IF=2.9]. 22. El-Baalbaki G, Arthurs E, Levis B, Thombs BD*. Effects of befriending on depressive symptoms and distress: A precautionary note on promising findings. Br J Psychiatry. 2010;197(3):247. [IF=5.9]. 23. Thombs BD*, Roseman M, Arthurs E. Prenatal and postpartum depression in fathers and mothers. JAMA. 2010;304(9):961. [IF=30.0]. 24. Thombs BD*. Traumatic brain injury and major depressive disorder. JAMA. 2010;304(8):857. [IF=30.0]. 25. Knafo R, Jewett LR, Bassel M, Thombs BD*. Sexual function in women with systemic sclerosis: A comment on Schouffoer et al. Arthritis Care Res. 2010;62(8):1200. [IF=4.7]. 26. Razykov I, Newton EG, Lober J, Thombs BD*. Daily SMS reminders for asthma treatment adherence: A comment on Strandbygaard et al. Respir Med. 2010;104(8):1234-1235. [IF=2.5]. 27. Jewett LR, Newton E, Smith S, Thombs BD*. Time to Abandon Small-Sample Cohort Research in Health Psychology? Health Psychol. 2010;29(4):339-340. [IF=4.0].

Brett D. Thombs, PhD: Curriculum Vitae 35 of 55 28. Roseman M, Milette K, Zhao Y, Thombs BD*. Is Optimism Associated with Physical Health? A Commentary on Rasmussen et al. Ann Behav Med. 2010;37(3):204-206. [IF=3.2]. 29. Adeponle AB, Thombs BD*. Depression in hospitalized and stable heart failure patients in an urban Nigerian teaching hospital: A cautionary comment. Gen Hosp Psychiatry. 2010;32(2):e1-e2. [IF=2.7]. 30. Ziegelstein RC, Thombs BD, de Jonge P, Coyne JC. No laughing matter – reply. J Am Coll Cardiol. 2010;55(8):836-837. [IF=12.5]. 31. Schieir O, Milette K, Adeponle A, Thombs BD*. The effectiveness of tai chi for chronic musculoskeletal pain conditions: Is the evidence ready for meta-analysis? Comment on the article by Hall et al. Arthritis Care Res. 2010;62(1):139-140. [IF=4.2]. 32. Knafo R, Zhao Y, Newton E, Thombs BD*. In reference to Sexual Problems After Total or Partial Laryngectomy. Laryngoscope. 2009;119(8):1667-1668. [IF=2.0]. 33. Newton E, Jewett LR, Thombs BD*. Childhood psychosocial stressors and adult onset arthritis: A comment on Von Korff et al. Pain. 2009;144(3):340-344. [IF=5.4]. 34. Thombs BD*, Schieir O, Knafo R, Ziegelstein RC. Timing may be important, but methodology is everything: A commentary on Parker et al. Biol Psychiatry. 2009;66(3):e1-e2. [IF=8.9]. 35. Thombs BD*, Coyne JC. Should alternative diagnostic criteria be used to assess major depression severity among patients with cancer? A comment on Akechi et al. Gen Hosp Psychiatry. 2009;31(4):397-398. [IF=2.7]. 36. Coyne JC, Thombs BD, Mitchell AJ. Monahan et al.: PHQ-9 and PHQ-2 in Western Kenya. J Gen Intern Med. 2009;24(7):890. [IF=2.7]. 37. Thombs BD*, Adeponle AB, Kirmayer LJ, Rousseau C, Ziegelstein RC. More antidepressants for African Americans with coronary heart disease? Maybe – maybe not. Am Heart J. 2009;157(5):e33. [IF=4.3]. 38. Thombs BD*, de Jonge P, Ziegelstein RC. Screening for depression in patients with coronary heart disease – reply. JAMA. 2009;301(13):1338. [IF=31.7]. 39. Coyne JC, Thombs BD, Hagedoorn M. A meta-analysis of psychosocial interventions for cancer patients gone awry. Ann Behav Med. 2009;37(1):94-96. [IF=3.2]. 40. Thombs BD*, Bassel M, Jewett LR. Analyzing effectiveness of long-term psychodynamic psychotherapy. JAMA. 2009;301(9):930. [IF=31.7]. 41. Thombs BD*. Do more predictors improve mortality risk estimates among burn patients? Comment on McGwin et al. Burns. 2009;35(2):303-304. [IF=1.6]. 42. Thombs BD*, Hudson M. Problems using aggregate scores of the Medical Outcomes Study 36-item Short Form Health Survey in knee and hip osteoarthritis: Possible solutions. Osteoarthritis Cartilage. 2008;16(11):1431-1432. [IF=4.1]. 43. Coyne JC, Thombs BD. Was it shown that "close relationships and emotional processing predict decreased mortality in women with breast cancer?" A critique of Weihs et al. (2008). Psychosom Med. 2008;70(6):737-738. [IF=3.5]. 44. Eze-Nliam CM, Thombs BD, Bezerra Lima B, Smith CG, Ziegelstein RC. Depression and adherence to antihypertensive therapy. Am J Hypertens. 2008;21(7):724-725. [IF=3.1]. 45. Thombs BD*, Ziegelstein RC. Diabetes, depression, and death: A randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT): Response to Bogner et al. Diabetes Care. 2008;31(6):e54. [IF=7.9]. 46. Thombs BD*, Ziegelstein RC. The effect of a primary care practice-based depression intervention on mortality in older adults: Replication needed. Ann Intern Med. 2008;148(3):244-245. [IF=15.5]. 47. Thombs BD*. Perceived social support predicts outcomes following myocardial infarction: A call for screening? Health Psychol. 2008;27(1):1. [IF=3.0]. 48. Thombs BD*, Ziegelstein RC. Retrospective screening of patients for age of initial diagnosis of coronary artery disease: Shouldn’t we just ask? J Cardiovasc Nurs. 2008;23(1):79-81. [IF=N/A]. 49. Thombs BD*, Parakh K, Ziegelstein RC. Throw the window out the door. J Am Coll Cardiol. 2007;50(15):1519-1520. [IF=11.1]. 50. Hudson M, Thombs B, Baron M. Are the SF-36 physical and mental component scores useful measures in patients with systemic sclerosis? Arthritis & Rheumatism (Arthritis Care & Research). 2007;57(7):1339. [IF=7.7].

Brett D. Thombs, PhD: Curriculum Vitae 36 of 55 51. Parakh K, Bush DE, Ziegelstein RC, Thombs BD, Fauerbach JA. Mortality and adherence to pharmacotherapy after acute myocardial infarction. JAMA. 2007;297(17):1877. [IF=23.2]. 52. Ziegelstein RC, Thombs BD, Parakh K, Stewart DE, Abbey SE, Grace SL. The Brain and the heart: Independent or interactive. J Am Coll Cardiol. 2007;49(17):1824. [IF=9.7]. 53. Thombs BD*, Bresnick MG, Magyar-Russell G, Kim TJ. Early treatment of acute stress symptoms in pediatric burn patients with imipramine and fluoxetine: Commentary on Tcheung et al. Pediatr Crit Care Med. 2006;7(5):498. [IF=N/A]. 54. Thombs BD*, Grace SL, Ziegelstein RC. Do symptom dimensions of depression following myocardial infarction relate differently to physical health indicators and cardiac prognosis? Am J Psychiatry. 2006;163(7):1295-1296. [IF=8.3]. 55. Ziegelstein RC, Thombs BD. The heart, the brain, and the Kounis syndrome: reply. Eur Heart J. 2006;27(6):757-758. [IF=7.3].

G.3.7. Book Reviews 1. Thombs BD*. Review of the book Culture and children’s intelligence: Cross-cultural analysis of the WISC-III. J. Georgas, L. G. Weiss, F. J. R. van de Vijver, & D. H. Saklofske (Eds.). Transcult Psychiatry. 2008:45(4);708-711. [IF=N/A]. G.3.8. Book Chapters 1. Gholizadeh S, Fox RS, Mills SD, Jewett LR, Thombs BD, Malcarne VL. Coping with the disfigurement of scleroderma: Facial, skin, and hand changes. In Varga J, Denton CP, Wigley FM, Allanore Y, Kuwana M (eds.). Scleroderma: From pathogenesis to comprehensive management, 2nd ed. Chicago: Springer. In press. 2. Jewett LR, Kwakkenbos L, Thombs BD*. Psychosocial issues and care for patients with systemic sclerosis. In Varga J, Denton CP, Wigley FM, Allanore Y, Kuwana M (eds.). Scleroderma: From pathogenesis to comprehensive management, 2nd ed. Chicago: Springer. In press. 3. Kwakkenbos L, Thombs BD*. Non-drug approaches to treating Raynaud’s phenomenon. In Wigley FM, Herrick A, Flavahan A (eds.). Raynaud’s phenomenon. Chicago: Springer. 2014. 4. Jewett LR, Haythornthwaite J, Thombs BD*. Psychosocial issues and care for patients with scleroderma. In Varga J, Denton CP, Wigley FM (eds.). Scleroderma: From pathogenesis to comprehensive management. Chicago: Springer. 2012. 5. Jewett LR, Hudson M, Thombs BD*. A 38-year-old woman with elevated muscle enzymes, Raynaud’s phenomenon and positive anti-topoisomerase I antibody: Is she depressed? In Silver RM, Denton CP (eds.), Case studies in systemic sclerosis. Chicago: Springer. 2011. 6. Thombs BD*, Ziegelstein RC. Screening in cardiovascular care. In Mitchell AJ, Coyne JC (eds.), Screening for depression in clinical practice: A practical guide for detection and diagnosis of mood disorders in primary & secondary care, Oxford, UK: Oxford University Press. 2009. 7. Chen EC, Thombs BD, Costa C. Building connection through diversity in group counseling: A dialogical perspective. In Pope-Davis DB, Coleman HLK, Liu WM, Toporek RL (eds.), Handbook of multicultural competencies in counseling and psychology, Thousand Oaks, CA: Sage. 2003.

G.3.9. Professional or Cultural Journals 1. Carrier ME, Kwakkenbos L, Thombs BD*. Help others to live better with scleroderma. The Scleroderma Reporter. Scleroderma Society of Ontario. Spring/Summer 2015. 2. Carrier ME, Kwakkenbos L. Introducing the Scleroderma Patient-centered Intervention Network (SPIN ) Co-Director and Coordinator. The Scleroderma Reporter. Scleroderma Society of Ontario. Spring/Summer 2015 (supervised trainee contribution). 3. Gumuchian S, Delisle VC, Thombs BD*. Illuminating the support group experience: Helping leaders get the support they need. The Scleroderma Reporter. Scleroderma Society of Ontario. Spring/Summer 2015. 4. Thombs BD*. Towards better care for scleroderma: An update from the Scleroderma Patient-centered Intervention Network. The Scleroderma Connection, Scleroderma Society of Canada. Fall 2014.

Brett D. Thombs, PhD: Curriculum Vitae 37 of 55 5. Thombs BD*. Screening for postpartum depression is premature and possibly harmful. New York Times, Room for Debate. June 19, 2014. 6. SPIN Research Group*, Coping with Stress, The Scleroderma Connection, Scleroderma Society of Canada, Spring 2013. 7. Milette K. An update on SPIN’s online self-management program. Scleroderma Voice. Scleroderma Foundation. Summer 2013 (supervised trainee contribution). 8. Milette K. An update on SPIN’s online self-management program. The Scleroderma Connection. Scleroderma Society of Canada. Winter 2013 (supervised trainee contribution). 9. Milette K. An update on SPIN’s online self-management program. Sclerodata. Scleroderma Association of British Columbia. Spring 2013 (supervised trainee contribution). 10. Jewett LR. Scleroderma Patient-centered Intervention Network (SPIN). Sclerodata. Scleroderma Association of British Columbia. Summer 2012 (supervised trainee contribution). 11. Jewett LR. Scleroderma Patient-centered Intervention Network (SPIN). The Researcher – The Canadian Scleroderma Research Group Newsletter. Canadian Scleroderma Research Group. Fall- Winter 2011 (supervised trainee contribution). 12. Thombs BD*. Scleroderma Patient-centered Intervention Network (SPIN). The Scleroderma Report. Scleroderma Society of Ontario. Fall 2011-Winter 2012. 13. Levis B. Sexual functioning in women with scleroderma: the taboo report. Sclerodata. Scleroderma Association of British Columbia. Autumn 2011 (supervised trainee contribution). 14. Jewett LR. Getting under the skin: A look at body image in scleroderma. Canadian Scleroderma a News. Scleroderma Society of Canada. May 2010 (supervised student contribution). 15. Schieir O. The scleroderma pain puzzle: Putting the pieces together. Canadian Scleroderma News. Scleroderma Society of Canada. February 2010 (supervised student contribution). 16. Bassel M. The experience of fatigue: Sick and tired of being sick and tired? Canadian Scleroderma News. Scleroderma Society of Canada. February 2010 (supervised student contribution). 17. Newton E. Scleroderma and sadness: The inside scoop. Canadian Scleroderma News. Scleroderma Society of Canada. November 2009 (supervised student contribution). 18. Thombs BD*. Fatigue in scleroderma: A new Canadian Scleroderma Research Group study. Canadian Scleroderma News. Scleroderma Society of Canada. May 2008. 19. Neel M, Thombs BD, Fauerbach JA. Coping with real, remembered and imagined stress III: Cognitive methods. Burn Support News. Issue II. Grand Rapids, MI: The Phoenix Society, Inc. 2005. 20. Thombs BD*. What do culturally sensitive psychological practices mean? Network for Multicultural Training in Psychology Newsletter, 2003.

G.3.10. Peer-Reviewed Oral Conference Presentations, Symposia 1. Kwakkenbos L, Thombs BD*, Bartlett SJ, Carrier M-E, Hudson M, Mouthon L, Malcarne V, Sauve M, Khanna D, SPIN investigators. The PROMIS-29 in Systemic Sclerosis: Associations with Clinical Characteristics in the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting, San Francisco, California, USA. November 2015. 2. Gholizadeh S, Mills SD, Fox RS, Jewett L, Carrier M-E, Kwakkenbos L, Gottesman K, Roesch SC, Thombs BD, Malcarne VL, SPIN Investigators. A Psychometric Analysis of the Social Interaction Anxiety Scale (SIAS-6) in Systemic Sclerosis: Preliminary results from the Scleroderma Patient- centered Intervention Network (SPIN) Cohort. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting, San Francisco, California, USA, November 2015. 3. Levis B, Benedetti A, Thombs BD. Selective cutoff reporting in diagnostic test accuracy studies of depression screening tools: Comparing traditional meta-analysis to individual patient data meta- analysis. 2015 Cochrane Colloquium. Vienna, Austria. October 2015. 4. Levis B, Benedetti A, Thombs BD. Selective cutoff reporting in studies of diagnostic test accuracy of depression screening tools: Comparing traditional meta-analysis to individual patient data meta- analysis. Preventing Overdiagnosis 2015, Bethesda, Maryland, USA. September 2015. 5. Harel D, Steele RJ, Thombs BD, Hudson M, Baron M, Canadian Scleroderma Research Group. A

Brett D. Thombs, PhD: Curriculum Vitae 38 of 55 weighted summed score for the Center for Epidemiologic Studies - Depression Scale in systemic sclerosis. Joint Statistical Meetings, Seattle, Washington, USA. August 2015. 6. Kwakkenbos L, Minton O, Stone PC, Alexander S, Baron M, Hudson M, Thombs BD. Identifying clinically significant fatigue in rheumatic diseases: a case-definition approach. European League Against Rheumatism Congress 2015, Rome, Italy. June 2015. 7. Levis B, Benedetti A, Levis AW, Thombs BD*. Comparing traditional meta-analysis to individual patient data meta-analysis to assess the diagnostic accuracy of the Patient Health Questionnaire-9. In Thombs BD (Chair), Improving evidence-based psychological services by identifying and reducing reporting biases (Symposium). 2015 Canadian Psychological Association Convention, Ottawa, Ontario, Canada. June 2015. 8. Levis AW, Kelley GA, Thombs BD*. Assessing reporting bias in trials of exercise interventions for pain management in rheumatic diseases: An application of the test for excess significance. In Thombs BD (Chair), Improving evidence-based psychological services by identifying and reducing reporting biases (Symposium). 2015 Canadian Psychological Association Convention, Ottawa, Ontario, Canada. June 2015. 9. Rice DB, Thombs BD*. Sample size specification and population appropriateness in depression screening accuracy studies. In Thombs BD (Chair), Improving evidence-based psychological services by identifying and reducing reporting biases (Symposium). 2015 Canadian Psychological Association Convention, Ottawa, Ontario, Canada. June 2015. 10. Riehm K, Azar M, Thombs BD*. Outcome reporting and trial registration in top behavioral health journals. In Thombs BD (Chair), Improving evidence-based psychological services by identifying and reducing reporting biases (Symposium). 2015 Canadian Psychological Association Convention, Ottawa, Ontario, Canada. June 2015. 11. Kwakkenbos L, Thombs BD*, Bartlett S, Hudson M, Mouthon L, Malcarne V, Sauve M, Khanna D, SPIN Investigators. The PROMIS-29 in systemic sclerosis: associations with clinical characteristics. PROMIS Health Organization Inaugural Conference, Philadelphia, Pennsylvania, USA. May 2015. 12. Bartlett SJ, Carrier ME, Correira H, Kwakkenbos L, Thombs BD*, SPIN Investigators. PROMIS-29 en français: coordinating translation efforts in Canada and France for a universal approach. PROMIS Health Organization Inaugural Conference, Philadelphia, Pennsylvania, USA. May 2015. 13. Jewett LR, Delisle VC, Mendelson C, Malcarne VL, Hudson M, Thombs BD*. Visible differences from medical illness: body image concerns in scleroderma. In symposium (Malcarne VL, discussant): Overcoming barriers to developing, testing, and disseminating interventions for body image distress in a rare disease context: the Scleroderma Patient-centered Intervention Network (SPIN). Appearance Matters 6, Bristol, UK. July 2014. 14. Welling J, Thombs BD*. Patient organizations in the Scleroderma Patient-centered Intervention Network (SPIN): Partner, expert and advocate. In symposium (Malcarne VL, discussant): Overcoming barriers to developing, testing, and disseminating interventions for body image distress in a rare disease context: the Scleroderma Patient-centered Intervention Network (SPIN). Appearance Matters 6, Bristol, UK. July 2014. 15. Kwakkenbos L, Thombs BD*. Leveraging an innovative trial design for pragmatic evaluations of psychological interventions: the cohort multiple randomized controlled trial (cmRCT) design. In symposium (Malcarne VL, discussant): Overcoming barriers to developing, testing, and disseminating interventions for body image distress in a rare disease context: the Scleroderma Patient-centered Intervention Network (SPIN). Appearance Matters 6, Bristol, UK. July 2014. 16. Coronado-Montoya S, Levis AW, Kwakkenbos L, Steele R, Turner EH, Thombs BD*. Application of the excess significance bias test in randomized controlled trials of mindfulness-based mental health interventions. Lady Davis Institute of Medical Research 2014 Annual Retreat, Montreal, Quebec, Canada. May 2014. 17. Thombs BD*, Ziegelstein RC, Roseman M, Kloda LA, Ioannidis JPA. Re-Analysis of the United States Preventive Services Task Force Systematic Review on Screening for Depression in Primary Care. Preventing Overdiagnosis International Conference, Dartmouth University, Hanover, New Hampshire, USA. September 2013. 18. Razykov I, Thombs BD*. The Utility of the PHQ-9 to Assess Suicide Risk in Medical Patients. 2013 World Congress on Suicide – International Academy for Suicide Research, Montreal, Quebec,

Brett D. Thombs, PhD: Curriculum Vitae 39 of 55 Canada, June 2013. 19. Delisle V, Abbey S, Beck A, Dobson KS, Dozois DJA, Grace S, Stewart D, Ziegelstein R, Thombs BD*. The influence of somatic symptoms on Beck Depression Inventory scores in hospitalized post- myocardial infarction patients. In Thombs BD (Chair), Psychological measurement in hospital and health centers (Symposium). 2013 Canadian Psychological Association Convention, Quebec City, Quebec, Canada. June 2013. 20. Jewett L, Hudson M, Heinberg L, Wigley F, Haythornthwaite J, Baron M, Thombs BD*. Assessing visible differences from medical illness: Development and validation of a body image avoidance questionnaire for people living with scleroderma. In Thombs BD (Chair), Psychological measurement in hospital and health centers (Symposium). 2013 Canadian Psychological Association Convention, Quebec City, Quebec, Canada. June 2013. 21. Kwakkenbos L, Arthurs E, van den Hoogen F, Hudson M, van Lankveld W, Baron M, van den Ende C, Thombs BD*. Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) scale in systemic sclerosis: A comparison of Canadian and Dutch patients. In Thombs BD (Chair), Psychological measurement in hospital and health centers (Symposium). 2013 Canadian Psychological Association Convention, Quebec City, Quebec, Canada. June 2013. 22. Razykov I, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. The utility of the Patient Health Questionnaire-9 to assess suicide risk in medical patients. In Thombs BD (Chair), Psychological measurement in hospital and health centers (Symposium). 2013 Canadian Psychological Association Convention, Quebec City, Quebec, Canada. June 2013. 23. Kwakkenbos L, Thombs BD*. Novel approaches for evaluating psychological interventions: The cohort multiple randomized controlled trial (cmRCT) design. Theory Review. 2013 Canadian Psychological Association Convention, Quebec City, Quebec, Canada, June 2013. 24. Levis B, Thombs BD*. Individual patient-data meta-analysis to overcome shortcomings in traditional meta-analysis of screening test accuracy. Theory Review. 2013 Canadian Psychological Association Convention, Quebec City, Quebec, Canada, June 2013. 25. Razykov I, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. The utility of the Patient Health Questionnaire-9 to assess suicide risk in patients with systemic sclerosis. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting, Washington, DC, USA, November 2012. 26. Jewett LR, Hudson M, Baron M, Malcarne V, Thombs BD*, Canadian Scleroderma Research Group. Acquired disfigurement from medical illness: Correlates of body image distress among people with scleroderma. Appearance Matters 5, Bristol, UK, July 2012. 27. Levis B, Hudson M, Knafo R, Baron M, Nielson W, Hill M, Thombs BD*. Frequency and impact of symptoms experienced by patients with systemic sclerosis: Sexual activity and impairment among women with systemic sclerosis. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting, Chicago, Illinois, USA, November 2011. 28. Thombs BD*, Arthurs E, El-Baalbaki G, Meijer A, Ziegelstein R, Steele R. Forecasting yesterday’s weather: The risk of spectrum bias from the inclusion of already diagnosed/treated patients in studies of depression screening tools. 19th Cochrane Colloquium, Madrid, Spain. October 2011. 29. Delisle VC, Beck AT, Dobson KS, Dozois DJA, Thombs BD*. Revisiting differences in somatic symptoms of depression among men and women: Much ado about nothing? National Student Conference of the Canadian Society of Epidemiology and Biostatistics, Montreal, Quebec, Canada. June 2011. 30. Thombs BD*, Arthurs E (presenter), El-Baalbaki G, Meijer A, Ziegelstein R, Steele R. Risk of bias from the inclusion of already diagnosed or treated patients in diagnostic accuracy studies of depression screening tools. National Student Conference of the Canadian Society of Epidemiology and Biostatistics, Montreal, Quebec, Canada. June 2011. 31. Arthurs E, Hudson M, Baron M, Thombs BD*. Are French and English versions of the PHQ-9 comparable? An assessment of differential item functioning. National Student Conference of the Canadian Society of Epidemiology and Biostatistics, Montreal, Quebec, Canada. June 2011. 32. Arthurs E, Hudson M, Baron M, Thombs BD*. Are French and English versions of the PHQ-9 comparable? An assessment of differential item functioning. In Thombs BD (Chair), Myths and

Brett D. Thombs, PhD: Curriculum Vitae 40 of 55 measures: Mental health assessment in medical settings (Symposium). 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada. June 2011. 33. Leavens A, Patten S, Hudson M, Baron M, Thombs BD*. Are self-report depression scales biased in medical settings? Somatic symptoms reported on the PHQ-9 by patients with scleroderma compared to a general population sample. In Thombs BD (Chair), Myths and measures: Mental health assessment in medical settings (Symposium). 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada. June 2011. 34. Delisle V, Dozois DJA, Dobson KS, Beck AT, Thombs BD*. Revisiting the role of somatic symptoms among depressed women and men: Much ado about nothing? In Thombs BD (Chair), Myths and measures: Mental health assessment in medical settings (Symposium). 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada. June 2011. 35. Razykov I, Hudson M, Baron M, Thombs BD*. Screening for suicidal ideation and intent in medical patients: Is the PHQ-9 the answer? In Thombs BD (Chair), Myths and measures: Mental health assessment in medical settings (Symposium). 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada. June 2011. 36. Milette K, Thombs BD*. Moving research into practice: Why trial registration and outcome reporting standards matter. Theory Review. 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada, June 2011. 37. El-Baalbaki G, Lober J, Hudson M, Baron M, Thombs BD*. Measuring pain in systemic sclerosis: The Short-Form McGill Pain Questionnaire or a single-item measure of pain. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting, Atlanta, Georgia, USA, November 2010. 38. Bassel M, Hudson M, Taillefer S, Schieir O, Baron M, Thombs BD*. Frequency and impact of symptoms experienced by patients with systemic sclerosis: Results from a Canadian national survey. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting, Atlanta, Georgia, USA, November 2010. 39. Jewett LR, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Sociodemographic and disease correlates of body image in systemic sclerosis. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting, Atlanta, Georgia, USA, November 2010. 40. Jewett LR, Hudson M, Haythornthwaite JA, Heinberg L, Wigley F, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Development and validation of the Brief-Satisfaction with Appearance Scale (Brief-SWAP) for systemic sclerosis. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting, Atlanta, Georgia, USA, November 2010. 41. Delisle V, Dozois DJA, Dobson KS, Beck AT, Thombs BD*. Do women really report more somatic symptoms of depression than men? Innovations in Gender, Sex, and Health Research, Canadian Institutes of Health Research – Institute of Gender and Health, Toronto, Ontario, Canada, November 2010. 42. Thombs BD*. Should we expect that screening for depression will benefit patients? In BD Thombs (Chair). Current controversies in the definition, identification, and care of depression. Canadian Psychiatric Association Annual Conference, Toronto, Ontario, Canada, September 2010. 43. Roseman M, Milette K, Bero L, Coyne JC, Lexchin J, Turner E, Thombs BD*. Hidden conflicts of interest in meta-analyses of pharmacological treatments. First Annual Lady Davis Institute of Medical Research Scientific Retreat, Montreal, Quebec, Canada, May 2010. 44. Jewett LR, Thombs BD*. Psychological health and well-being in scleroderma: What can we do to help? 41st Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2010. 45. Razykov I, Thombs BD*. Psychological health and well-being in scleroderma: What are the most pressing issues? 41st Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2010. 46. Roseman M, Milette K, Bero L, Coyne JC, Lexchin J, Turner E, Thombs BD*. Hidden conflicts of interest in meta-analyses of pharmacological treatments. 8th Annual Canadian Cochrane Symposium, Ottawa, Ontario, Canada, May 2010.

Brett D. Thombs, PhD: Curriculum Vitae 41 of 55 47. Adeponle AB, Groleau D, Thombs BD, Kirmayer LJ. Use of cultural consultation to resolve uncertainty in the diagnosis of psychosis in immigrant patients. Society for the Study of Psychiatry and Culture, 2010 Annual Conference, Montreal, Quebec, Canada, April-May 2010. 48. Jewett LR, Thombs BD*, Hudson M, Heinberg L, Wigley F, Haythornthwaite JA. Measuring body image avoidance in patients with systemic sclerosis. American College of Rheumatology, 2009 Scientific Meeting, Philadelphia, Pennsylvania, USA, October 2009. 49. Newton E, Schnitzer M, Steele R, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. The longitudinal trajectory of depressive symptoms in systemic sclerosis. American College of Rheumatology, 2009 Scientific Meeting, Philadelphia, Pennsylvania, USA, October 2009. 50. Knafo R, Thombs BD*. Female sexual dysfunction in sclerdoerma: Too important to ignore. In Thombs BD (Chair), Clinical psychology in medical settings: Does one size fit all? (Symposium). 2009 Canadian Psychological Association Convention, Montreal, Quebec, Canada, June 2009. 51. Bassel M, Thombs BD*. The great equalizer: How self-report depression questionnaires disproportionately inflate prevalence estimates. In Thombs BD (Chair), Clinical psychology in medical settings: Does one size fit all? (Symposium). 2009 Canadian Psychological Association Convention, Montreal, Quebec, Canada, June 2009. 52. Newton E, Thombs BD*. A longitudinal analysis of depressive symptoms and treatment among patients with scleroderma. In Thombs BD (Chair), Clinical psychology in medical settings: Does one size fit all? (Symposium). 2009 Canadian Psychological Association Convention, Montreal, Quebec, Canada, June 2009. 53. Jewett L, Thombs BD*. Validity and reliability of the Body Image Avoidance Questionnaire for Acquired Disfigurement (BIAQ-AD). In Thombs BD (Chair), Clinical psychology in medical settings: Does one size fit all? (Symposium). 2009 Canadian Psychological Association Convention, Montreal, Quebec, Canada, June 2009. 54. Thombs BD*. Does size matter? A review of effect sizes. Theory Review. 2009 Canadian Psychological Association Convention, Montreal, Quebec, Canada, June 2009. 55. Thombs BD*. Should we screen for depression in specialty medical settings? A review of screening basics. Theory Review. 2009 Canadian Psychological Association Convention, Montreal, Quebec, Canada, June 2009. 56. Knafo R, Thombs BD*, Jewett L, Hudson M, Wigley F, Haythornthwaite JA. The impact of systemic sclerosis on female sexual function: A systematic comparison study. McGill University Department of Psychiatry Student Research Day, Montreal, Quebec, Canada, May 2009. 57. Bassel M, Thombs BD*, Hudson M, Taillefer SS, Baron M, Canadian Scleroderma Research Group. Sociodemographic, disease, and symptom correlates of fatigue in scleroderma. 40th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2009. 58. Newton E, Thombs BD*, Hudson M, Steele R, Schnitzer M, Taillefer S, Baron M, Canadian Scleroderma Research Group. The longitudinal trajectory of depressive symptoms in systemic sclerosis. 40th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2009. 59. Schieir O, Thombs BD*, Hudson M, Boivin JF, Steele R, Bernatsky S, Hanley J, Baron M, Canadian Scleroderma Research Group. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. 40th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2009. 60. Razykov I, Thombs BD*, Hudson M, Bassel M, Baron M, Canadian Scleroderma Research Group. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. 40th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2009. 61. Jewett LR, Thombs BD*, Hudson M, Heinberg L, Wigley F, Haythornthwaite J. Development of body image avoidance measures for patients with scleroderma. 40th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2009. 62. Knafo R, Thombs BD*, Jewett LR, Hudson M, Wigley F, Haythornthwaite J. A systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples. 40th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2009.

Brett D. Thombs, PhD: Curriculum Vitae 42 of 55 63. Coyne JC, Thombs BD, Hagedoorn M, Meta-analyses to establish the effectiveness of psychosocial interventions in health psychology: Is the literature ready? Society of Behavioral Medicine, 30th Annual Meeting & Scientific Sessions, Montreal, Quebec, Canada, April 2009. 64. Schieir O, Thombs BD*, Hudson M, Boivin JF, Hanley J, Taillefer S, Canadian Scleroderma Research Group, Baron M. Pain in systemic sclerosis: Examining clinical correlates of pain in patients with systemic sclerosis. Department of Epidemiology, Biostatistics, and Occupational Health Research Day, McGill University, Montreal, Quebec, Canada, April 2008. 65. Thombs BD*, Whooley MA, Ziegelstein RC. Identifying and addressing barriers to screening for depression in cardiovascular care. In Ziegelstein RC (Chair), Why don't cardiologists care (about depression and anxiety)? – Identifying and overcoming barriers. (Symposium). American Psychosomatic Society, 66th Annual Scientific Conference, Baltimore, Maryland, USA, March 2008. 66. Montoro R, Thombs BD, Burgos G, Igartua K. Suicide and harassment based on being perceived as gay: Results from the Quebec Youth Risk Behaviour Survey. 7th Congress of the International Society for Adolescent Psychiatry and Psychology, Montreal, Quebec, Canada, July 2007. 67. Thombs BD*. Cross-cultural measurement in clinical psychology: Methodological and practical considerations. In Ryder AG (Chair), Research at the intersection of clinical and cultural psychology: The study of mental health in context, part I. (Symposium). Canadian Psychological Association, 2007 Annual Convention, Ottawa Ontario, Canada, June 2007. 68. Schieir O, Thombs BD*, Couture F, Fitzcharles MA, Gagne M, Garfield B, Gutkowski A, Kang H, Kapusta M, Ligier S, Mathieu JP, Menard H, Starr M, Stein M, Zummer M, Baron M. Baseline depression predicts depression and pain at 6 month when controlling for objective disease severity; 38th Laurentian Conference of Rheumatology; Mont Tremblant Quebec, Canada, May 2007. 69. Thombs BD*, Singh VA, Milner SM. Increased risk of mortality in burn injury related to medical comorbidities: Evidence from the National Burn Repository. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S74. 70. Singh VA, Thombs BD, Milner SM. Increased risk of mortality in burn injury among children under four years old: Evidence from the National Burn Repository. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S61. 71. Thombs BD*, Singh VA, Milner SM. Female gender as a risk factor for mortality from burn injury: Evidence from the National Burn Repository. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S104. 72. Lawrence JW, Rosenberg L, Thombs BD, Fauerbach JA. Comparing parent and child perceptions of stigmatizing behavior. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S67. 73. Lawrence JW, Rosenberg L, Thombs BD, Fauerbach JA. Comparing the body-esteem of adolescent and young adult burn survivors to a nonburned control group. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S120. 74. Thombs BD*, Lattyak RM, Magyar-Russell G, Lawrence JW, Fauerbach JA. Screening for symptoms of acute stress in patients with burn injury: An evaluation of the Stanford Acute Stress Reaction Questionnaire. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S89. 75. Magyar-Russell GM, Bresnick MG, DeLateur BJ, Fauerbach JA, Ober MS, Thombs BD, Notes LD. The impact of psychological factors on adherence to a therapeutic exercise program among burn survivors. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S103. 76. Thombs BD*, Bresnick MG, Lawrence JW, McCann UD, Magyar-Russell G, Fauerbach JA. Depression in burn injury: Prevalence, persistence, comorbidity with PTSD, and association with functional outcome. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S85. 77. Lawrence JW, Rosenberg L, Thombs BD, Fauerbach JA. Measuring perceived stigmatization among pediatric burn survivors. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S88. 78. Fauerbach JA, Lezotte D, Holavanahalli R, Wiechman S, Engrav L, Kowalske K, B. DeLateur, MD, Thombs BD, Milner S, Patterson DR. Defining and tracking impairment after burn injury. Proc Amer

Brett D. Thombs, PhD: Curriculum Vitae 43 of 55 Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S101. 79. McKibben JB, Magyar-Russell G, Fauerbach JA, Thombs BD, Lawrence JW. Predicting post traumatic stress disorder from acute stress disorder in burn injured patients: A longitudinal study. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S104. 80. Fauerbach JA, Lezotte D, Engrav L, Kowalske K, DeLateur BJ, Holavanahalli R, Magyar-Russell GM, McKibben J, Thombs BD, Patterson DR. Measuring post-burn participation in home, work and social Roles. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S102. 81. Fauerbach JA, Thombs BD, Lezotte D, Holavanahalli R, Wiechman S, Engrav L, Kowalske K, DeLateur BJ, Magyar-Russell GM, Patterson Dr. Early predictors of long term psychological distress. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S76. 82. Fauerbach JA, Heltshe S, Lezotte D, Holavanahalli R, Maygar-Russell GM, McKibben J, Thombs BD, Kowlaske K, Patterson DR, deLateur BJ. Early predictors of long-term participation in society following burn injury. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S64. 83. Notes LD, Magyar-Russell G, Lawrence JW, Fauerbach JA, Thombs BD. Body image satisfaction in burn survivors: Transition from the hospital to the community. Mid-Atlantic Burn Association, 28th Annual Meeting, Princeton New Jersey, USA, November 2005. 84. Lattyak RM, Bresnick MG, Notes LD, Magyar-Russell G, Fauerbach JA, Thombs BD*. A systematic review of posttraumatic stress disorders after burn injury: Implications for assessment and treatment. Mid-Atlantic Burn Association, 28th Annual Meeting, Princeton New Jersey, USA, November 2005. 85. Bresnick MG, Lattyak RM, Notes LD, Magyar-Russell G, Fauerbach JA, Thombs BD*. A systematic review of depression after burn injury: Implications for assessment and treatment. Mid-Atlantic Burn Association, 28th Annual Meeting, Princeton New Jersey, USA, November 2005. 86. Ullrich PM, Wiechman SA, Fauerbach JA, Kowalske KJ, Blakeney P, Engrav LH, Esselman PC, Lezotte DC, Thombs BD, Patterson DR. Course of distress over two-years among patients followed at NIDRR Burn Model System sites. Proc Amer Burn Assoc, 37th Annual Meeting, Chicago Illinois, USA, April 2005. J Burn Care Res. 2005;26(2 Suppl):S115. 87. Lawrence JW, Fauerbach JA, Thombs BD. Burn severity and importance of appearance: Testing the competence x importance model of body-esteem. Proc Amer Burn Assoc, 37th Annual Meeting, Chicago Illinois, USA, April 2005. J Burn Care Res. 2005;26(2 Suppl):S115. 88. Thombs BD*, Fauerbach JA, Lawrence JW, Wiechman SA, Patterson DR, Kowalske KJ, Blakeney P, Rose MW. Body image satisfaction in burn survivors: Natural history across periods of wound healing, maximal scar activity, and approaching scar maturity. Proc Amer Burn Assoc, 37th Annual Meeting, Chicago Illinois, USA, April 2005. J Burn Care Res. 2005;26(2 Suppl):S56. 89. Thombs BD*. Psychological assessment in patients with acute burn injuries. Mid-Atlantic Burn Association, 27th Annual Meeting, Baltimore Maryland, USA, December 2004. 90. Thombs BD*. The diverse therapy group: How valid is consensual validation? American Psychological Association, 2002 Annual Convention, Chicago Illinois, USA, August 2002. 91. Thombs BD*. Building connection through feedback in the diverse counseling group: The group leader as participant-observer. In Trammel RL & Chen EC (Co-Chairs), Working with diverse populations in groups: Competencies, issues, and challenges (Symposium). American Psychological Association, 2001 Annual Convention, San Francisco California, USA, August 2001.

G.3.11. Peer-Reviewed Poster Presentations 1. Azar M, Rice D, Kwakkenbos L, Carrier ME, Shrier I, Hudson M, Thombs BD, SPIN Investigators. Exercise Habits and Associated Factors in Scleroderma: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study. 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 2. Carrier ME, Kwakkenbos L, Thombs BD, SPIN Investigators. An International Collaboration to

Brett D. Thombs, PhD: Curriculum Vitae 44 of 55 Collect Data and Develop Online Interventions for Scleroderma Patients and an Update from the Scleroderma Patient-centered Intervention Network (SPIN). 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 3. Delisle VC, Gumuchian ST, Malcarne VL, El-Baalbaki G, Pelaez S, Thombs BD. The Scleroderma Support Group Team. The Scleroderma Support Group Survey: Understanding People’s Experiences with Scleroderma Support Groups. 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 4. Delisle VC, Jewett LR, Malcarne VL, Hudson M, Thombs BD. The Experience of Being Diagnosed and Living with Scleroderma: Improving Communication Between Patients and Health Care Professionals. 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 5. Gholizadeh S, Mills SD, Fox RS, Jewett LR, Carrier ME, Kwakkenbos L, Gottesman K, Roesch SC, Thombs BD, Malcarne VL, SPIN Investigators. A Psychometric Analysis of the Social Interaction Anxiety Scale (SIAS-6) in Systemic Sclerosis: Results from the Scleroderma Patient-centered Intervention Network Cohort. 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 6. Gumuchian ST, Delisle VC, Peláez S, Carrier ME, Jewett L, El-Baalbaki G, Kwakkenbos L, Thombs BD, Bartlett SJ. Exploring the Sources of Emotional Distress and Management Strategies among People Living with Scleroderma through Focus Groups: A Scleroderma Patient-centered Intervention Network Study. 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 7. Jewett LR, Delisle VC, Malcarne VL, Peláez S, Hudson M, Thombs BD. The Experience of Living with Visible Differences from Scleroderma. 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 8. Jewett LR, Malcarne VL, Kwakkenbos L, Harcourt D, Rumsey N, Körner A, Steele RJ, Hudson M, Baron M, Haythornthwaite JA, Heinberg L, Wigley FM, Thombs BD, Canadian Scleroderma Research Group (CSRG). Development and Validation of the Body Concealment Scale For Scleroderma (BCSS). 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 9. Kwakkenbos L, Thombs BD, Bartlett SJ, Carrier ME, Hudson M, Mouthon L, Malcarne V, Sauve M, Khanna D, SPIN Investigators. Associations of Clinical Disease Characteristics with PROMIS-29 Domains: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study. 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 10. Kwakkenbos L, Thombs BD, Bartlett SJ, Carrier ME, Hudson M, Mouthon L, Malcarne V, Sauve M, Khanna D, SPIN Investigators. Construct Validity of the PROMIS-29 in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study. 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 11. Levis B, Kwakkenbos L, Hudson M, Baron M, Thombs BD. Fatigue in Scleroderma: A Canadian Scleroderma Research Group Study Investigating Sociodemographic and Disease Correlates. 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 12. Mills SD, Gholizadeh S, Fox RS, Jewett LR, Carrier ME, Kwakkenbos L, Gottesman K, Roesch SC, Thombs BD, Malcarne VL, the SPIN Investigators. Psychometric Properties of the Social Appearance Anxiety Scale in Patients with Limited and Diffuse Systemic Sclerosis: Analysis from the Scleroderma Patient-centered Intervention Network Cohort. 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 13. Rice D, Kwakkenbos L, Steele R, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group. Characteristics of Patients with Clinically Significant Fatigue in Scleroderma. 4th Systemic Sclerosis World Congress, Lisbon. Portugal. February 2016. 14. Riehm KE, Kwakkenbos L, Carrier ME, Nielson W, Nielsen K, Thombs BD, SPIN Investigators. Can the Self-Efficacy to Manage Chronic Disease Scale Be Used to Evaluate Self-Efficacy in Patients with Systemic Sclerosis? A Scleroderma Patient-Centered Intervention Network Cohort Study. 4th Systemic Sclerosis World Congress, Lisbon, Portugal. February 2016. 15. Kwakkenbos L, Thombs BD*, Bartlett SJ, Carrier M-E, Hudson M, Mouthon L, Malcarne V, Sauve M, Khanna D, SPIN investigators. Construct Validity of the PROMIS-29 in Systemic Sclerosis: Results from the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific

Brett D. Thombs, PhD: Curriculum Vitae 45 of 55 Meeting, San Francisco, California, USA. November 2015. 16. Mills SD, Gholizadeh S, Fox RS, Jewett LR, Carrier M-E, Kwakkenbos L, Gottesman K, Roesch SC, Thombs BD, Malcarne VL, SPIN Investigators. Psychometric Properties of the Social Appearance Anxiety Scale in Patients with Limited and Diffuse Systemic Sclerosis: Analysis from the Scleroderma Patient-centered Intervention Network Cohort. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting, San Francisco, California, USA. November 2015. 17. Coroiu A, Kwakkenbos L, Thombs BD, Korner A. The Self-Compassion Scale (SCS): Confirmatory factor analysis with a general population sample. 49th Annual Convention of the Association of Behavioral and Cognitive Therapies, Chicago, Illinois, USA. November 2015. 18. Azar M, Rice D, Hudson M, Kwakkenbos L, Thombs BD*, SPIN Investigators. Exercise Habits and its Associated Factors in Scleroderma. 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 2015. 19. Carrier M-E, Kwakkenbos L, Thombs BD*, SPIN investigators. An international collaboration to collect data and develop online interventions for scleroderma patients: the Scleroderma Patient- centered Intervention Network (SPIN). 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 2015. 20. Delisle VC, Gumuchian ST, Malcarne V, Hudson M, Thombs BD*. The Scleroderma Support Group Survey: Understanding people’s experiences with scleroderma support groups. 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 2015. 21. Delisle VC, Jewett L, Malcarne V, Hudson M, Thombs BD*, Canadian Scleroderma Research Group. The experience of being diagnosed and living with scleroderma: improving communication between patients and health care professionals. 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 2015. 22. Gumuchian S, Delisle V, Razykov I, Carrier M-E, El-Baalbaki G, Kwakkenbos L, Thombs BD*, Bartlett SJ. Using focus group discussions to develop an online resource to help individuals with scleroderma manage emotional distress. 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 2015. 23. Jewett LR, Delisle VC, Peláez S, Malcarne VL, Hudson M, Thombs BD*. The experience of living with visible differences from a rare and unpredictable disease: Body image in scleroderma. 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 2015. 24. Kwakkenbos L, Thombs BD*, Bartlett S, Hudson M, Mouthon L, Malcarne V, Sauve M, Khanna D, SPIN investigators. Measuring quality of life in scleroderma using the PROMIS-29 measure: evidence from the Scleroderma Patient-centered Intervention Network (SPIN). 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 2015. 25. Levis B, Kwakkenbos L, Coronado-Montoya S, Hudson M, Baron M, Thombs BD*. Sociodemographic and Disease Variables Associated with Fatigue in Systemic Sclerosis. 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 2015. 26. Milette K, Nielson W, Khanna D, Thombs BD*. Learning from personal experiences of people coping with and managing scleroderma. 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 2015. 27. Rice D, Kwakkenbos L, Steele R, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Characteristics of patients with clinically significant fatigue in scleroderma. 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 2015. 28. Riehm KE, Kwakkenbos L, Carrier ME, Nielson W, Nielsen K, Thombs BD*, SPIN Investigators. Can the Self-Efficacy to Manage Chronic Disease Scale be used to evaluate self-efficacy in patients with systemic sclerosis? A psychometric analysis in the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort. 2015 Scleroderma National Conference, Scleroderma Society of Canada, Hamilton, Ontario, Canada. September 2015. 29. Jewett LR, Delisle VC, Malcarne VL, Hudson M, Thombs BD*. Living with visible differences from a rare disease: Body image in scleroderma. 123rd American Psychological Association Convention,

Brett D. Thombs, PhD: Curriculum Vitae 46 of 55 Toronto, Ontario, Canada, August 2015. 30. Levis B, Benedetti A, Levis AW, Thombs BD*. Selective cutoff reporting in studies of diagnostic accuracy of depression screening tools. 123rd American Psychological Association Convention, Toronto, Ontario, Canada, August 2015. 31. Rice DB, Thombs BD*. Sample Size Specification and Population Appropriateness in Depression Screening Accuracy Studies. 123rd American Psychological Association Convention, Toronto, Ontario, Canada, August 2015. 32. Kwakkenbos L, Thombs BD*, Bartlett S, Hudson M, Mouthon L, Malcarne V, Sauve M, Khanna D, SPIN investigators. Construct validity of the PROMIS-29 in systemic sclerosis: preliminary results from the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. European League Against Rheumatism Congress 2015, Rome, Italy. June 2015. 33. Levis AW, Kelley GA, Thombs BD*. Assessing reporting bias in trials of exercise interventions for pain management in rheumatic diseases: An application of the test for excess significance. European League Against Rheumatism Congress 2015, Rome, Italy. June 2015. 34. Levis B, Benedetti A, Levis AW, Thombs BD*. Selective cutoff reporting in studies of diagnostic test accuracy of depression screening tools: Comparing traditional meta-analysis to individual patient data meta-analysis. Society for Epidemiologic Research 48th Annual Meeting. Denver, Colorado, USA. June 2015. 35. Rice DB, Thombs BD*. Sample Size Specification and Population Appropriateness in Depression Screening Accuracy Studies. 2015 Canadian Psychological Association Convention, Ottawa, Ontario, Canada, June 2015. 36. Levis B, Benedetti A, Levis AW, Thombs BD*. Selective reporting in studies of diagnostic test accuracy: Comparing traditional meta-analysis to individual patient data meta-analysis to assess the diagnostic accuracy of the Patient Health Questionnaire-9. 2015 Canadian Psychological Association Convention, Ottawa, Ontario, Canada, June 2015. 37. Gumuchian S, Delisle V, Razykov I, Carrier M-E, El-Baalbaki G, Kwakkenbos L, Thombs BD, Bartlett S. Focus groups to inform the development of a scleroderma emotional distress internet- based tool. 2015 Canadian Psychological Association Convention, Ottawa, Ontario, Canada, June 2015. 38. Delisle VC, Jewett LR, Malcarne VL, Hudson M, Thombs BD*. The experience of being diagnosed and living with scleroderma. Improving communication between patients and health care professionals. 2015 Canadian Psychological Association Convention, Ottawa, Ontario, Canada, June 2015. 39. Jewett LR, Delisle VC, Malcarne VL, Hudson M, Thombs BD*. The experience of living with visible differences from a rare and unpredictable disease: Body image in scleroderma. 2015 Canadian Psychological Association Convention, Ottawa, Ontario, Canada, June 2015. 40. Coroiu A, Kwakkenbos L, Thombs BD, Körner A. Preliminary evaluation of a 7-item melanoma knowledge questionnaire. 2015 Canadian Psychological Association Convention, Ottawa, Ontario, Canada, June 2015. 41. Kwakkenbos L, Thombs BD*, Bartlett S, Hudson M, Mouthon L, Malcarne V, Sauve M, Khanna D, SPIN Investigators. Construct validity of the PROMIS-29 in systemic sclerosis: preliminary results from the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. PROMIS Health Organization Inaugural Conference, Philadelphia, Pennsylvania, USA. May 2015. 42. Levis B, Kwakkenbos L, Coronado-Montoya S, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Sociodemographic and disease correlates of fatigue in systemic sclerosis. 46th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2015. 43. Rice D, Kwakkenbos L, Steele R, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Demographic and disease correlates of clinically significant fatigue in systemic sclerosis: Preliminary evidence using case-definition criteria. 46th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada. May 2015. 44. Gumuchian S, Delisle V, Razykov I, Carrier, M-E, El-Baalbaki G, Kwakkenbos L, Thombs BD*, Bartlett SJ. Focus groups to inform the development of a scleroderma emotional distress coping tool. 46th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2015.

Brett D. Thombs, PhD: Curriculum Vitae 47 of 55 45. Kwakkenbos L, Thombs BD*. Novel approaches for pragmatic evaluations and dissemination of E- health interventions: the Scleroderma Patient-centered Intervention Network. 4th Association for Researchers in Psychology and Health Conference, Ghent, Belgium, February 2015. 46. Kwakkenbos L, Minton O, Stone PC, Alexander S, Baron M, Hudson M, Thombs BD*. Case- definition criteria for identifying patients with clinically significant fatigue in chronic medical illness. 4th Association for Researchers in Psychology and Health Conference, Ghent, Belgium, February 2015. 47. Mills SD, Fox RS, Gholizadeh S, Roesch SC, Baron M, Hudson M, Steele R, Thombs BD, Malcarne VL. Trajectories of disability over time among patients with systemic sclerosis. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting, Boston, MA, USA, November 2014. 48. Kwakkenbos L, Thombs BD*. Overcoming barriers to developing, testing, and disseminating psychosocial and rehabilitation interventions in a rare disease context: the Scleroderma Patient- centered Intervention Network (SPIN). International Conference on Rare Disease and Orphan Drugs (ICORD) Annual Meeting, Ede, The Netherlands. October 2014. 49. Kwakkenbos L, Jewett LR, Thombs BD*. Overcoming barriers to developing, testing, and disseminating psychosocial and rehabilitation interventions in a rare disease context: the Scleroderma Patient-centered Intervention Network (SPIN). International Society for Research on Internet Interventions (ISRII) 7th Scientific Meeting, Valencia, Spain, October 2014. 50. Thombs BD*. The Scleroderma Patient-centered Intervention Network (SPIN) for conducting large- scale international trials of non-pharmacological interventions in scleroderma: A way ahead for lupus? Lupus 2014, Quebec City, Quebec, Canada, September 2014. 51. Milette K, Mendelson C, Khanna D, Nielson W, Thombs*. The SPIN self-management program for scleroderma: Learning from personal experiences (preliminary analysis). 122nd American Psychological Association Convention, Washington, DC, USA, August 2014. 52. Levis B, Razykov I, Kwakkenbos L, Hudson M, Baron M, Hagedoorn M, Thombs BD*, Canadian Scleroderma Research Group. The role of marital satisfaction in emotional distress among women with scleroderma. 45th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2014. 53. Kwakkenbos L, Jewett LR, Thombs BD*, SPIN Investigators. An international collaboration to conduct large-scale trials of non-pharmacological interventions in scleroderma: the Scleroderma Patient-centered Intervention Network (SPIN). 45th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2014. 54. Kwakkenbos L, Willems LM, Baron M, Hudson M, van den Ende CHM, Thombs BD*, Canadian Scleroderma Research Group. Can scores from English, French and Dutch versions of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) be pooled? An assessment of differential item functioning in patients with systemic sclerosis. 45th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, May 2014. 55. Coronado-Montoya S, Levis AW, Kwakkenbos L, Steele RJ, Turner EH, Thombs BD. Application of the excess significance bias test in randomized controlled trials of mindfulness-based mental health interventions: a cross-sectional study. Cochrane Canada 11th Annual Symposium, Ottawa, Ontario, Canada, April 2014. 56. Malcarne VL, Mayes MD, Assassi S, Fox RS, Gholizadeh S, Gottesman K, Harcourt D, Kwakkenbos L, Jewett LR, Mendelson C, Mills SD, Rumsey N, Strohauer T, Williamson H, Thombs BD. Developing an Intervention for Body Image Distress in Systemic Sclerosis: An Update from the Scleroderma Patient-centered Intervention Network (SPIN). 3rd Systemic Sclerosis World Congress, Rome, Italy, February 2014. 57. Kwakkenbos L, Jewett LR, Thombs BD. An international collaboration to conduct large-scale trials of non-pharmacological interventions in scleroderma: the Scleroderma Patient-centered Intervention Network (SPIN). 3rd Systemic Sclerosis World Congress, Rome, Italy, February 2014. 58. Kwakkenbos L, Willems LM, Baron M, Hudson, M, van den Ende CHM, Thombs BD, Canadian Scleroderma Research Group. Can scores from English, French and Dutch versions of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) be pooled? An assessment of differential item functioning in patients with systemic sclerosis. 3rd Systemic Sclerosis World Congress, Rome, Italy, February 2014.

Brett D. Thombs, PhD: Curriculum Vitae 48 of 55 59. Coronado-Montoya S, Kwakkenbos L, Thombs BD*. Assessing publication bias in systematic reviews and meta-analyses in the context of small n trials: application of a capture-recapture method. 21st Cochrane Colloquium, Quebec City, Quebec, Canada, September 2013. 60. Levis B, Thombs BD*. The DEPRESsion Screening Data (DEPRESSD) Registry: A protocol for a registry to support individual patient data meta-analyses of the diagnostic accuracy of depression screening tools. 21st Cochrane Colloquium, Quebec City, Quebec, Canada, September 2013. 61. Levis B, Thombs BD*. Addressing bias in estimates of diagnostic accuracy of depression screening tools: A data registry for individual patient data meta-analyses. Preventing Overdiagnosis International Conference, Dartmouth University, Hanover, New Hampshire, USA, September 2013. 62. Razykov I, Delisle VC, El-Baalbaki G, Kwakkenbos L, Thombs BD, Bartlett SJ. Developing an Internet-based intervention for coping with emotions and stress in scleroderma: A qualitative study. Scleroderma Society of Canada 15th Annual Scleroderma Conference, Hamilton, Ontario, Canada, September 2013. 63. Milette K, Mendelson C, Khanna D, Nielson W, Thombs BD. The SPIN self-management program for scleroderma: Learning from personal experiences (a preliminary look). Scleroderma Society of Canada 15th Annual Scleroderma Conference, Hamilton, Ontario, Canada, September 2013. 64. Willems LM, Kwakkenbos L, Leite C, Thombs BD, van den Hoogen FHJ, Maia A, van den Ende CHM. Frequency and impact of disease symptoms experienced by patients with systemic sclerosis: a comparison among five European countries. European League Against Rheumatism 2013 – Annual European Congress of Rheumatology. Madrid, Spain, June 2013. 65. Coronado-Montoya S, Kwakkenbos L, Thombs BD*. Risk of bias in systematic reviews and meta- analyses of psychological interventions due to missing trial data: The case of mindfulness-based therapies. 2013 Canadian Psychological Association Convention, Quebec City, Quebec, Canada, June 2013. 66. Levis B, Burri A, Hudson M, Baron M, Thombs BD*. Canadian Scleroderma Research Group. Comparison of sexual activity and sexual impairment rates between women with systemic sclerosis and women from a general population sample. 2013 Canadian Psychological Association Convention, Quebec City, Quebec, Canada, June 2013. 67. Milette K, Hudson M, Körner A, Baron M, Thombs BD*. Canadian Scleroderma Research Group. Sleep disturbances in systemic sclerosis: Evidence for the role of gastrointestinal symptoms, pain, and pruritus. 2013 Canadian Psychological Association Convention, Quebec City, Quebec, Canada, June 2013. 68. Jewett LR, Razykov I, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Prevalence of current, 12-month, and lifetime depressive disorder among patients with systemic sclerosis. 44th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, April 2013. 69. Delisle VC, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Gender and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian Scleroderma Group Registry. 44th Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada, April 2013. 70. Levis B, Burri A, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. Sexual activity and sexual functioning among women with systemic sclerosis compared to women from a population sample. American College of Rheumatology/Association for Rheumatology Health Professionals Annual Scientific Meeting, Washington, DC, USA, November 2012. 71. Racine M, Thombs BD, Hudson M, Baron M, Nielson WR, Canadian Scleroderma Research Group. Clinical correlates of pain versus itch in scleroderma: An exploratory study. 14th World Congress on Pain, International Association for the Study of Pain, Milan, Italy, August 2012. 72. Milette K, Thombs B*, Hudson M, Baron M. Sleep Disturbances in Scleroderma: Evidence for the Role of Pain and Gastrointestinal Symptoms 120th Annual Convention of the American Psychological Association, Orlando, Florida, USA, August 2012. 73. Roseman M, Bero L, Coyne JC, Lexchin J, Turner E, Thombs BD*. Reporting of conflicts of interest in Cochrane reviews of trials of pharmacological treatments. 19th Cochrane Colloquium, Madrid, Spain, October 2011.

Brett D. Thombs, PhD: Curriculum Vitae 49 of 55 74. Delisle VC, Abbey S, Beck A, Dobson K, Dozois D, Grace S, Stewart D, Ziegelstein R, Thombs B*. The influence of somatic symptoms on Beck Depression Inventory scores in patients hospitalized with an acute coronary syndrome. 119th Annual Convention of the American Psychological Association, Washington D.C., USA, August 2011. 75. Jewett L, Hudson M, Baron M, Thombs B*. Acquired disfigurement from medical illness: Modeling correlates of body image distress among people with scleroderma. 119th Annual Convention of the American Psychological Association, Washington D.C., USA, August 2011. 76. Milette K, Roseman M, Thombs B*. Transparency of outcome reporting and trial registration of randomized controlled trials in top behavioural health journals: A systematic review. 119th Annual Convention of the American Psychological Association, Washington D.C., USA, August 2011. 77. Milette K, Razykov I, Pope J, Hudson M, Motivala S, Baron M, Thombs B*. Clinical correlates of sleep problems in systemic sclerosis: The prominent role of pain. 119th Annual Convention of the American Psychological Association, Washington D.C., USA, August 2011. 78. Arthurs E, Hudson M, Baron M, Thombs BD*. Are French and English versions of the PHQ-9 comparable? An assessment of differential item functioning. 3rd North American Congress of Epidemiology, Montreal, Quebec, Canada. June 2011. 79. Thombs BD*, Arthurs E (presenter), El-Baalbaki G, Meijer A, Ziegelstein RC, Steele R. Risk of Bias from the Inclusion of Already Diagnosed or Treated Patients in Diagnostic Accuracy Studies of Depression Screening Tools. 3rd North American Congress of Epidemiology, Montreal, Quebec, Canada. June 2011. 80. Razykov I, Hudson M, Baron M, Thombs BD*. Screening for suicide in medical patients: Is the PHQ- 9 the Answer? 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada. June 2011. 81. Arthurs E, Hudson M, Baron M, Thombs BD*. Are French and English versions of the PHQ-9 comparable? An assessment of differential item functioning. 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada. June 2011. 82. Jewett LR, Hudson M, Baron M, Thombs BD*. Sociodemographic and disease-related predictors of body image distress among people with scleroderma: Examining acquired disfigurement from a chronic disease. 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada. June 2011. 83. Milette K, Roseman M, Thombs BD*. Transparency of outcome reporting and trial registration of randomized controlled trials in top psychosomatic and behavioural health journals: A systematic review. 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada. June 2011. 84. Zhao Y, Montoro R, Igartua K, Thombs BD*. Who identifies as gay, lesbian, or bisexual among adolescents with same-sex attraction/fantasy or behaviour? 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada. June 2011. 85. Delisle VC, Beck AT, Dobson KS, Dozois DJA, Thombs BD*. Do women really report more somatic symptoms than men? 2011 Canadian Psychological Association Convention, Toronto, Ontario, Canada. June 2011. 86. Delisle VC, Abbey SE, Beck AT, Dobson KS, Dozois DJA, Grace SL, Stewart DE, Ziegelstein RC, Thombs BD*. The influence of somatic symptoms on BDI versus BDI-II scores in patients hospitalized following myocardial infarction. National Student Conference of the Canadian Society of Epidemiology and Biostatistics, Montreal, Quebec, Canada. June 2011. 87. Levis B, Hudson M, Knafo R, Baron M, Thombs BD, Nielson WR, Hill M, Canadian Scleroderma Research Group. Sexual activity and impairment among female scleroderma patients. Laurentian Conference of Rheumatology. Mont-Tremblant, Quebec, Canada. May 2011. 88. Razykov I, Hudson M, Baron M, Thombs B*. Development and validation of a pruritus measure in patients with systemic sclerosis. Canadian Rheumatology Association Annual Meeting, Cancun, Mexico, February 2011. 89. Roseman M, Milette K, Bero L, Coyne JC, Lexchin J, Turner E, Thombs BD*. Hidden conflicts of interest in meta-analyses of pharmacological treatments. Joint Colloquium of the Cochrane & Campbell Collaborations, Keystone, Colorado, USA, October 2010.

Brett D. Thombs, PhD: Curriculum Vitae 50 of 55 90. Milette K, Roseman M, Thombs BD*. Transparency of outcome reporting in behavioral health research: A systematic review. XXVIII European Conference on Psychosomatic Research. Innsbruck, Austria, June 2010. 91. Milette K, Roseman M, Thombs BD*. Transparency of outcome reporting in behavioral health research: A systematic review. 8th Annual Canadian Cochrane Symposium, Ottawa, Ontario, Canada, May 2010. 92. Razykov I, Thombs BD*, Hudson M, Bassel M, Baron M. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Canadian Rheumatology Association, 2010 Conference, Quebec City, Quebec, Canada, February 2010. 93. Knafo R, Thombs BD*, Wigley F, Haythornthwaite JA. Clinical correlates of sexual impairment in women with systemic sclerosis. Canadian Rheumatology Association, 2010 Conference, Quebec City, Quebec, Canada, February 2010. 94. Jewett LR, Thombs BD*, Hudson M, Heinberg L, Wigley F, Haythornthwaite JA. Measuring body image avoidance in patients with systemic sclerosis. Canadian Rheumatology Association, 2010 Conference, Quebec City, Quebec, Canada, February 2010. 95. Newton E, Schnitzer M, Steele R, Hudson M, Baron M, Thombs BD*, Canadian Scleroderma Research Group. The longitudinal trajectory of depressive symptoms in systemic sclerosis. Canadian Rheumatology Association, 2010 Conference, Quebec City, Quebec, Canada, February 2010. 96. Knafo R, Thombs BD*, Hudson M, Wigley F, Haythornthwaite JA. Clinical correlates of sexual impairment in women with systemic sclerosis. American College of Rheumatology, 2009 Scientific Meeting, Philadelphia, Pennsylvania, USA, October 2009. 97. Zhao Y, Thombs BD*, Montoro R, Igartua K. Risk of mental health problems among non- heterosexual identified adolescents: What about adolescents who are unsure of their sexual identity? 2009 Canadian Psychological Association Convention, Montreal, Quebec, Canada, June 2009. 98. Magyar-Russell G, Cai JX, Thombs BD, Bavja T, Singh PP, Kuhl E, Amin N, Marine J, Ziegelstein RC. Prevalence of anxiety and depression in patients with implantable cardioverter defibrillators: A systematic review of the literature. American Psychosomatic Society, 67th Annual Scientific Meeting, Chicago, Illinois, USA, March 2009. 99. Schieir O, Thombs BD*, Bernatsky S, Hudson M, Boivin J-F, Hanley J, Taillefer S, Canadian Scleroderma Research Group, Baron M. Pain is associated with higher physician use in patients with systemic sclerosis. American College of Rheumatology, 2008 Scientific Meeting, San Francisco, California, USA, October 2008. 100. Schieir O, Thombs BD*, Hudson M, Bernatsky S, Boivin J-F, Hanley J, Canadian Scleroderma Research Group, Baron M. Clinical signs and symptoms associated with global pain among patients with limited and diffuse scleroderma. American College of Rheumatology, 2008 Scientific Meeting, San Francisco, California, USA, October 2008. 101. Schieir O, Thombs BD*, Hudson M, Boivin JF, Hanley J, Taillefer S, Canadian Scleroderma Research Group, Baron M. “Where does it hurt? Patient characteristics and clinical signs & symptoms associated with global pain in SSc. 2nd Annual Scientific Meeting of the Canadian Scleroderma Research Group, Ottawa, Ontario, Canada, September 2008. 102. Adeponle AB, Thombs BD*, Adelekan ML, Kirmayer LJ. Family participation in treatment and post-discharge appointment and medication adherence at a Nigerian psychiatric hospital. Society for the Study of Psychiatry and Culture, 2008 Conference, San Diego, California, USA, June 2008. 103. Thombs BD*, Hudson M, Taillefer S, Canadian Scleroderma Research Group, Baron M. Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Canadian Rheumatology Association, 2008 Annual Meeting, Mont Tremblant, Quebec, Canada, March 2008. 104. Thombs BD*, Bassel M, Hudson M, Taillefer S, Canadian Scleroderma Research Group, Baron M. Sociodemographic and clinical correlates of fatigue in patients with systemic sclerosis: Evidence from 482 Canadian Scleroderma Research Group Registry patients. Canadian Rheumatology Association, 2008 Annual Meeting, Mont Tremblant, Quebec, Canada, March 2008. 105. Schieir O, Thombs BD*, Hudson M, Taillefer S, Canadian Scleroderma Research Group, Baron M. Socio-demographic and clinical correlates of pain in patients with systemic sclerosis. Canadian Rheumatology Association, 2008 Annual Meeting, Mont Tremblant, Quebec, Canada, March 2008.

Brett D. Thombs, PhD: Curriculum Vitae 51 of 55 106. Hudson M, Thombs BD, Fritzler M, Bernstein J, Canadian Scleroderma Research Group, Baron M. Gender differences in antibody expression in systemic sclerosis. Canadian Rheumatology Association, 2008 Annual Meeting, Mont Tremblant, Quebec, Canada, March 2008. 107. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Canadian Scleroderma Research Group, Baron M. Quality of life in systematic sclerosis compared to the general population and patients with other chronic conditions. Canadian Rheumatology Association, 2008 Annual Meeting, Mont Tremblant, Quebec, Canada, March 2008. 108. Bhat U, Parakh K, Thombs BD, Fauerbach JA, Bush DE, Ziegelstein RC. Baseline physical function is an independent predictor of long-term mortality after myocardial infarction: A ten-year study. American Heart Association, 2007 Scientific Sessions, Orlando, Florida, USA, November 2007. 109. Hudson M, Thombs BD, Canadian Scleroderma Research Group, Baron M. Time to diagnosis in systemic sclerosis: Is gender a factor? American College of Rheumatology, 2007 Scientific Meeting, Boston, Massachussetts, USA, November 2007. 110. Thombs BD*, Hudson M, Taillefer SS, Canadian Scleroderma Research Group, Baron M. Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. American College of Rheumatology, 2007 Scientific Meeting, Boston, Massachussetts, USA, November 2007. 111. Thombs BD*, Ziegelstein RC, Stewart DE, Abbey SE, Grace SL. Both depression and self-rated physical health during hospitalization for an acute coronary syndrome predict mortality one year later. 15th European Congress of Psychiatry, Madrid, Spain, March 2007. Eur Psychiatry. 2007;22(1 Suppl):S249. 112. Thombs BD*, Ziegelstein RC, Stewart DE, Abbey SE, Grace SL. Depression during hospitalization for an acute coronary syndrome predicts physical function one year later. 15th European Congress of Psychiatry, Madrid, Spain, March 2007. Eur Psychiatry. 2007;22(1 Suppl):S249. 113. Thombs BD*, Ziegelstein RC, Stewart DE, Abbey SE, Grace SL. Comorbid anxiety and depression during hospitalization for an acute coronary syndrome increase risk of mortality one year later. 15th European Congress of Psychiatry, Madrid, Spain, March 2007. Eur Psychiatry. 2007;22(1 Suppl):S290. 114. Bresnick MG, Thombs BD*. Self-Inflicted burn injury: Patient characteristics, mortality and length of hospital stay in a national sample of 30,382 adult patients. Amer Burn Assoc, 39th Annual Meeting, San Diego, California, USA, April 2007. 115. Thombs BD*, Price LA, Milner SM. Liver Disease in burn injury: Evidence from a national sample of 30,382 adult patients. Amer Burn Assoc, 39th Annual Meeting, San Diego, California, USA, April 2007. 116. Spence RJ, Thombs BD, Haines J. Burns below the knee. An indication for hospitalization. Amer Burn Assoc, 39th Annual Meeting, San Diego, California, USA, April 2007. 117. Cockrell GY, Thombs BD. Assessing demographics and outcomes related to catastrophic skin diseases: Shortcomings in extant data collection methods. Proc Amer Burn Assoc, 38th Annual Meeting, Las Vegas, Nevada, USA, April 2006. J Burn Care Res. 2006;27(2 Suppl):S156. 118. Alvarez W, Ziegelstein RC, Meuchel J, Thombs BD, Latif M, Dasgupta N. (October, 2005). SSRI use in acute coronary syndromes: Effect on major adverse cardiac events and bleeding complications. American College of Clinical Pharmacy 2005 Annual Meeting, San Francisco California, USA, October 2005. Pharmacotherapy. 2005;25:1444. 119. Ortega A, Torres L, DiMaggio A, Strong W, Hanson K, Thombs BD*. Body appearance satisfaction in female college students: Comparing graduates of coeducational and single-sex high schools across ethnicity. Eastern Psychological Association, 2003 Annual Meeting, Baltimore Maryland, USA, March 2003. [Mentored undergraduate course project].

G.4. Selected Media Coverage G.4.1. International - A seal of approval for clinical treatments, Association for Psychological Science Observer, July/August 2015.

Brett D. Thombs, PhD: Curriculum Vitae 52 of 55 - 2013 ACR/ARHP Annual Meeting: health professionals in the spotlight, The Rheumatologist, January 2014. - International collaboration working to improve the lives of those living with scleroderma, Scleroderma Voice (The member magazine of the Scleroderma Foundation), Fall 2013. - Depression screening in patients with cardiac disease, BMJ Evidence-based Nursing Podcasts, April 15, 2013. - Is big pharma getting too much flak? Reuters, Baltimore Sun, Chicago Tribune, September 18, 2012. - In Session with Brett D. Thombs, PhD: Is screening for depression in primary care actually beneficial? Psychiatry Weekly, Volume 6, Number 27, November 28, 2011. - It’s time to rebuild the evidence base: With medical science so contaminated by conflicts of interest, what evidence can we trust? Ray Moynihan, BMJ, 2011;342:d3004. - Pooled trials drowning in conflict-of-interest oversights, Nazlie Latefi, Nature Medicine, 2011;17:400- 401. - Radio broadcast interview: (Suicide risk among lesbian, gay, bisexual and transgender youth). Voice of America, April 20, 2011. - Suicide risk may be lower for gays, lesbians in ‘supportive’ areas, Los Angeles Times, April 18, 2011 - Bias creeps into meta-studies: US medical journal, Agence France Press, March 8, 2011. - Influential research misses financial conflicts, Reuters, Hartford Courant, Chicago Tribune, March 8, 2011 - Major drug review research fails to disclose funding sources, Health Day News Report, U.S. News & World Report, Bloomberg Businessweek, MSN Health, March 8, 2011. - Scientists Often Ignore Financial Conflicts When Reviewing Drugs, Study Finds, AOL Health, March 9, 2011. - Gay, lesbian, bisexual higher suicide risk, United Press International, February 8, 2010. - Teens who self-identify as gay, lesbian, at suicide risk, Times of India, February 7, 2010. - Will treating depression treat heart disease? Wall Street Journal, September 8, 2009. - Researchers debate universal depression screening in cardiac patients, American Psychiatry News, February, 2009. - Depression and cardiovascular disease: A need for increased awareness, Journal Watch Cardiology, 2008:3-3. - Call for depression screening of heart patients is premature, The Johns Hopkins University Gazette, Baltimore, Maryland, USA, December 15, 2008. - Depressionen und Infarktrisiko: Das herz im griff der seele [Depression and risk of infarct: The heart in the hands of the soul], Frankfurter Allgemeine Zeitung, Germany, December 10, 2008. - CVD depression screening set to stay in QOF despite new evidence, Pulse, United Kingdom, November 17, 2008. - American Heart Association urges screening cardiac patients for depression, Baltimore Sun, Baltimore, Maryland, USA, November 17, 2008. - A heart-and-mind link; In cardiac cases, depression can hurt recovery. Now there’s a push for screening, Los Angeles Times, Los Angeles, California, USA, November 17, 2008. - Test burdensome: Cardiologists may ignore depression, Arab Times, Kuwait, November 13, 2008. - Routine depression screening, The Times, Malta, November 13, 2008. - Depression and heart link questioned, United Press International, November 13, 2008. - Screening heart patients for depression doesn’t help, says study, Asian News International, November 12, 2008. - Depressed? Your cardiologist might not ask, Reuters, November 12, 2008. - Screening heart patients for depression not effective: McGill, Johns Hopkins study; American Heart Association call for routine screening ‘premature,’ scientists say, Ascribe News, November 11, 2008. - Study questions screening heart attack patients for depression: International experts say there isn’t enough evidence to prove its value, U.S. News & World Report, November 11, 2008. - Study questions screening heart attack patients for depression, Washington Post, Washington, DC, November 11, 2008. - Persistent depression after heart trouble harmful, Reuters, February 5, 2008.

Brett D. Thombs, PhD: Curriculum Vitae 53 of 55 - Increased depression help needed for burns patients, Expert Review of Dermatology, 2(1), February, 2007. - Burn patients need more help coping with depression, Health Behavior News Service, January 15, 2007. - Many burn patients experience depression, United Press International, January 11, 2007.

G.4.2. National/Local - Adults overdiagnosed, overprescribed for ADD/ADHD? CJAD News, August 1, 2015. - Explosion de diagnostics du TDAH chez l’adulte, Le Devoir, July 25, 2015. - Radio talk show (10 minute segment): (Is adult ADHD being overdiagnosed?). The Ed Hand Show, 1310 News, Ottawa, Ontario, July 27, 2015. - Radio talk show (20 minute segment): (Is adult ADHD being overdiagnosed?). Kingkade & Breakenridge Show, News Talk 770, Calgary, Alberta, July 28, 2015. - Emerging Stars, McGill Headway, Spring 2015. - Television Interview: Doctors and obesity: Encouraging weight loss has little benefit, new Canadian guidelines acknowledge, CBC News: The National, January 26, 2015. - Outstanding emerging researchers get new Principal’s Prize, McGill Reporter, May 27, 2014. - Fuzziness in funding, McGill News, Fall/Winter 2012. - Impossible de se fier aux revues systématiques sur les médicaments, déclarent des chercheurs québécois, L’actualité médicale, October 10, 2012. - ‘Critical information’ from drug trials kept from doctors and patients: study, Montreal Gazette, August 22, 2012. - Santé mentale des jeunes: le fédéral finance trois projets de recherche, Profession Santé, February 15, 2012. - Patients cancéreux: le dépistage de la dépression causerait plus de tort que de bien, Profession Santé, November 15, 2011. - Radio talk show (15 minute segment): (Rethinking recommendations for depression screening in primary care). The Rutherford Show. Airs on multiple stations across Alberta, Canada, September 16, 2011. - Radio talk show (30 minute segment): (Risk of bias from inclusion of patients who already have diagnosis of or are undergoing treatment for depression in diagnostic accuracy studies of screening tools for depression: systematic review). The Rutherford Show. Airs on multiple stations across Alberta, Canada, August 22, 2011. - Radio talk show (30 minute segment): (Risk of bias from inclusion of patients who already have diagnosis of or are undergoing treatment for depression in diagnostic accuracy studies of screening tools for depression: systematic review). Tommy Schnurmacher Show, CJAD Radio, Montreal, Quebec, August 19, 2011. - Des tests peu fiables pour dépister la depression. Le Devoir (front page), August 19, 2011. - Radio broadcast interview: (Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments). HealthBeat, CJAD Radio, Montreal, Quebec, March 13, 2011. - Médicaments – Qui finance les essays cliniques? Les liens entre les chercheurs et l’industrie phamaceutique sont rarement relevés dans les publications médicales. Le Devoir, March 9, 2011. - Sponsorship biases keep MDs in the dark: Conflicts of interest between researchers, pharmaceutical firms not fully disclosed, Vancouver Sun, March 9, 2011. - Medical studies affected by funding, study finds, Montreal Gazette, March 9, 2011. - Hidden hand can influence doctor's decisions: Researcher-drug company links may lead to conflict of interest, Victoria Times Colonist, March 9, 2011. - Undisclosed funding sources raise issue of bias in medical studies: Report, Vancouver Province, Edmonton Journal, Regina Leader-Post, Saskatoon StarPhoenix, Windsor Star, Ottawa Citizen, Calgary Herald, March 9, 2011. - Les études sur les médicaments devraient mentionner leur source de financement, La Presse Canadienne, March 9, 2011. - Medical journals still publishing studies that fail to reveal funding: study, Globe and Mail, March 10, 2011. - The investigation of conflicts of interest, McGill Daily, April 4, 2011.

Brett D. Thombs, PhD: Curriculum Vitae 54 of 55 - Radio broadcast interview: (Sexual orientation and risk of suicide ideation and attempt). Health on Earth, CKUT, Montreal, Quebec, May 11, 2010. - The Award for Excellence in Psychological or Clinical Research, Pulse, Jewish General Hospital, Montreal, Quebec, Winter 2011. - Sexual identity and teen suicide: A deeper look at a groundbreaking McGill study on the connections between the two, The McGill Daily, Montreal, Quebec, April 2, 2010. - Suicide risk in gay and lesbian teens: Self-identity is critical say researchers, JGH News, Jewish General Hospital, Montreal, Quebec, Spring 2010. - Radio news: (Sexual orientation and risk of suicide ideation and attempt). Radio Canada International, February 16, 2010. - Gay teenagers more likely to think about suicide: study, National Post, Vancouver Sun, February 11, 2010. - Gay teens’ suicide risk higher: Montreal study; Homophobia to blame, McGill researchers say, Montreal Gazette (front page), February 12, 2010. - La perception de l’identité sexuelle favorise les idées suicidaires, La Presse Canadienne, February 5, 2010. - Vivre mieux avec la sclérodermie, Découvrir: La Revue de la Recherche de L’ACFAS, 2009;Mars- Avril:14-15. - Evidence lacking for mass screening of heart patients for depression: study; Basic questions from cardiologists would find that about a third of patients screen positive for depression according to researcher, The Times – Transcript, Moncton, New Brunswick, Canada, November 15, 2008. - Screening all heart patients for depression not seen as especially useful, says study, Prince George Citizen, Prince George, British Columbia, Canada, November 13, 2008. - Screening little benefit for patients, Nanaimo Daily News, Nanaimo, British Columbia, November 12, 2008. - Depression test too imprecise, Leader Post, Regina, Saskatchewan, November 12, 2008. - Depression screening little benefit for heart patients, Alberni Valley Times, Port Alberni, British Columbia, November 12, 2008. - No evidence heart patients need to be screened for depression: study, National Post, Don Mills, Ontario, November 12, 2008. - Depression screening does not help heart patients: Researcher, Vancouver Sun, Vancouver, BC, November 12, 2008. - No reason to screen all heart patients for depression, The Canadian Press, November 12, 2008. - Depression tests are inexact tools: study, Montreal Gazette, Montreal, QC, November 12, 2008. - Radio broadcast interview: (Depression screening in cardiovascular care). The World at Six, Canadian Broadcasting Corporation, November 12, 2008.

G.5. Coverage of Research in Books for the Lay Public - Cassels A. Seeking sickness: Medical screening and the misguided hunt for disease. Greystone Books, 2012, pp. 81-83.

Brett D. Thombs, PhD: Curriculum Vitae 55 of 55